A shekara ta 2000, an yi wa mutane kusan miliyan uku da suka mutu a bara.
Kuma wannan shine yadda yakamata a bi da duk wani ciwon kirji, musamman a shekarunku.
Kuma yana da zazzabi.
Kuma ya kamata a gwada yawan cholesterol da kake da shi a cikin jini.
Kuma yanzu kana da zazzabi a wannan lokaci?
Shin kuna da wannan ciwon kirji yanzu?
Kuma kana da matsalar numfashi.
Kuma za ku iya gaya mani waɗanne alamun da kuke da su a wannan batun?
Kuma yaya zazzabi ya kasance
Kuma ina da salma
Kuma ina da ɗan zazzaɓi da tari.
Kuma a yau ina da ciwon kirji mai tsanani.
Kuma yanzu ne lokacin da ya dace a gare ku, zazzabi mai zafi.
Kuma ya sãmi wani ciwon kirji
Kuma ina jin kamar ina da zazzabi.
Kuma ina so ku bayyana mini abin da ciwon kirji yake da shi.
Kuma suna da zazzabi.
Kuma kuna da tarihin ciwon sukari.
Kuma kun san cewa, kamar yadda na ji kamar kirji na ya fashe
Kuma sun san cewa mutane suna yi mini ba'a koyaushe.
Kuma a yanzu kuna jin ciwon kirji.
Kuma ya ce wannan matsin lamba ne a kirjinka.
Ko da akwai wani a cikin iyalinka da ke da ciwon zuciya, ciwon zuciya, bugun zuciya, hawan cholesterol, da kuma hawan jini
Shin akwai wasu alamun ko matsaloli da kuka lura da su da suka shafi ciwon tsoka?
Shin akwai wasu da suke da irin wannan ciwo a gida?
Shin kuna da wasu alamun bayyanar cututtuka?
Ya kamata ka yi amfani da kowane irin maganin numfashi?
Har ila kana da ciwon kirji
Domin wannan shine lokacin mura.
Amma bai kamata mu manta da ciwon zuciya da kuma ciwon kirji ba.
Amma yanzu, matsalar da ta fi tsanani ita ce ciwon kirji.
Amma ina da matsalar numfashi.
Amma na san cewa mutane da yawa za su yi watsi da ni.
Amma dole ne mu kula da kowace ciwon kirji da hankali.
Amma yanzu suna numfashi da kyau, ko ba haka ba?
Na manta da shi sosai saboda ciwon kirji.
Kamar dai wani yana matsa maka kirji ne.
Har ila kana jin ka ƙyale numfashi ya yi maka wuya
Shin suna nuna irin wannan yanayin?
Shin kana da hawan jini ko kuma wata cuta mai tsanani?
Shin kana da wata cuta mai tsanani, kamar ciwon sukari?
Shin akwai wani nau'i na numfashi da ke da ciwon kirji?
Shin kana da hawan jini?
Kuna da takunkumin numfashi da ke tare da shi?
Shin sun san alamun da take nunawa?
Ka ga hoton?
Ka sha ruwa mai yawa a yau
Amma na samu ciwon sukari
Amma, tana da alamun da suka yi kama da nawa.
Yaya girman harbin da kake yi?
Yaya Matsayin Jininka Yake?
Idan zazzabin ya ci gaba
Idan kana da zazzabi mai yawan dari biyu ko fiye
Idan kana ganin alamun ka da kuma matsalolin ka suna bukatar ƙarin tabbaci
Na ji zafin rana jiya
Ina da zazzabi kaɗan
Na yi zazzabi jiya
Ina da ciwo mai tsanani a nan a kirji
Ina da ciwon numfashi kuma
Zan aiko muku da hoto.
Ina da ɗan ciwon kirji a yau
Ina da ciwon kai da zazzabi a yau
A ganina, ciwon zazzabi ne
A ganina, wannan zazzabi ne mai sauƙi.
Shin mutum mai tsanani yana kama da wanda ke zaune a ƙirjinka?
A lokacin da na soma ciwon kai da zazzabi, sai na soma jin ciwon.
Ina da ciwo a tsakiyar kirji
Kamar ciwon kirji, yana da matsi
Ina da shi a cikin zuciyata
A tsakanin kirjina
A tsakiyar kirji
Ina jin ciwon ciki
Ina da wannan ciwon kirji mai ban tsoro.
Ina so ku bayyana mini wannan ciwon kirji.
Wasu suna da ciwon sukari, wasu kuma suna da ciwon jini.
Ina da ƙuƙwalwa a cikin ƙuƙumma.
Yanzu za ka iya samun tachipirina mai ɗanɗano don dafa abinci
Yanzu Mary, kwana nawa ne tun da ka fara ganin wadannan alamu
Yanzu ya ce kana da ciwon kirji
Ina jin ciwon kirji a wasu lokatai
To, kuna da alamun da ke tare da wannan, sai dai rashin lafiya.
Ko kuma ji kamar wani yana zaune a kirjinka?
Yana kama da ciwon kai da ciwon tsoka da ciwon huhu da kuma ciwon huhu.
Ina da 'yanci na yi wa kaina wa'azi.
Ka nuna mini hoton da ke nuna yadda kake ji.
Idan kana da zazzabi
Saboda haka, kana ganin wasu cikin waɗannan alamun suna da alaƙa da yin ciki?
Shin yaranku suna nuna irin wannan alamar?
Ka gaya mini game da ciwon ƙirjinka
A lokacin da ake yin sanyi, zafin jiki yana ƙaruwa
Na yi ciwon zazzabi na kwana biyu da suka shige
A daren jiya, zazzabi ya fara ƙaruwa
Wannan likita ne mai suna Porter, daga sashen gaggawa na Triadge Center.
Za ku iya gaya mani kadan game da ciwon kirjinku?
Yanzu, na ji ciwo a cikin kirji a gaban jiki na.
Sai na ji ciwon kirji sosai.
To, idan na kasance a cikin ƙirjina,
Wane irin ciwo ne ke damun ki?
Yaushe ne wannan ciwon kirji ya fara?
A ina ne kake jin zafi a kirjinka?
Wannan shi ne abin da ke sa ka ji ciwon kirji
Za ka ji kamar ƙirjinka ya yi ƙarfi
Sun san cewa ina da ciwon sukari da dai sauransu, ko ba haka ba?
Ya ce kana da wannan ciwon kirji
A tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020, yawan masu kamuwa da cutar coronavirus (COVID-19) ya karu cikin sauri a Tarayyar Turai/Yankin Tattalin Arzikin Turai.
Adadin masu kamuwa da cutar coronavirus (COVID-19) na nuna irin wannan yanayin a cikin EU / EU Economic Area da Burtaniya, wanda ke tabbatar da cewa cutar ta COVID-19 ta duniya tana yaduwa cikin sauri a duk ƙasashe, duk da cewa ta bambanta a ƙasa.
Bisa ga kwarewar da aka samu daga Italiya, ƙasashe, asibitoci da sassan kulawa mai zurfi suna buƙatar haɓaka shirye-shiryen su don kula da lafiyarsu, musamman ma yawan marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa mai zurfi.
A ranar 31 ga Disamba, 2019, an samu rahoton wasu cututtukan sambab da ba a san dalilin su ba a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta ba da rahoton cewa sabon kwayar cutar coronavirus ce ke haifar da cutar, wanda ake kira da cutar coronavirus mai saurin kamuwa da cuta 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an sake masa suna da cutar coronavirus (COVID-19).
Shaida ta nuna cewa kashi 80% na marasa lafiya da ke dauke da COVID-19 suna da ƙananan cututtuka, wato, kamuwa da numfashi tare da kumburi ko kuma ba tare da kumburi ba, kuma mafi yawansu suna murmurewa.
Kashi 14% na masu cutar kansa suna ci gaba zuwa mafi munin COVID-19 wanda ke buƙatar asibiti, kuma sauran kashi 6% na masu cutar suna fuskantar mummunan yanayin da ke buƙatar kulawa mai ƙarfi.
Kashi 4% na marasa lafiya da ke asibiti sun mutu saboda COVID-19.
A cikin wannan binciken, mun kimanta yanayin COVID-19 a cikin kowace EU / Yankin Tattalin Arzikin Turai da Burtaniya (UK) tare da lardin Hubei na China.
Mun kwatanta adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da Burtaniya da kuma Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Al'amuran COVID-19 a Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya
COVID-19 ya ci gaba da yaduwa daga China zuwa wasu yankuna na duniya, kuma cutar ta COVID-19 ta kasance ta fi yawa a duniya.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba ta duniya.
Spiteri et al., a cikin Eurosurveillance 2020, wanda aka buga a ranar 5 ga Maris, sun ba da rahoton farkon tabbatar da shari'o'in COVID-19 na Turai bisa ga ma'anar WHO.
A cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai, Faransa ce ta fara bayar da rahoton mutane uku da aka tabbatar da cutar a ranar 24 ga Janairu, 2020, wadanda suka fito daga Wuhan, lardin Hubei, China.
Ya zuwa ranar 15 ga Maris, 2020, an samu sabbin cututtukan COVID-19 a duk kasashe 30 na Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya, tare da samun mutum 39,768 da suka kamu da cutar da kuma mutuwar mutane 1,727 daga 31 ga Disamba, 2020, wanda 17,750 daga cikinsu da kuma mutuwar mutane 1,441 sun fito ne daga Italiya kadai.
Sanin jimillar adadin masu cutar COVID-19 da kuma yawan abin da ya faru
Bayanai na lambobin COVID-19 a kowace ƙasa ta duniya, kamar yadda Cibiyar Kula da Cututtuka da Kula da Cututtuka ta Turai (ECDC) ta bayyana, ana samun su ne kawai daga tushen hukuma kamar su ofisoshin ma'aikatar lafiya, hukumomin kiwon lafiya na ƙasa da na yanki, da WHO, wanda ke sabuntawa kowace rana da karfe 8:00 na safe.
An yi amfani da waɗannan bayanan don kimanta yanayin COVID-19 a cikin EU / EEA da Burtaniya da kuma kwatanta su da Italiya.
A matsayin wakilin adadin masu cutar COVID-19, mun sanya adadin COVID-19 a matsayin babban abin da ya faru na kwanaki 14, saboda haka muna la'akari da yanayin COVID-19 a cikin kowace EU / EEA da Burtaniya daga Janairu 1 zuwa Maris 15, 2020.
Bugu da kari, mun kwatanta adadin wadanda suka kamu da cutar a kowace kasa har zuwa karfe 8:00 na safiyar ranar 15 ga Maris, 2020 da na Italiya daga ranar 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya
Yanayin shari'o'in COVID-19 a cikin EU / EEA da Burtaniya a cikin kwanaki 14 na jimlar lokaci an bi shi a lardin Hubei (China) gaba ɗaya (Hoto 1).
Ga EU/EEA da Burtaniya gabaɗaya, adadin COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu, sannan ya ƙaru sosai a ranar 28 ga Fabrairu, 2020 (kayan aiki).
Wannan ya samo asali ne daga karuwar gaggawa a cikin shari'o'in da aka ruwaito daga Italiya, amma, sauran ƙasashen EU / EEA da Burtaniya sun nuna irin wannan yanayin karuwa a cikin adadin COVID-19 (kayan aiki).
Hoto na 2 ya nuna jimillar adadin masu kamuwa da cutar COVID-19 a Tarayyar Turai/Ƙasashen Tattalin Arzikin Turai da Burtaniya idan aka kwatanta da Italiya daga Janairu 31-Maris 15, 2020.
Ya zuwa ranar 15 ga Maris da karfe 8:00 na safe, wasu kasashe 15 na Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya sun sami adadin adadin masu kamuwa da cutar da ya yi daidai da na Italiya a makonni 3 da suka gabata ko kasa da haka.
Sakamakonmu ya nuna cewa adadin masu cutar COVID-19 da aka ruwaito sun karu cikin sauri a Tarayyar Turai/Yankin Tattalin Arzikin Turai da Burtaniya.
Yanayin yanayin COVID-19 a duk duniya ya nuna cewa annobar ta duniya tana ƙaruwa a kusan kowace ƙasa.
Wannan yana faruwa ne yayin da kasashe ke cikin matakai daban-daban, da bambance-bambance a cikin martani na kiwon lafiyar jama'a na ƙasa, da ma ma ma'anar shari'o'i daban-daban da ladabi daban-daban a cikin ƙasashe daban-daban don zaɓar marasa lafiya waɗanda za a iya gwada su don gano COVID-19.
A farkon watan Maris na 2020, likitoci a jihohin Italiya da ke fama da cutar sun bayyana cewa kashi 10% na marasa lafiya na COVID-19 suna buƙatar kulawa mai tsanani, kuma majiyoyin kafofin watsa labarai sun ba da rahoton cewa asibitoci da ɗakunan kulawa mai mahimmanci a waɗannan jihohin sun isa matakin kulawa.
A halin yanzu, akwai bayanai game da shari'o'in COVID-19 da ake bi da su a asibitoci da / ko sashen kula da kulawa mai zurfi na EU / Yankin Tattalin Arzikin Turai don kashi 6% da 1% na shari'o'in bi da bi (ba a nuna bayanan ba).
"Amma, dole ne a tattara su a hankali don ƙarfafa bayanan sa ido na yau da kullun, wanda ke mai da hankali kan adadin waɗanda aka ruwaito da kuma adadin mutuwar".
Wani bincike da aka yi a shekara ta 2010-11 ya nuna cewa a Turai, akwai bambanci sosai tsakanin gado mai kula da lafiyar jiki da na al'ada, daga gado 29.2 a Jamus ga mutane 100,000 zuwa 4.2 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da wadatar fiye da Italiya (12.5 na kulawar kulawa da kulawa ta tsakiya don mutane 100,000, a cikin 2010).
Yanayin samfurin da ya shafi haɗin ƙarfin tallafi na kiwon lafiya wanda ke haifar da haɗarin sama da 90 a cikin ɗakunan marasa lafiya masu tsanani, ƙididdigar yaduwar COVID da aka gano a cikin masauki a kowace ƙasar EU / EEA da Burtaniya, an gabatar da su a cikin sabon bita na shida na ECDC na COVID-19.
Saboda yawan masu cutar a cikin EU/EEA da kuma Burtaniya, kuma asibitoci da dakunan kula da marasa lafiya na musamman suna ba da sabis ga wasu rukunin jama'a, ya kamata a bayyana bayanai game da masu cutar da gadajen kula da marasa lafiya a matakin NUTS-2.
Kwarewar da aka samu daga Italiya da sauran abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa annobar COVID-19 ta duniya tana saurin yaduwa a cikin EU / Yankin Tattalin Arzikin Turai da Burtaniya.
Saboda haka, ƙasashe, asibitoci da sassan kulawa na gaggawa suna buƙatar shirya don ci gaba da yaduwar SARS-CoV-2 a cikin al'ummomi da kuma karuwar adadin marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa ta musamman, misali a yankunan Italiya da cutar ta shafa.
A cikin wani bincike na ECDC na kwanan nan, an nuna cewa, hanzarin da kuma cikakkiyar hanyar rage yaduwar SARS-COV-2 yana da mahimmanci, daga kiyaye cutar zuwa ragewa, saboda saurin karuwar adadin masu cutar da ake tsammanin zai faru idan ba a aiwatar da shi ba da wuri ba, ba zai ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, yarda da daidaitawa ba.
Binciken hadari na gaggawa zai iyakance matakan kiwon lafiyar al'umma, wanda aka tsara don rage tasirin cutar ta duniya.
Kasashe ba su da damar kara kokarin da suke yi na hana yaduwar cutar SARS-CoV-2 da kuma rage nauyin da ke tattare da kula da lafiya.
In ba haka ba, tsarin kiwon lafiya na sauran ƙasashen EU / EEA zai cika da marasa lafiya da ke buƙatar kulawa ta likita a cikin kwanaki ko makonni masu zuwa.
Cutar kwayar cutar korona ta 2019 (COVID-19) ta barke a matsayin annoba da ta haifar da cutar SARS, cutar coronavirus 2 (SARS-CoV-2), wacce ta riga ta shafi mutane sama da 80,000 a China da sauran kasashen duniya, inda ta yi sanadiyar mutuwar mutane sama da 3,000.
Kamar SARS-CoV, wanda ya haifar da cutar SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya yaduwa ta hanyar tsuntsaye kuma yana haifar da alamun cutar.
Koyaya, COVID-19 yana da ƙarancin nauyi da ƙimar mutuwa fiye da SARS, amma yawan kamuwa da cuta ya fi girma kuma yana shafar tsofaffi maza fiye da matasa da mata.
A yayin da ake wallafa labarai masu yawa game da sabon cutar, wannan labarin zai yi ƙoƙari ya ba da cikakken bayani game da aikin bincike mai saurin girma.
Muna rufe mahimman batutuwa game da cutar, ilimin halittu, ilimin ƙwayoyin cuta, ganowa, magani da rigakafi.
"Duk da cewa har yanzu akwai tambayoyi da yawa da za a amsa, muna fatan wannan binciken zai taimaka wajen fahimtar cutar da kuma kawar da ita".
Bikin bazara na ranar 25 ga Janairu, 2020 ya kasance abin tunawa ga duk Sinawa, saboda sabon cutar da ke haifar da kwayar cutar, inda aka gargadi Sinawa da su zauna a gidajensu a lokacin bikin da kuma bayan bikin.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (COVID) da ta haifar da cutar rashin numfashi mai tsanani a shekarar 2003, don haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sanya mata suna SARS-CoV-2, kuma ta sanya sunan cutar da ke da nasaba da ita, COVID-19.
Cutar ta fara ne a Wuhan, China, kuma ta bazu cikin sauri a duk faɗin ƙasar, ta kai kusan ƙasashe 50 na duniya.
Ya zuwa ranar 2 ga Maris, 2020, adadin mutanen da suka kamu da cutar COVID-19 ya karu da 80,000, kuma sama da marasa lafiya 40,000 aka sallame su daga asibiti, kuma sama da 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 shine babban makiyin jama'a kuma yana da damar yin illa fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu tun fitowar rahoton farko a ranar 7 ga Janairu, 2020, an buga sama da labarai 200 game da COVID-19, gami da ilimin ƙwayoyin cuta, ilimin cututtukan cuta, ilimin cututtukan cuta, da magani, waɗanda suka ƙaddara jerin ƙwayoyin cuta da aka ware daga marasa lafiya daban-daban.
Wannan binciken yana ƙoƙarin taƙaita sakamakon bincike a cikin sabon batun bincike mai saurin canzawa.
A duk inda zai yiwu, za mu gwada COVID-19 da SARS da kuma wani cuta mai haifar da COVID, ciwon mara na numfashi na Gabas ta Tsakiya (MERS, annoba ta 2012).
Za mu tattauna abin da muka koya game da rigakafin cutar da kuma tarihin cutar, da kuma wasu sauran tambayoyi masu gaggawa.
CoVs, waɗanda galibi ba a ɗauka su ne masu cutar da ke haifar da mutuwa a cikin mutane, sune babban dalilin kusan kashi 15% na mura 4.
Koyaya, mun sami manyan CoVs masu haifar da cuta sau biyu a wannan karni (SARS-CoV da MERS-CoV); waɗannan ƙwayoyin cuta sun fara bayyana a cikin 2003 a China da 2012 a Saudi Arabiya, sannan suka bazu cikin sauri zuwa wasu ƙasashe da yawa, suna haifar da mummunan rashin lafiya da mutuwar.
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta CoV da aka rubuta a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1, an fara bayar da rahoton cutar sambabbe da ba a san asalinsa ba daga Wuhan zuwa Hukumar Lafiya ta Kasa ta China a ranar 31 ga Disamba, 2019.
An sake sabon COVID bayan kwana bakwai.
A ranar 15 ga Janairu, 2020, an sami mutuwar farko a cikin ruwa.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwan da ke makwabtaka da ita, jihohi da ƙasashe.
A ranar 20 ga watan Janairu, an bayar da rahoton kamuwa da cutar a ma'aikatan kiwon lafiya, wanda ke nuna cewa cutar ta iya yaduwa daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an dakatar da dukkan hanyoyin sufuri na jama'a a birnin Wuhan, kuma an rufe birnin gaba daya.
Binciken farko na asibiti kan cutar a ranar 24 ga Janairu ya nuna cewa daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai ke da hulɗa kai tsaye da kasuwar kiwon teku, inda aka yi imanin cewa asalin kamuwa da cutar daga dabbobi ne.
A ranar 30 ga watan Janairu, WHO ta ayyana annobar a matsayin babbar matsalar lafiya a duniya.
A lokacin da aka shirya wannan rahoto, cutar ta riga ta bazu a China da kusan wasu ƙasashe 50 (hoto 2.2).
"Tun da yanayin yana canzawa cikin sauri, za a iya tantance girman cutar da kuma yadda za ta yi tsanani a nan gaba".
A ranar 11 ga Fabrairu, 2020, an gudanar da bincike kan marasa lafiya 8,866 a cibiyoyi da dama, daga cikinsu akwai 4,021 da aka tabbatar da cutar COVID-19 da ke nuna halin da ake ciki na cutar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Ko da yake SARS-CoV-2 na shafar mutane a kowane zamani, amma ya fi shafar mutanen da ke tsakanin shekaru 30 zuwa 65.
Rabin mutanen da suka kamu da cutar (47.7%) sun haura shekaru 50, kuma kaɗan ne ke ƙasa da shekaru 20, kuma mutane 14 ne kawai ke ƙasa da shekaru 10.
Yawan maza da ke kamuwa da cutar SARS-CoV-2 (0.31 cikin 100,000) ya fi na mata (0.27 cikin 100,000).
COVID-19 ya yadu a cikin Hubei da kewayenta.
Matsakaicin kwanaki 5 (2-9) daga ranar kamuwa da COVID-19 zuwa gwajin.
A matsakaici, mutum yana fara nuna alamun cutar bayan kwana 4.8 (3.0-7.2).
Matsakaicin lokacin da mutum ya mutu daga farkon cutar ya kai kwanaki 9.5 (4.8-13).
Matsakaicin yawan haihuwa (R0) ya kasance 3.77 (95% CI: 3.51-4.05), kuma daidaitaccen R0 ya kasance 2.23-4.82.
"Yawan adadin wadanda suka kamu da cutar ya karu ne kafin 23 ga watan Janairu, lokacin da ake bikin bazara a kasar Sin.
1.44% na marasa lafiya da suka mutu tare da tabbataccen shari'ar (95% CI: 1.10-1.86%) da kuma daidaitaccen mutuwar 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku na haɗari na COVID-19 sune jinsi (maza), shekaru (≥60), da kuma ciwon huhu mai tsanani.
CoVs wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Ana iya raba su zuwa manyan nau'ikan guda huɗu: alpha, beta, gamma da delta, wanda aka san cewa alpha da beta CoVs suna cutar da mutane.
Envelope spike (S) glycoprotein yana haɗuwa da kwayar mai karɓar kwayar cutar ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta ta kwayar cuta.
An saki kwayar RNA ta kwayar cutar zuwa cikin cytoplasm; bayan an gama cinye kwayar cutar, RNA ta kwayar halitta da kuma glucoproteins na envelope da kuma sunadarai na nucleocapsid sun samar da wani abu a cikin kwayar halitta ko kuma a waje da kwayar cutar, wanda ke haɗuwa da kwayar plasma kuma ya saki kwayar cutar.
An fara ba da rahoton cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV kuma an sami daidaiton kwayoyin halitta sama da kashi 99.98% a cikin samfura 10 da aka ɗauka daga kasuwar abincin teku ta Hunan a cikin ruwan da cutar ta fara bulla.
Kwayar cutar SARS-CoV-2 tana da kamanceceniya da SARS-CoV maimakon MERS-CoV.
Ta hanyar microscopy na lantarki, an gano ƙananan SARS-CoV-2 a cikin ƙananan sassan numfashin mutum.
An gano ACE2 na ɗan adam a matsayin mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, haɗin S protein a cikin SARS-CoV-2 tare da ACE2 na ɗan adam ya raunana daga SARS-CoV, wanda ya danganta da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 an tsara shi ne ta hanyar sabon furotin mai gajeren lokaci wanda aka sanya shi ta hanyar orf3b kuma an sake shi ta hanyar furotin na orf8.
SARS-CoV-2 orf3b na iya taka rawa a cikin kwayar cutar kuma yana iya hana bayyanar IFNβ; duk da haka, orf8 ba shi da wani sanannen yanki mai aiki ko dalilin motsawa.
A ranar 18 ga Fabrairu, 2020, Zoo da abokan aikinsa sun ba da rahoton cewa cikakken tsayin tsarin cryoEM na ACE2 na ɗan adam shine ƙuduri 2.9 Å, wanda ya fito daga hadaddun amino acid mai ɗaukar B0AT1.
An tabbatar da cewa hadaddun da ke da tabbaci da rufewa sun sake haɗuwa kamar diamer kuma hadaddun ACE2-B0AT1 na iya haɗa sunadarai biyu na S, wanda ke ba da tabbaci ga ganewar CoV da kamuwa da cuta.
B0AT1 na iya zama wata hanyar warkarwa don gwajin magani don hana kamuwa da cutar SARS-CoV-2.
An samo asali da kuma rarraba shi
SARS-CoV da MERS-CoV sun samo asali ne daga tsuntsayen dare kuma an watsa su ga mutane ta hanyar tsuntsaye da raƙuma, bi da bi.
Ta hanyar kwatanta asalin SARS-CoV-2 da sauran CoVs, an yi tunanin cewa tsuntsayen dare sune farkon masu karɓar SARS-CoV-2, saboda sabon kwayar cutar ta kasance daidai da kashi 96% na nau'ikan SARS guda biyu da aka samo daga tsuntsayen dare bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, ba a san matsakaiciyar mai ɗaukar hoto ba wanda ya ba da damar cutar ta ƙetare iyakokin jinsin ta cutar da mutane, kuma har yanzu ana bayyana hanyar watsawa.
"G da abokan aikinsa sun nuna cewa macizai ne suka watsa kwayar cutar daga tsuntsaye na dare zuwa ga mutane, wanda ke buƙatar sake haɗuwa da furotin S".
A cewar wani bincike, masu bincike a Guangzhou, China, sun gano cewa pangolins masu dogon hanci da suke cin tururuwa, dabbobi masu shayarwa da ake amfani da su a maganin gargajiya na kasar Sin, sune masu watsa SARS-CoV-2 na matsakaici, bisa ga daidaiton kwayoyin halitta 99% tsakanin CoV da SARS-CoV-2 da aka gano a pangolins.
Duk da haka, rarraba bambancin 1% a cikin kwayoyin halittar biyu ya bambanta sosai, saboda haka ana jiran sakamako na ainihi don tabbatar da tabbacin (Fig. 33).
Har yanzu ba a san halayen jiki da na sunadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV suna rayuwa har tsawon awanni 48 a cikin bushewa, kuma a ƙasa da 20 °C da zafi 40%-50% har zuwa kwanaki 5.
SARS-CoV-2 na iya samun halaye iri ɗaya.
An bayar da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da zafin jiki a 56 °C zuwa 30 °C. Ether, 75% ethanol, maganin rigakafi na chlorine, acid na paracetic, chloroform da sauran maganin shafawa, ban da chloroxide, suna iya rage cutar sosai.
Jama'a gabaɗaya suna cikin haɗarin kamuwa da sabon kwayar cutar saboda rashin ƙarfin rigakafin SARS-CoV-2.
A halin yanzu, ba a yi cikakken bincike game da yadda cutar SARS-CoV-2 ke amsa cutar ba.
Saboda haka, za mu iya yin nuni ne kawai ga binciken da aka yi a baya a kan wasu SARS-CoV da kuma MERS-CoV (Figure (Figure 4).4).
Gabaɗaya, bayan kamuwa da mai watsa shiri, ana fara gano shi ta hanyar masu karɓar alamun alamomi (PRRs) waɗanda ke aiki akan tsarin rigakafin mai watsa shiri, waɗanda suka haɗa da masu karɓar mai kama da C-type lectin, mai karɓar mai kama da Toll (TLR), mai karɓar NOD (NLR), da mai karɓar RIG-I-like (RLR).
Kwayar cutar tana amfani da hanyoyi daban-daban don haifar da kumburi a cikin jikin mutum, samar da kwayoyin cuta masu hana kwayar cuta, da kuma samar da nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Koyaya, furotin SARS-CoV N na iya taimakawa kwayar cutar ta tsere daga tsarin rigakafi.
Ba da daɗewa ba, tsarin rigakafin jiki mai saurin motsawa zai shiga cikin aikin yaƙi da kwayar cutar.
Kwayoyin T, ciki har da CD4+ da CD8+ T, suna taka muhimmiyar rawa wajen hana kamuwa da cutar.
CD4+ T sun motsa kwayoyin B su samar da kwayoyin cutar, yayin da CD8+ T suka kashe kwayoyin cutar kai tsaye.
T-cell mai taimakawa yana samar da proinflammatory cytokines don taimakawa kwayoyin cuta.
Koyaya, CoV na iya hana aikin T-cell ta hanyar hanzarta mutuwar T-cell.
Magungunan rigakafi na ruwa, kamar su C3a da C5a da kuma kwayoyin rigakafi, suna da mahimmanci wajen hana kamuwa da kwayar cutar.
Misali, kwayoyin cutar da aka gano daga mai warkewa sun sanya MERS-CoV ya zama mara amfani.
A wani ɓangare kuma, idan tsarin garkuwar jiki ya yi amfani da shi fiye da kima, zai iya haifar da lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayi, zai iya haifar da rashin aiki da kuma mutuwa.
Cutar SARS-CoV-2 na iya shafar tsofaffi da mata masu juna biyu da ke da cututtuka daban-daban.
"Yana da kyau a ce mutanen da suka kamu da ƙwayoyin cuta masu yawa ko kuma waɗanda suke da ƙarancin garkuwar jiki suna iya kamuwa da cutar fiye da sauran mutane".
Kimanin matsakaicin lokacin haifuwa na SARS-CoV-2 shine kwanaki 1-14, mafi yawan kwanaki 3-7 bisa ga binciken da aka yi akan shari'o'in farko 425 da ke cikin ruwa.
Amma, binciken da aka yi a kan mutane 1,099 ya nuna cewa matsakaicin lokacin da ake zubar da ciki kwanaki 3 ne, kuma daga kwanaki 0 zuwa 24 ne.
Kamar yadda aka ambata a sama, binciken da aka yi kwanan nan ya nuna cewa cutar tana da tsawon kwana 4.8 (3.0-7.2), bisa ga bayanan da aka samu a kan mutane 8,866 da suka kamu da ita.
Ma'aikatan kiwon lafiya za su bukaci su daidaita lokacin keɓewa bisa ga lokacin da aka fi dacewa da haihuwa, don hana mutane da ke da cutar daga yada cutar ga wasu.
A matsayin al'ada, mutane da ke da cutar ko kuma waɗanda ke da cutar yawanci suna buƙatar keɓewa na tsawon kwanaki 14.
Shin ya kamata a ƙara wa mutum keɓewa zuwa kwanaki 24?
Alamar farko da ta fi dacewa ta COVID-19 ita ce zazzabi, wanda zai iya bayyana ba tare da wani abu ba ko kuma tare da wasu alamun kamar tari mai bushe, rashin numfashi, ciwon tsoka, kumburi, ciwon kai, ciwon makogwaro, ciwon kirji, tashin hankali da kumburi.
Wasu marasa lafiya suna da matsalar numfashi da kuma/ko kuma rashin iskar oxygen a cikin jini tun daga ranar da suka kamu da cutar.
A cikin mawuyacin hali, marasa lafiya suna iya fara nuna ciwon numfashi mai tsanani, rashin lafiyar jiki, ciwon acidic acid, da kuma coagulopathy.
"Masu fama da zazzabi da/ko cututtukan numfashi da kuma zazzabi mai tsanani, ko da ba su da wata matsala a binciken daukar hoto na huhu, ya kamata a fara gwada su don gano cutar.
Wani binciken da aka gudanar a karshen watan Disamba na shekarar 2019 ya nuna cewa kashi 98% na masu fama da cutar sun kamu da kumburi, kashi 76% sun kamu da tari, kashi 55% sun kamu da numfashi, kuma kashi 3% sun kamu da tari, kuma kashi 8% na marasa lafiya sun bukaci taimakon na'urar numfashi.
Kwanan nan, an sami irin wannan binciken a cikin ƙungiyoyin iyali biyu da kuma a cikin ƙungiyar da ke kamuwa da cutar daga wani mutum wanda ba shi da alamun cutar.
Idan aka kwatanta, binciken da aka yi a shekarar 2012 ya nuna cewa manyan alamun cutar na masu cutar MERS-CoV sune zazzabi (98%), tari mai bushe (47%) da kuma rashin numfashi (55%).
Koyaya, kashi 80% na masu cutar COVID-19 sun fi buƙatar na'urar numfashi, saboda yawan mutuwar MERS ya fi na COVID-19.
An kuma lura da ciwon hanci (26%) da ciwon makogwaro (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, zazzabi (99% - 100%), tari mai bushe (29% - 75%), rashin numfashi (40% - 42%), tari (20-25%), da ciwon makogwaro (13-25%) sune manyan abubuwan da suka faru; kuma 14% - 20% na marasa lafiya suna buƙatar taimakon numfashi.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2 cikin dari, yayin da adadin waɗanda aka tabbatar da su a duniya ya kai 66,576.
A kwatankwacinsa, a watan Nuwamba na shekara ta 2002, kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar SARS sun mutu.
A cewar Merse, yawan mutanen da aka yi bincike a watan Yunin 2012 ya nuna cewa kashi 37 cikin dari na mutane 2,494 da aka tabbatar da cutar sun mutu.
Wani bincike na farko ya nuna cewa SARS-CoV-2 R0 ya kai 6.47, tare da 95% na CI na 5.71-7.23, kuma SARS-CoV R0 ya kai 2 zuwa 4.
An nuna kwatancen SARS-CoV-2 da MERS-CoV da SARA-CoV bisa ga alamun bayyanar cututtuka, yawan mutuwa, da R0 a cikin tebur na 1.1.
"Lambobin da ke sama sun nuna cewa SARS-CoV-2 na da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma yana da ƙananan haɗarin kisa fiye da su".
Saboda haka, sarrafa cutar SARS-CoV-2 ya fi kalubalen sarrafa MERS-CoV da SARS-CoV.
Cutar ta gama gari sau da yawa tana faruwa a cikin iyali ɗaya ko a cikin rukuni ɗaya ko a cikin abin hawa, kamar jirgin ruwa mai nishaɗi.
Yawancin marasa lafiya suna da tarihin tafiya ko zama a cikin ruwa ko wasu yankuna da ke fama da cutar a cikin makonni biyu kafin cutar ta bayyana, ko kuma sun kasance tare da mutane ko marasa lafiya da ke da cutar.
Amma, rahotanni sun nuna cewa mutane na iya ɗaukar kwayar cutar sama da makonni biyu ba tare da nuna alamun cutar ba, kuma masu lafiya da suka tsira daga asibiti na iya sake ɗaukar kwayar cutar, wanda hakan zai ba da gargadi don tsawaita lokacin keɓewa.
A farkon wannan ciwon, marasa lafiya suna da ƙarancin adadin farin jini (musamman lymphocytes).
Misali, an gano lymphophenia tare da ƙididdigar farin jini; 4×109/L; gami da ƙididdigar lymphocytes; 1×109/L mafi girman adadin aspartate aminotransferase da Virimiya 1,099 a cikin marasa lafiya na COVID-19.
A wasu marasa lafiya, an sami karuwar ƙwayar hanta da ƙwayar tsoka da kuma ƙwayar myoglobin a cikin jini, kuma an sami karuwar furotin mai aiki da C da kuma ƙarancin erythrocytes a cikin yawancin marasa lafiya.
A cikin marasa lafiya masu tsananin rashin lafiya, yawan D-dimer, wanda shine samfurin rage fibrin, yana ƙaruwa a cikin jini kuma yawan ƙwayoyin jini masu ƙwayoyin cuta yana raguwa.
Sakamakon radiography na kirji a yawancin marasa lafiya na COVID-19 ya nuna rashin lafiya, wanda ke nuna cewa akwai kumburi a bangarorin biyu ko kuma wani abu mai kumburi a cikin huhu.
Marasa lafiya sukan sha fama da ciwon huhu na yau da kullum, ciwon huhu mai tsanani, da kuma ciwon numfashi mai tsanani (ARDS).
ARDS yana sa mutum ya yi kumburi, ya yi ruwa, kuma ya yi ciwo mai yawa, kuma hakan yana sa iska ta yi sanyi sosai.
Kwayoyin alveoli na nau'i na I da na II suna rage yawan sinadarin lipid da furotin, suna ƙara damuwa, suna sa huhu su yi tsami, kuma suna ƙara haɗarin kamuwa da huhu.
Saboda haka, sakamakon da aka samu a kan hotunan kirji mafi muni yawanci yana da alaƙa da yanayin da ya fi muni.
A ranar 18 ga watan Fabrairun 2020, binciken farko na COVID-19 ya nuna lalacewar ƙwayoyin cuta, samuwar ƙwayoyin cuta, ƙwayoyin cuta da ke shiga cikin huhu, da kuma ƙwayoyin da aka karɓa daga cutar da ta mutu, wanda ya yi daidai da binciken kamuwa da kwayar cutar da ARDS, kuma ya yi daidai da na SARS da MERS.
Gano SARS-CoV-2 RNA ta hanyar fasahar dakin gwaje-gwaje da ake kira reverse-transcriptase polymerase chain reaction (RT-PCR) ya zama muhimmin abu don gano cutar COVID-19.
Koyaya, saboda karuwar sakamakon rashin tabbaci wanda ke hanzarta barkewar cutar, an fara amfani da samfurori na asibiti a cikin Sin (wanda yanzu ba ya dogara da RT-PCR kawai) don gano cutar a ranar 13 ga Fabrairu, 2020.
Haka kuma ya faru a binciken cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, alamun asibiti, gwajin dakin gwaje-gwaje, da binciken radiology yana da mahimmanci don ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group sun gabatar da wata yarjejeniya ta gano SARS-CoV-2 ta hanyar bincike ta hanyar amfani da fasahar CRISPR-based SHERLOCK, wacce ke gano kwayoyin SARS-CoV-2 RNA na roba a cikin ƙasa da awa ɗaya ta amfani da dipstick ba tare da buƙatar ƙarin kayan aiki ba, daga 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kwafi a shigar da microliter).
Muna fatan cewa idan za a iya tabbatar da sabuwar hanyar ta hanyar samfuran asibiti, za ta iya haɓaka ƙwarewa da kwanciyar hankali sosai.
Saboda rashin ƙwarewa game da sabon CoV, likitoci na iya ba da kulawa ta tallafi ga COVID-19 kuma suna gwada wasu hanyoyin warkewa waɗanda aka yi amfani da su ko aka yi niyya don magance wasu cututtukan da ke haifar da kwayar cuta, kamar SARS-CoV da MERS-CoV (tebur (tebur 2.2).
Wannan magani ya haɗa da maganin rigakafi, maganin rigakafi, maganin steroid, maganin jini, maganin gargajiya, da kuma taimakon tunani.
An kuma ba da shawarar yin amfani da ruwan jini daga marasa lafiya da suka warke.
Kamfanonin samar da magunguna suna hanzarin samar da maganin rigakafi da allurar rigakafi.
SARS-CoV-2 ya fara kaiwa ga huhu, tare da ƙananan sassan jiki kamar tsarin narkewa da koda, waɗanda ke samar da ACE2.
Amma, cututtukan numfashi da kuma rashin aiki su ne manyan abubuwan da ke sa marasa lafiya tsoro da kuma manyan abubuwan da ke sa mutuwa.
Saboda haka, taimakon numfashi yana da muhimmanci wajen rage alamun cutar da kuma ceton rayuka, ya haɗa da maganin iskar oxygen, iskar oxygen mai yawa, iska mai guba da iska mai guba, da kuma iska mai guba ta inji, kamar yadda nauyin mai ya dace.
"Masu fama da cututtukan numfashi masu tsanani suna bukatar taimakon maganin oxygen na jikin mutum (ECMO), wanda ya inganta hanyar yin amfani da zuciya da huhu don magance cututtukan zuciya ko na numfashi da ke iya hallaka rai".
Bugu da kari, kiyaye daidaiton sinadarin lantarki, rigakafin kamuwa da cuta na biyu da kuma cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
An san cewa dalilin da ke haifar da Cytokin Storm shine yawan aikin rigakafi a cikin marasa lafiya na SARS da MERS.
Cutar cytokine ta bayyana a matsayin amsawa ta tsarin rigakafin kumburi kuma yana haifar da sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan sunadarai suna sa ƙwayoyin cuta masu saurin kamuwa da cuta su saki ƙwayoyin cuta masu yawa, waɗanda ke haifar da ARDS da kuma ɓangarorin jiki daban-daban.
Immunosuppression yana da mahimmanci a maganin cututtukan cytokine, musamman ga marasa lafiya masu tsanani.
An yi amfani da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut
Sauran magungunan da ake amfani da su don cutar cytokine Storm sun haɗa da motsawar amsawar rigakafin T-cell; hana IFN-γ, IL-1, da TNF; hana JAK; blinatumab; mai kunna siginar cytokine 4; da masu hana HDAC.
Ana amfani da maganin steroid don magance cutar SARS, don rage lalacewar tsarin garkuwar jikin mutum.
Koyaya, steroids masu yawa ba su da taimako sosai wajen rage lalacewar huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, yana iya shafar ci gaban cutar, musamman ma mutuwar ƙashin ƙashi, bayan sakamako mai tsanani.
Koyaya, an ba da shawarar cewa a ba da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuk
A lokacin rubuta wannan labarin, ba a tabbatar da ingancin maganin rigakafin cutar ba.
Koyaya, Remdesivir, kwatankwacin nucleotide, wanda aka ba ta hanyar jini, ya nuna tasiri a cikin wani mara lafiyar COVID-19 na Amurka.
Remdesivir wani sabon maganin rigakafi ne da Gilead ta samar, wanda aka fara amfani da shi don magance cututtukan da suka taso daga ƙwayoyin cutar Ebola da Marburg.
Daga baya, an nuna cewa Remdesivir yana hana ayyukan ƙwayoyin cuta masu RNA guda ɗaya, gami da ƙwayoyin cuta na MERS da SARS.
A cewarsa, Gilead ta tura kayan zuwa China don yin gwaji tare da mutanen da ke dauke da cutar SARS-CoV-2, kuma ana sa ran sakamakon.
Bugu da ƙari, an ba da shawarar yin amfani da barbitinib, interferon-α, lopinavir/ritonavir, da ribavirin a matsayin magani ga marasa lafiya da ke da alamun cututtukan numfashi.
Rashin jin daɗi, tashin hankali, tari, ciwon hanta da sauran halayen maganganu masu illa na iya faruwa saboda maganin hadewar lopinavir/ritonavir.
Ya kamata a lura da yadda waɗannan magunguna suke shafan sauran magunguna da ake amfani da su.
Ana samar da jini da kuma ƙwayoyin cuta daga marasa lafiya da suka warke
An daɗe ana yin jinin mutanen da suka warke daga cututtuka don a kula da su ko kuma a hana mutane da suke da lafiya kamuwa da cutar.
Hakika, waɗanda suka warke suna da rigakafin da ya fi na kwayoyin cutar a cikin jininsu.
Anbodies sune immunoglobulin (Ig) da kwayoyin B ke samarwa, wanda ke yaki da kwayoyin cuta da sauran abubuwa na waje, da kuma gano wasu kwayoyin a cikin kwayoyin cuta, wanda ke sa su zama marasa amfani.
A sakamakon haka, an karɓi jini daga jinin marasa lafiya da suka warke daga COVID-19 kuma an ba da allurar rigakafi ga marasa lafiya 10 da suka kamu da cutar.
Alamar cutar ta inganta cikin awanni 24, rage kumburi da matsin lamba, da kuma ingantaccen iskar oxygen a cikin jini.
Amma, ana bukatar gwaji da kuma gwaji don a iya ba da shawarar hanyoyin da za a yi amfani da su a wurare da yawa har sai an yi wasu hanyoyin magani.
Bugu da ƙari, saboda tasirin maganin, wasu lalacewar da ke tattare da jini ya kamata a kula da su a hankali.
Alal misali, ƙwayoyin cuta suna iya hana ƙwayar cuta ta hana ta kamuwa da cuta kuma su sa ta kamu da cutar cytokine, wadda ke iya kashe mutum.
Yawancin lokaci, adadin rigakafin yana raguwa a cikin jini, kuma ana bukatar filastik don kula da marasa lafiya.
Yana da wahala a samar da wasu kwayoyin cutar da za su iya magance cutar a duniya.
Saboda haka, ana bukatar gano kwayoyin halittar da ake buƙata don cire kwayoyin B daga marasa lafiya da suka warke da kuma samar da ƙwayoyin cuta masu tasiri ko kuma bincika sunadarai masu mahimmanci na kwayar cutar don samar da ƙwayoyin cuta masu tasiri.
Ta wannan hanyar, za mu iya ƙara yawan maganin rigakafi.
An yi amfani da TCM a cikin Sin don magance cututtuka daban-daban na dubban shekaru.
Amma, sakamakon da ake samu ya dangana ne a kan haɗuwa da abubuwa dabam dabam a cikin ƙira guda, wanda ƙira ya bambanta bisa ga yanayin TCM.
Yawancin abubuwan da suka dace sun kasance ba a san su ba ko kuma sun kasance masu rikitarwa, saboda yana da wuya a gano da kuma tabbatar da irin waɗannan abubuwa ko kuma abubuwan da suka haɗa.
A halin yanzu, TCM ya zama ɗayan manyan hanyoyin magani na madadin marasa lafiya waɗanda ke da ƙananan alamun cutar ko waɗanda suka murmure daga mummunan cutar saboda rashin ingantaccen magani na COVID-19.
Misali, Shu Feng Jie Du da Lian Hua Qing Wen sun sami inganci wajen maganin COVID-19.
Jihohi da dama a kasar Sin da suka yi amfani da maganin TCM a kashi 87% na marasa lafiya sun sami gagarumar nasarar ceto ga marasa lafiya na COVID-19, ciki har da Gansu (63.7%), Ningxia (50%), da Hunan (50%).
Amma, wannan kwatancin bai da ma'ana sosai domin akwai wasu abubuwa da yawa da za su iya shafan yanayin, kamar yawan marasa lafiya da kuma yadda suke da ciwo.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike da ya kwatanta maganin gargajiya na yamma (WM) shi kaɗai da maganin WM da TCM.
Sun gano cewa lokacin da zafin jiki ya dawo, lokacin da alamun suka ɓace, da lokacin asibiti sun ragu sosai a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai.
Abin mamaki, yawan kamuwa da cuta (daga mai sauƙi zuwa mai tsanani) ya ragu sosai a cikin rukunin WM+TCM fiye da ƙungiyar WM kawai (7.4% vs. 46.2%); kuma yawan mutuwar ya ragu sosai a cikin ƙungiyar WM+TCM fiye da ƙungiyar WM kawai (8.8% vs. 39%).
Amma, ana bukatar gwaji mai yawa da kuma kulawa a wurare da yawa don tabbatar da inganci da amincin TCM.
Bayyana hanyoyin da za a bi da kuma bayyana sassan da suka dace ko kuma haɗuwa da hanyoyin TCM zai iya zama abin sha'awa sosai.
Masu cutar da ake zargi ko kuma waɗanda aka tabbatar da cutar COVID-19 suna jin tsoron cutar mai saurin yaduwa, kuma waɗanda ke keɓewa suna jin ba su da lafiya, suna jin kadaici, da fushi.
Ƙari ga haka, cututtuka da ake samu daga kamuwa da cuta, kamar zazzabi, rashin numfashi, da tari, kamar rashin barci da ake samu daga maganin maganin carticholesteroid, na iya sa mutum ya ƙara yin sanyin gwiwa.
A farkon barkewar cutar SARS, an bayar da rahoton rashin lafiyar kwakwalwa da dama, ciki har da ci gaba da rikici, tashin hankali, tashin hankali, rashin hankali, alamun rashin lafiyar kwakwalwa, rashin jin daɗi, da tunanin kashe kansa.
Kulawa da keɓewa na tilas, wanda shine ɗayan hanyoyin magance cutar COVID-19, na iya haifar da damuwa da jin laifi ga mutane game da cutar, sakamakon keɓewa, da kuma keɓewar da ke tattare da dangi da abokai.
Saboda haka, ana ba da kulawa ta lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da kuma waɗanda suka haɗu da su kuma suna buƙatar su gaba ɗaya.
Tallafin da za a bayar ya kamata ya hada da kafa kungiyoyin kiwon lafiya na kwakwalwa da yawa, sadarwa a sarari da kuma ingantaccen bayani game da barkewar cutar SARS-CoV-2 da tsare-tsaren magani, da kuma amfani da kayan aikin lantarki da aikace-aikace don kauce wa hulɗa da juna.
Bugu da ƙari, maganin rigakafi mai tasiri yana da mahimmanci don dakatar da yaduwar cutar daga wuraren da ake ajiye dabbobi da kuma mutane zuwa masu haɗari, kuma maganin rigakafi yana da amfani wajen sarrafa cututtukan cututtuka da ke haifar da sababbin ƙwayoyin cuta.
An yi ƙoƙari don samar da alluran rigakafin S protein wanda zai iya ƙarfafa rigakafin cutar SARS-CoV a cikin dogon lokaci.
An gwada allurar rigakafin cutar SARS a kan dabbobi.
Amma, ana bukatar a tantance ko waɗannan alluran rigakafin za su iya yin tasiri a kan tsofaffi, da kuma yadda za a rage mutuwar mutane, da kuma yadda za a hana cutar daga dabbobi kafin a fara gwajin asibiti.
Dalilin da ya sa hakan zai iya zama saboda SARS ya ragu shekaru 17 da suka gabata kuma ba a sami sabon shari'ar ba tun daga lokacin.
Akasin haka, a Gabas ta Tsakiya, cutar ta MERS ta ci gaba da yaduwa sosai, kuma ta yadu zuwa wasu yankuna, inda ta riga ta kamu da cutar daga dabbobi zuwa mutane.
An tsara dabarun allurar rigakafin Mars ta amfani da ƙwayoyin cuta marasa aiki, plasma na DNA, masu ɗaukar hoto na ƙwayoyin cuta, nanoparticles, abubuwa masu kama da ƙwayoyin cuta da ƙananan ƙwayoyin sunadarai na dakin gwaje-gwaje, wasu kuma an gwada su akan samfuran dabbobi.
Samar da ingantacciyar allurar rigakafin SARS-CoV-2 ga mutanen da ke da rigakafin cutar gaggawa ce kuma muhimmiyar aiki don shawo kan annobar da ke gudana.
Koyaya, saboda dogon lokacin da ake buƙata don samar da allurar rigakafi (a matsakaita watanni 18) da kuma yanayin canjin CoVs, magance matsalar yana da ƙalubale.
Saboda COVID-19 sabon cuta ne, ana fara nuna cikakken aikin asibiti a dubban marasa lafiya.
A yawancin lokaci, marasa lafiya suna warkewa a hankali ba tare da sun yi rashin lafiya ba.
Koyaya, kamar SARS da MERS, COVID-19 yana haifar da mummunan lalacewa da mutuwa a cikin waɗanda ke da mummunan cuta.
Saboda haka, gina tsarin tsinkaya na cutar yana da mahimmanci don hukumomin kiwon lafiya su iya tsara ayyukan su, musamman a yankunan da ke da karancin albarkatu.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan abubuwan na iya shafar ko alaƙa da tarihin marasa lafiya na COVID-19 (tebur (tebur 33):
Shekaru: Shekaru ya kasance mai mahimmanci wajen sanin tarihin cutar SARS, kuma wannan ya shafi COVID-19.
Kamar yadda aka ambata a sama, binciken da aka yi kan mutane 8,866 da suka kamu da cutar, ya nuna cewa kashi 47.7% na marasa lafiya sama da shekaru 50 sun kamu da cutar COVID-19 a tsakanin shekaru 30-65.
Gaskiyar cewa marasa lafiya da ke buƙatar kulawa ta musamman sun fi tsofaffi (matsakaicin shekaru 66 zuwa 51) fiye da waɗanda ke da cututtuka da matsalolin kiwon lafiya da ba su da matsala, yana nuna cewa shekaru shine babban abin ƙididdiga ga yiwuwar murmurewa ga marasa lafiya na COVID-19.
Jima'i: Kamar yadda aka ambata a sama, SARS-CoV-2 ya fi rinjayar maza fiye da mata (0.31 cikin 100,000 maza, 0.27 cikin 100,000 mata).
Matsalolin kiwon lafiya da cututtuka masu maimaitawa: marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa ta likita suna da haɗarin kamuwa da cututtukan zuciya da cututtukan numfashi.
Matsalar cututtukan zuciya ita ce babbar hanyar mutuwar marasa lafiya na SARS.
SARS-CoV-2 na iya haifar da matsalolin lafiyar hanta a cikin marasa lafiya na COVID-19 saboda rahoton da aka bayar na haɗuwa da ACE2-positive cholangiocytes.
Ya kamata a fahimci cewa shekaru da cututtuka suna da alaƙa sosai kuma ɗayan na iya tsoma baki da ɗayan.
Binciken dakin gwaje-gwaje na rashin lafiya: An ba da shawarar yin amfani da matakin C-reactive protein (CRP) a cikin jini don nuna girman kumburi ko lalacewar ƙwayar cuta, don gano tarihin halitta na cutar, amsawa ga magani da kuma tsarin dawowa na ƙarshe.
An kuma ba da shawarar alaƙar da ke tsakanin matakin CRP da hasashen cutar COVID-19 da yanayin ci gaba.
Bugu da ƙari, ƙaruwa na lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana samun waɗannan ƙwayoyin a wurare dabam dabam na jiki, musamman a zuciya da hanta, kuma ana fitar da su sa'ad da nama ya lalace.
Saboda haka, cututtukan zuciya ko hanta sune alamun da aka saba da su.
Ana iya amfani da manyan alamun asibiti, radiography na kirji da kuma tsawon lokacin alamun asibiti, tare da wasu batutuwa, don hango sakamakon COVID-19 da matsalolin kiwon lafiya.
Amfani da steroids: Kamar yadda aka ambata a sama, ana amfani da steroids a matsayin magani na taimako don cututtukan cututtuka don rage lalacewar tsarin rigakafin mutum da kuma na numfashi.
An yi amfani da maganin corticosteroid mai yawa a kan marasa lafiya da ke fama da cutar SARS, kuma mutane da yawa da suka warke sun yi rashin ƙashi, sun naƙasa kuma sun yi rayuwa mai wuya.
Saboda haka, ya kamata a yi amfani da steroids a ƙananan allurai da gajeren lokaci a cikin marasa lafiya na COVID-19 idan ya cancanta.
Rashin hankali: Kamar yadda aka ambata a sama, yawancin marasa lafiya a lokacin annobar COVID-19 suna fuskantar matsanancin damuwa da rashin tabbas saboda dogon lokaci a keɓewa, ganin danginsu da sauran marasa lafiya suna mutuwa.
"Shirye-shiryen tunani da kuma tallafi na dindindin suna da muhimmanci wajen taimaka wa waɗannan marasa lafiya su warke daga damuwa kuma su koma rayuwa ta yau da kullum".
Bisa ga binciken alƙaluma na yanzu, COVID-19 yana da halaye na watsawa daban da SARS.
Baya ga sake haifuwa a cikin ƙananan numfashi, SARS-CoV-2 ya sake haifuwa a cikin ƙananan numfashi kuma ba ya nuna sauƙi ko babu alamun a farkon matakin kamuwa da cuta, kamar sauran CoVs masu haifar da mura.
Saboda haka, mutane da ke da cutar na iya samar da babban adadin kwayar cutar a farkon matakin ko lokacin fashewa saboda ayyukansu na yau da kullun, wanda ke sa ya zama da wahala a sarrafa cutar.
Koyaya, SARS-CoV yana yaduwa yayin da marasa lafiya suka fi rashin lafiya kuma yawancin watsawa ba ya faruwa a farkon matakan cutar.
Saboda haka, annobar COVID-19 ta yanzu ta fi ta SARS muni kuma ta fi wahalar sarrafawa.
Ana ta yin gagarumin kokarin dakile yaduwar SARS-CoV-2 a China, ciki har da hana zirga-zirga gaba daya da kuma keɓewar jama'a a Wuhan da garuruwan da ke kewaye da ita.
Duk da cewa wadannan matakan na da matukar tasiri ga tattalin arzikin kasar da sauran bangarorin kasar, raguwar sabbin masu kamuwa da cutar na nuna cewa annobar ta ragu.
Kimanin kimantawa shine cewa cutar za ta ƙare a watan Maris kuma yaduwar cutar za ta ragu a cikin watanni 3-4.
Amma, wasu masana ba su da irin wannan ra'ayin.
A cewar Paul Hunter, COVID-19, wanda ya fi SARS yaduwa, ba zai ƙare ba a shekarar 2020.
"A cikin wani bincike da suka yi, da kuma Ira Longini, sun samar da wani tsari na hasashen sakamakon cutar, inda suka nuna cewa SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin hanci da kuma makogwaron marasa lafiya da aka sallame daga asibiti makonni biyu da suka gabata, wanda ke nuna cewa cutar da aka gano kwanan nan, kamar mura, na iya sake faruwa.
"Duk da haka, saboda raguwar sabbin shari'o'in, akwai alamun fatan alheri a China, wanda ke nuna cewa dabarun yanzu ba su da tasiri".
An kiyasta cewa cutar Ebola za ta kai mutane miliyan daya a farkonta, kuma ta kashe mutane miliyan ɗari.
Koyaya, saboda tsauraran matakan keɓewa da keɓewa, cutar ta ci gaba da kasancewa cikin iko.
Kamar SARS-CoV, SARS-CoV-2 na iya zama mai rauni kuma ya mutu a cikin tsari ko kuma kwayar cuta mai rauni da ke rayuwa tare da mutane kuma yana iya haifar da cuta.
A ƙasa akwai kwatancen tsakanin barkewar COVID-19 da SARS da MERS (Hoto (Hoto.
SARS-CoV-2 yana yaduwa ta hanyar tari ko tari, da kuma ta hanyar hulɗa kai tsaye da kayan da ke dauke da kwayar cutar.
An kuma gano kwayar cutar a kan naman kaza, wanda ke nuna cewa ana iya yada ta daga naman kaza zuwa bakin.
Wani binciken da aka yi kwanan nan a kan mutane 138 da suka kamu da cutar, ya nuna cewa kashi 41 cikin 100 na cutar na iya kasancewa sanadiyyar kamuwa da cutar a wani wuri, ciki har da marasa lafiya 17 da ma'aikatan kiwon lafiya 40 da ke da cutar.
Saboda haka, ya kamata a yi taka tsantsan don kare mutane, musamman ma masu kula da lafiya, ma'aikatan zamantakewa, dangin, abokan aiki, da waɗanda suka haɗu da marasa lafiya ko waɗanda ke da cutar.
Layin farko na kariya da za mu iya amfani da shi don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska, abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (lambar samfurin 1860s) don taimakawa wajen sarrafa yaduwar kwayar cutar.
Masks na tiyata na hana saukad da cutar daga cutar daga yawo cikin iska ko mannewa a saman kayan aiki don hana yaduwa ga wasu mutane.
Koyaya, kawai abin rufe fuska na N95 (lambar lamba 1860s) shine wanda zai iya shawo kan ƙwayoyin cuta masu girman 10 zuwa 80 nm; kawai kashi 5% na ƙananan ƙwayoyin cuta ne ke iya shiga cikin numfashi; SARS-CoV-2 yayi kama da SARS-CoV, duka suna da kusan 85 nm.
Masu kula da lafiyar da ke hulɗa kai tsaye da marasa lafiya ba za su sa N95 (lambar samfurin 1860s) da abin rufe fuska ba, saboda ko da idan an saka abin rufe fuska guda biyar a kan juna, ƙananan abubuwa na iya shiga.
Ma'aikatan kiwon lafiya, ban da abin rufe fuska, ya kamata su sanya tufafin da aka tsara da kansu don rage hulɗa da kwayar cutar.
Ƙwayoyin cuta suna iya kamuwa da mutum ta wurin idanu.
A ranar 22 ga Janairu, 2020, wani likita ya yi amfani da abin rufe fuska na N95 kuma ya kamu da cutar SARS-CoV-2, wanda wataƙila ya shiga jikinsa ta hanyar idanunsa.
Saboda haka, masu kula da lafiya ya kamata su sanya abin rufe fuska ko abin rufe fuska lokacin da suke aiki tare da marasa lafiya.
Ana ba da shawarar ga jama'a da ke zaune a yankunan da cutar ta kamu da cutar ko kuma waɗanda za su iya kamuwa da ita, cewa kowa ya wanke hannu da sabulu fiye da yadda ya saba, ya ware kansa daga cikin gida, kuma ya rage hulɗa da mutanen da ke iya kamuwa da cutar.
Ya kamata mutane su kasance nesa da marasa lafiya na tsawon kafa uku.
Wadannan matakan na da tasiri wajen rage hadarin kamuwa da cutar da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya bayyana a matsayin sabon kwayar cutar ga duniya, ya kamata a yi gargadi sosai game da irin kamaninsa da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, saboda mummunan ƙwaƙwalwar cutar SARS da China ta fuskanta a 2003.
Koyaya, daraktan Cibiyar Kula da Cututtuka ta Watwat ya yi ta'aziyya ga jama'a har zuwa 19 ga Janairu, 2020, yana mai cewa sabon kwayar cutar ba ta da saurin yaduwa daga mutum zuwa mutum, kuma ba ta da iyakancewa, kuma ba shi da wahala a hana ta da kuma sarrafa ta.
Wannan sakon ya kara wayar da kan jama'a, musamman a lokacin da kasar ke shirin bikin bazara, kuma ya kawo lokaci mai mahimmanci don sarrafa cutar yayin da take cikin ruwa.
Kungiyoyin kula da cututtuka a China na iya ɗaukar wannan darasi mai wuya kuma suyi aiki mai ƙarfi don ci gaba.
Alal misali, waɗannan hukumomi suna bukatar (1) su kasance da hankali sosai sa'ad da suke ba da sanarwa ga jama'a, domin 'yan ƙasa suna ɗaukan kowane kalma da muhimmanci kuma suna iya canja ra'ayinsu da shawarwarinsu; (2) su kasance masu lura da kuma amsawa ga bayanai da ba su da kyau daga asibitoci maimakon jiran rahotanni na yau da kullum daga likitoci ko masu mulki; (3) su kasance masu ƙuduri wajen hana annobar ta ɓarke fiye da ƙoƙarin ƙarfafa jama'a; kuma (4) su ba da ƙarin lokaci don gudanar da gwaje-gwaje masu kyau da suka dace da nufin inganta fahimtar jama'a game da cututtuka da kuma gwadawa da kuma inganta tsarin amsawa na al'umma.
Cutar COVID-19, wanda kwayar cutar coronavirus SARS-CoV-2 ta haifar, ta fara ne a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya yaɗu a duk ƙasar Sin, kuma a lokacin da ake rubuta wannan labarin, ya yaɗu a ƙasashe kusan 50.
Saboda kwayar cutar ta yi kama da SARS-CoV kuma alamun COVID-19 da SARS sun yi kama, barkewar COVID-19 ta haifar da tsammanin sake dawowar SARS.
Koyaya, akwai wasu mahimman bambance-bambance tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don sarrafa annobar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa, maza fiye da mata, kuma yawan kamuwa da cutar da mutuwar ya fi na matasa.
Yawan mutuwar SARS ya fi na COVID-19 (10.91% idan aka kwatanta da 1.44%).
Masu cutar COVID-19 suna iya yada kwayar cutar ko da ba su da alamun cutar, yayin da masu cutar SARS sukan yada kwayar cutar a lokacin da suke cikin mawuyacin hali, wanda hakan ke sa ya zama da wuya a iya sarrafa yaduwar COVID-19 fiye da SARS.
Wannan ya ba da wani ɓangare na dalilin da yasa SARS-CoV-2 ya fi sauri kuma ya yadu fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya na COVID-19.
A wani bangare kuma, masu cutar da aka warkar na iya sake kamuwa da cutar.
Wadannan binciken sun kara barazanar yaduwar kwayar cutar sosai.
Yayin da bincike kan COVID-19 ke ci gaba cikin sauri, akwai wasu mahimman batutuwa da ke buƙatar warwarewa, kamar su:
A ina ne SARS-CoV-2 ya fito?
Ko da yake an gano daidaiton kwayoyin halitta kashi 96% tsakanin SARS-CoV-2 da nau'ikan SARS guda biyu na tsuntsaye, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 ya fito ne daga tsuntsaye ba.
"Wane irin dabba ne ya fara daukar kwayar cutar, kamar tsuntsaye masu kama da dare, wanda ya kasance mai matukar barazana wajen daukar kwayar cutar zuwa ga mutane?"
Ba tare da sanin amsoshin tambayoyin na 1 da na 2 ba, ba za mu iya dakatar da yaduwar cutar ba, kuma cutar na iya kaiwa ga kowane lokaci.
Ko da yake an tabbatar da alaƙar SARS-CoV-2 da ACE2 ta hanyar samfurin kwayoyin halitta da gwajin kwayoyin halitta, ta yaya kwayar cutar ke shiga cikin ƙwayoyin iska kuma ta haifar da cuta?
Shin kwayar cutar tana da alaƙa da ƙwayoyin ACE2 a wasu sassan jiki?
Idan ba a sami amsoshi masu gamsarwa ga waɗannan tambayoyin ba, ba za mu iya samun ganewar asali da kuma magani mai kyau ba.
Yaya Tsawon Cutar Za Ta Yi?
Ta yaya ƙwayar halitta take nunawa yayin da cutar take yaɗuwa daga mutum zuwa mutum?
Za a yi annobar duniya, kamar yadda cutar SARS ta yi ko kuma za a yi ta ci gaba da cutar kamar yadda mura ta yi?
Yana da muhimmanci mu nemi amsoshin waɗannan tambayoyin da kuma wasu da yawa, amma zai ɗauki lokaci.
Amma duk da haka, duk da tsadar da za a biya, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma rayuwarmu ta yau da kullun.
An gano cewa cutar korona ta fara ne a shekara ta 2000.
Canji da daidaitawa sun haifar da kwayar cutar coronavirus da masu dauke da ita, gami da mutum, shekaru dubbai.
Kafin shekara ta 2003, an gano cewa kwayar cutar HCoVs biyu tana haifar da rashin lafiya kamar mura.
Cutar cutar sankara ta SARS da cutar sankarar sankara ta Gabas ta Tsakiya (MERS) sun nuna cewa cutar HCoV tana da matukar hadari da barazana ga rayuwa.
"A ƙarshen shekarar 2019, barkewar cutar SARS-CoV-2 a tsakiyar kasar Sin ta sa an sake mayar da hankali kan kwayar cutar kuma ta ba mu mamaki da yadda take yaduwa, amma ta rage cutar idan aka kwatanta da takwaranta SARS-CoV.
Tun da cutar HCoV cuta ce ta dabbobi, fahimtar tushen HCoV a cikin dabbobi yana da matukar amfani.
Yawancin HCoVs sun fito ne daga tsuntsaye na dare, kuma ba su haifar da cutar a cikinsu ba.
Ana kuma kiran wasu HCoVs matsakaiciyar manyan masu ɗaukar kaya.
Ana iya gano masu daukar kwayar cutar ta hanyar hana mutum kamuwa da cuta.
Binciken hulɗar masu ɗaukar COVID a cikin dabbobi na iya ba da kyakkyawar fahimta game da cutar COVID a cikin mutane.
A cikin wannan bita, muna ba da bayanin game da HCoVs bakwai, tarihin gano su, da kuma taƙaitaccen bayanin da ke akwai, tare da mai da hankali kan asalin asali da kuma hanyar sadarwa.
Abu mai mahimmanci, mun gwada bambance-bambance na HCoVs dangane da farkon kwayar cutar da sake tsara kwayoyin halittar.
An tattauna game da cutar COVID-19 na yanzu a cikin wannan mahallin.
Bugu da ƙari, an kuma ba da shawarar ma'aunin nasarar canja wurin mai ɗaukar hoto da tasirin kwayar cutar akan yanayin cutar.
Kwayar cutar korona ta kasance cikin rukuni na ƙwayoyin cuta da ake kira coronaviruses, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu kyau da kuma ƙwayoyin cuta na RNA guda ɗaya.
Wadannan ƙwayoyin cuta suna da babban kwayar halitta daga ƙwayoyin cuta na RNA, daga 26 zuwa 32 kilobes, kuma an sanya su suna Zhukovchky saboda tsarin su yana kama da kambi a ƙarƙashin microscope na lantarki.
A tsarin, akwai kwayoyin halittar da ke da tsarin halittar iri ɗaya wanda ba a rarraba su ba.
Kimanin kashi biyu bisa uku na kwayar cutar tana dauke da manyan masu buɗewa guda biyu (ORF1a da ORF1b), wanda ke canza sunadarai da yawa zuwa pp1a da pp1ab.
Ana sarrafa polyproteins a hankali don samar da sunadarai 16 marasa tsari, wanda aka ware daga nsp1 ~ 16.
Sauran sassan sune ORFs tare da spike (S), envelope (E), membrane (M) da nucleotide (N) don tsarin furotin.
Ana kuma yin amfani da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
Bisa ga bambancin tsarin sunadarai, ana rarraba kwayar cutar ta antireso zuwa nau'i hudu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV); daga cikin wadannan, beta-CoVs suna da mafi yawan kwayar cutar HCoVs, kuma an rarraba su zuwa ƙananan ƙwayoyin halitta biyar (A, B, C, da D).
Bayanan jinsin sun nuna cewa kwayar halittar nocturnal da kuma na linzamin kwamfuta sune tushen asalin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban mai samar da gamma-CoVs da delta-CoVs.
A cikin dubban shekaru, C. cocci sau da yawa sun wuce iyakar jinsin. Wasu kuma sun zama sanadin cututtuka masu tsanani ga mutane.
Har yanzu an gano mutane bakwai da ke fama da cutar HCoVs.
Daga cikin su akwai alpha-CoVs HCoV-229E da HCoV-NL63.
Sauran beta-CoVs guda biyar masu kamuwa da cutar HCoV-OC43, HCoV-HKU, SARS-CoV, SARS-CoV na Gabas ta Tsakiya, da SARS-CoV-2 sun hada da.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamun rashin lafiya kamar mura da / ko tari.
Akasin haka, SARS-CoV, MERS-CoV da kuma sabon nau'in SARS-CoV-2 sune manyan masu haifar da cutar, wanda ke haifar da kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar numfashi (ARDS) da kuma bayyanar cututtukan ƙwayar cuta.
An gano samfurin HCoV-229E na farko, B814, daga ruwan hanci na marasa lafiya masu mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayani game da cutar HCoV-229E da HCoV-OC43, dukansu suna haifar da alamun hana kai.
A gaskiya ma, an yarda da cewa cutar HCoV ba ta da illa har sai an sami barkewar cutar SARS.
Cutar SARS ta 2003 ita ce ta fi kowacce annoba a tarihin 'yan kwanakin nan, ta kashe mutane sama da 8,000, wanda kashi 10% na su sun sake kamuwa da cutar.
Shekaru goma bayan haka, annobar cutar MERS ta Gabas ta Tsakiya ta sake faruwa a yankin Larabawa kuma ta bazu cikin sauri zuwa wani ɓangare na duniya.
Sabuwar kwayar cutar HCoV (2019-nCoV) ta 2019, wacce aka sake masa suna SARS-CoV-2, ita ce sanadin annobar annobar coronavirus 2019 (COVID-19), wanda cutar ta kashe mutane sama da 91,000 a tsakanin Maris 3 zuwa 2020 kuma ta yi sanadiyar mutuwar mutane sama da 3120.
"Duniya na bukatar shirya kanta don annobar SARS-CoV-2 mai zuwa, saboda an yi gargadin gaggawa".
An haifi dukan waɗannan tsuntsaye bakwai daga tsuntsaye, beraye, ko kuma dabbobi.
Bayanai da yawa sun nuna cewa asalin kwayar cutar ta HCoVs daga tsuntsaye ne, inda ƙwayoyin cuta ke daidaitawa da kyau kuma ba sa haifar da cuta, duk da cewa suna nuna bambancin jinsi.
Cutar COVID-19 ta haifar da manyan kalubale na kiwon lafiya, kimiyya, zamantakewa da ɗabi'a a China da duniya baki ɗaya.
Nazarin asalin Covech yana ba da ra'ayi don fahimtar tarihin halitta, matsin lamba da ke bayan shi, da abubuwan da ke hana rarraba nau'in.
Wannan zai iya jagorantar ko sauƙaƙe bincike na manyan, matsakaita da masu ɗaukar dabbobi na SARS-CoV-2 tare da mahimman shawarwari don hana yaduwar nan gaba.
A cikin wannan binciken, muna ba da cikakken bayani game da asalin zoonotic, watsawa tsakanin jinsuna, da kuma dalilin cutar HCoVs.
Musamman, muna tattauna batun kwayar cutar HCoVs, wanda ya danganci kuma ya kamata a jaddada cewa yayin da aka watsa su a cikin yanayin da suke ciki, suna yin rauni sosai amma suna haifar da cutar bayan an watsa su zuwa sabon mai ɗaukar hoto.
Mun kuma bincika yanayin juyin HCoV, wanda yawanci yana haifar da ƙarancin cutar.
An kuma tattauna sakamakon ci gaba da yaduwar cutar SARS-CoV-2 a cikin wannan mahallin.
An san dabbobin da ke da garkuwar dabbobi tun daga ƙarshen shekarun 1930.
Kafin gano kwayar HCoV-229E B814 a farkon hanci na marasa lafiya masu mura, an gano nau'ikan kwayar cutar a cikin dabbobi da yawa da suka kamu da cutar, ciki har da turkey, beraye, shanu, aladu, kuliyoyi da karnuka.
An gano kwayar cutar HCoVs bakwai a cikin shekaru goma da suka gabata.
An bayyana batun tarihin binciken Hekowitz a cikin tsari a cikin tebur na 1.
An fara gano kwayar cutar HCoV-229E a cikin kamuwa da cutar numfashi ta sama a cikin 1966 daga cikin masu fama da cutar numfashi, sannan kuma an yi amfani da WI-38 don haɓaka cikin layin sel na huhu.
An lura da zazzabi da tari a cikin kashi 10 zuwa 20 cikin dari na marasa lafiya da ke dauke da cutar HCoV-229E da kuma cututtukan mura, ciki har da ciwon kai, tari, jin zafi da ciwon makogwaro.
Daga baya, a cikin 1967, an gano yaduwar HCoV-OC43 a cikin jerin kwayoyin halitta da kwakwalwar beraye masu shayarwa.
Abubuwan asibiti na cutar HCoV-OC43 sun yi kama da cututtukan da ke haifar da cutar HCoV-229E, wanda ba a iya gano alamun cutar ba, kamar su ƙwayoyin cuta na mura A da kuma sauran cututtukan numfashi kamar rhinoviruses.
Dukansu HCoV-229E da HCoV-OC43 suna yaduwa a duniya, kuma suna yaduwa a cikin hunturu mai sanyi.
Gabaɗaya, lokaci na bayyanar cututtuka na waɗannan ƙwayoyin cuta guda biyu bai kai mako guda ba, sannan kuma ya biyo bayan ciwo na tsawon makonni biyu.
Dangane da binciken da aka yi a kan mai sa kai, mutane masu lafiya da ke dauke da cutar HCoV-229E sun sami saurin mura.
An gano cewa marasa lafiya da ke da rauni a cikin rigakafin su suna da cututtukan numfashi na ƙasa.
SARS, wanda kuma aka sani da cutar huhu ta SARS, ita ce annoba ta farko da aka rubuta a tarihin ɗan adam, kuma SARS-CoV-2 ne asalin cutar, kuma an gano HCoV-3 a cikin tarihin ɗan adam.
An fara gano cutar SARS a lardin Guangdong na kasar Sin a karshen shekarar 2002, a cewar 'yan Turai.
Cutar SARS ta bazu zuwa kasashe da nahiyoyi da dama, inda ta yi sanadiyar kamuwa da cutar 8,096 da kuma mutuwar mutane 774.
An kiyasta cewa kowane mutum da ya kamu da cutar zai iya haifar da karuwar masu kamuwa da cutar, wanda ke haifar da matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin.
Alamun farko na marasa lafiya da ke dauke da cutar SARS-CoV-2 sune malaliya, ciwon kai, zazzabi, jin zafi da sanyi, kuma rashin numfashi, rashin nutsuwa da kuma damuwa na numfashi sune alamun da ke faruwa daga baya.
Lymphopenia (ƙarancin ƙwayoyin lymphocyte a cikin jini), gwajin ciwon hanta, da ƙaruwa na creatine kinase (enzyme da ke fitar da jini daga tsoka) su ne wasu cututtuka da SARS ke haddasa a dakin gwaje-gwaje.
An kuma lura da lalacewar alveolar, ƙaruwar ƙwayoyin epithelial, da kuma ƙaruwa na macrophage a cikin marasa lafiya na SARS.
A matsakaita, kashi 20 zuwa 30 cikin dari na marasa lafiya suna buƙatar kulawa ta musamman da na'urar numfashi.
Bugu da ƙari, ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
An fara gano kwayar cutar ne a kan wani dangin wani mai cutar da ya je Hong Kong daga Guangzhou domin a yi masa tiyata.
Tun daga wannan lokacin, an ba da babbar himma ga binciken HCoV.
An ware HCoV-NL63 daga jariri mai wata bakwai a Netherlands a ƙarshen shekara ta 2004.
A farko dai, ana ganin ana yaduwa a cikin yara, manya, da marasa lafiya masu cutar numfashi.
Rashin jin daɗi, ƙyamar ido, zazzabi da kuma ciwon huhu sun zama ruwan dare na yau da kullun ga cututtukan da HCoV-NL63 ke haifarwa.
Wani binciken da aka yi a Netherlands ya nuna cewa kwayar cutar ta kama da kwayar cutar da aka samo daga hanci na jariri mai wata takwas da ke fama da ciwon huhu.
An fi saninsa a Netherlands, amma ya yaɗu a duk duniya.
An kiyasta cewa HCoV-NL63 yana ɗaukar kusan kashi 4.7% na cututtukan numfashi na yau da kullun, tare da mafi girman abin da ke faruwa a lokacin hunturu, kaka da farkon Satumba.
HCoV-NL63: yana da alaƙa da ƙuƙwalwar ƙuƙwalwa, wanda aka fi sani da croup.
A wannan shekarar, an ware wani mai shekaru 71 da ke kwance a asibiti a Hong Kong saboda cutar huhu da kuma ciwon huhu.
Baya ga cututtukan huhu da ciwon makogwaro da ake samu a cikin al'umma, an kuma bayar da rahoton cewa HCoV-HKU1 yana da alaƙa da ƙaruwar cutar asma.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk duniya yana haifar da ƙananan cututtukan numfashi.
Dukkanin wadannan kwayoyin cutar HCoVs da aka yada a cikin al'umma an tsara su ne don su yi aiki sosai a kan mutane, kuma a gaba ɗaya ba su da wata dama ta haifar da cututtuka masu saurin kamuwa da cuta, kodayake saboda wasu dalilai da ba a sani ba, sun haifar da haɗari kamar nau'ikan HCoV-NL63, wanda ke haifar da kamuwa da cuta a cikin ƙananan numfashi a cikin China.
Gabaɗaya, waɗannan HCoVs suna da ƙwarewar watsawa da yawa kuma suna ci gaba da kasancewa tsakanin mutane, suna zama masu kashewa ko masu cutarwa.
An fara gano cutar ta MERS-CoV a cikin wani mutum mai shekaru 60 da haihuwa wanda cutar ta canza zuwa ciwon huhu kuma ta dakatar da koda a cikin 2012 a Saudi Arabia.
Kodayake yawancin magungunan da aka tabbatar da su daga dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an sami rahoton cututtukan na biyu da suka bazu a cikin lambobin sadarwa na baya-bayan nan a ƙasashen Turai da Tunisia.
Wani kuma ya faru a Koriya ta Kudu a shekarar 2015 a karkashin mulkin Faransa, inda aka kama mutane 186.
Sakamakon binciken ya nuna cewa MERS na iya zama cutar SARS ta hanyar zama ciwon huhu mai saurin ci gaba.
Ba kamar SARS ba, yawancin marasa lafiya da ke dauke da cutar MERS sun sami ciwon koda da yawa, wanda ya sa MERS ta zama ta musamman a cikin cututtukan da ke haifar da cutar HCoV.
fiye da kashi 30 cikin dari na marasa lafiya suna fama da cututtukan ciki da hanji, kamar tari da kuma narkewa.
Tun daga ranar 14 ga Fabrairu, 2020, an sami fiye da mutane 2,500 da aka tabbatar da su a dakin gwaje-gwaje, wanda ya kai kashi 34.4% na mutuwar, wanda ya sanya MERS-CoV ɗaya daga cikin ƙwayoyin cuta mafi haɗari ga yara.
A tsakiyar watan Disamba na shekarar 2019, an gano mutane da dama da ke dauke da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ce cutar ta SARS-CoV-2 ta haifar da ciwon hanjin da ke saurin tashi a cikin hanjin jiki, wanda ya jawo hankalin duniya.
Ya zuwa ranar 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duniya, tare da mutuwar kashi 3.4%.
A Hubei, kasar Sin, yawan mutanen da suka kamu da cutar ya kai kashi 4.2 bisa dari, kuma a wasu yankuna, ya kai kashi 1.2 bisa dari.
SARS-CoV-2 na haifar da cututtukan numfashi masu haɗari kamar SARS-CoV da MERS-CoV waɗanda ke bayyana a cikin zazzaɓi, kumburi da kuma rashin numfashi.
An yi amfani da shi a kan wasu marasa lafiya.
Cutar huhu tana ɗaya daga cikin alamun cutar da ke da tsanani, kuma tana iya saurin kai wa ga ciwon numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kusancin juna saboda babban tsarin su na nucleotide na 82%, ana rarraba su a ƙarƙashin rassan bishiyoyi daban-daban a cikin tushen zuriyarsu.
SARS-CoV-2 ba shi da cutarwa sosai idan aka kwatanta da SARS-CoV da MERS-CoV, amma yana da saurin yaduwa.
An bayar da rahoton cewa akwai wasu cututtuka na SARS-CoV-2 da ba su da alamun cutar, wanda wataƙila ya ba da gudummawa ga saurin yaduwar cutar a duniya.
Kwatanta SARS-CoV-2 da sauran kwayar cutar HCoVs shida da kuma kwatanta su ya nuna muhimman kamance da bambance-bambance.
A farkon, yanayin da cutar ta E. coli take ciki da kuma tsawon lokacin da take ciki iri ɗaya ne.
A wannan yanayin, SARS-CoV-2 ya bi halaye na sauran nau'ikan HIV guda shida.
An gano cutar COVID-19 a tsakanin SARS-CoV da kuma HCoVs huɗu na mutane (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana da halaye da yawa waɗanda suka haɗa da rashin ƙayyadaddun, marasa ƙarfi, ko rashin alamun cutar a lokacin kamuwa da cutar ta HCoVs na al'umma.
A gefe guda, kodayake yanayin ya bambanta, cutar COVID-19 tana da kama da cutar SARS-CoV.
Na uku, yaduwar SARS-CoV-2 ta nuna halaye masu ban mamaki na SARS-CoV da HCoVs da ke cikin al'umma.
A gefe guda, yaduwar SARS-CoV-2 tana da girma kamar yadda cutar HIV ta yadu a cikin al'umma.
A wani bangare kuma, ba a tabbatar da cewa SARS-CoV-2 zai rage yaduwar cutar ba kamar SARS-CoV da MERS-CoV bayan an kwantar da shi a cikin mutane.
A ƙarshe, ana iya gano SARS-CoV-2 a cikin samfurin gwangwani, wanda yayi kama da sauran HCoVs.
"Ya kamata a bayyana a cikin wasu bincike na gaba, aƙalla a wasu yanayi, cewa SARS-CoV-2 yana da muhimmiyar rawa a cikin watsawar baki na baki, kamar yadda lamarin SARS-CoV-2 yake".
Akwai sha'awar ganin ko akwai wani nau'in SARS-CoV-2 da ke canzawa kamar yadda ake yada shi a cikin al'umma.
Duk da haka, halayen SARS-CoV-2 sun kasance masu tasiri sosai ga ƙarshen COVID-19, gami da yaduwar cutar, cutar, ci gaba da yaduwa bayan yaduwar mutum.
Dukkanin HCoVs huɗu da aka samo daga al'umma waɗanda ke haifar da ƙananan alamun sun daidaita da mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun dace da waɗannan ƙwayoyin cuta guda huɗu.
A wasu kalmomi, annoba ta duniya na farkon HCoVs na iya zama mai yaduwa.
An kawar da cutar HCoVs da ke haifar da mummunar cutar a cikin mutane da kuma wadanda ke fama da cutar HCoVs.
Don yin wannan, HCoVs suna samar da tarin abubuwan da ke haifar da ƙuntatawa a cikin mutane.
A wannan yanayin, yiwuwar daidaitawa ta hanyar cutar SARS-CoV-2 ta kasance mai tsawo kuma ta shafi mutane da yawa.
Idan ya dace, zai yi wuya a ware alaƙar tsakanin mutane ko kuma a dakatar da shi ta hanyar wasu matakan sarrafa cuta.
A cikin shekaru da yawa, an sami sau huɗu na COVID da ke tattare da al'umma a cikin al'umma, wanda ke haifar da mura a cikin waɗanda ke da rigakafin cutar.
Wadannan ƙwayoyin cuta ba sa bukatar dabba ta farko.
Akasin haka, SARS-CoV da MERS-CoV, wadanda ke haifar da cututtuka masu yawa, ba su da sauƙin daidaitawa ga mutane kuma ba za a iya dakatar da yaduwarsu daga mutum zuwa mutum ba.
Ana buƙatar bincika ci gaba da haifuwa a cikin masu ɗaukar cutar da kuma yiwuwar yaduwar waɗanda ake zargi da cutar a cikin mutane, musamman ta hanyar ɗayan matsakaici da mai ɗaukar hoto.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV/MERS-CoV da kuma nau'ikan HCoV huɗu da ke da al'umma.
HCoVs suna da saurin yaduwa, aƙalla na ɗan lokaci, kamar yadda suke yaduwa a cikin al'umma.
Koyaya, yana da cutar fiye da kwayar cutar HCoVs da ke da nasaba da al'umma kuma ba mai cutarwa ba ne fiye da SARS-CoV ko MERS-CoV.
A nan gaba za a ga ko ya dace da mutane sosai kuma ko zai iya yaduwa daga mutum zuwa mutum ba tare da mai ɗaukar kaya ko mai watsawa ba.
Kafin mu tattauna daga wane dabba ne HCoVs suka fito, yana da amfani mu tattauna ma'anar juyin halitta, halitta, haɗi, da kuma halayen masu masaukin baki na HCoVs.
Idan ƙwanƙolin sun raba babban hoto wanda ke kusa da matakin jerin nucleotide tare da asalin farko, dabba za ta zama mai ɗaukar juyin HCoV.
Kwayar cutar ta kamuwa da kwayar cutar ta hanyar kwayar halitta, wadda ta fi dacewa da mutum kuma ba ta yaduwa sosai.
A cikin tsari, mai ɗaukar hoto yana riƙe da HCoVs a kai a kai kuma na dogon lokaci.
A cikin duka biyun, masu dauke da cutar sun kamu da cutar ta halitta kuma suna dauke da cutar HCoVs ko kuma kwayar cutar mahaifa.
Akasin haka, idan HCoV ya shiga cikin masu watsawa a cikin sabon nau'i kafin ya shiga cikin mutane ko kuma a cikin yanayin da ya shiga cikin mutane, ba zai haɗu da sabon mai ɗaukar hoto ba kuma yawanci yana haifar da cuta.
Wannan mai dauke da cutar zai iya zama tushen kwayar cutar da ke iya cutar da mutum kuma yana iya taka rawa wajen sa cutar ta yadu cikin sauri, ta hanyar watsawa ga mutane don kara yawan kamuwa da cutar.
Sai dai idan ya yi yaduwa a cikin wannan mai ɗaukar hoto na ɗan lokaci, HCoV na iya ci gaba da zama cutar da ke lalata yawan jama'ar duniya.
Akasin haka, HCoVs na iya daidaitawa da masu ɗaukar matsakaici kuma suna haifar da annoba na dogon lokaci.
A wannan yanayin, matsakaicin mai ɗaukar kaya shine mai ɗaukar kaya na halitta.
Bayanai na cututtukan cututtuka sun nuna tarihin hulɗa da dabbobi waɗanda suka haɗu da babban yanayin SARS.
Binciken ya nuna cewa, bambancin da ke tsakanin su da sauran jama'a, jinsin dabbobi sun fi kama da IgG na SARS-CoV.
An gano wasu ƙwayoyin cuta masu kama da SARS-CoV a kasuwar dabbobi na farko, kamar su Pygma Larvata da Raccoon Dog.
Wannan ya kasance a kaikaice saboda babu wani SARS da aka sake yin rajista bayan an cire duk masu cutar daga kasuwa.
Amma, an ba da rahoton cewa ba a sami SARS-CoV a cikin dabbobi kamar kuliyoyi ba kafin haɗuwa da kasuwar dabbobi ta waje ko a kan masu motsa jiki, wanda ke nuna cewa dabbobi kamar kuliyoyi matsakaiciyar mai ɗaukar hoto ce, ba mai ɗaukar SARS-CoV ta halitta ba.
Musamman a kasuwar Gandu, kashi 80% na dabbobi daban-daban suna da maganin rigakafin SARS-CoV, saboda haka ba za a iya ware nau'ikan dabbobi masu shayarwa da ke watsa SARS-CoV ba.
Waɗannan ba masu ɗaukar SARS-CoV ba ne.
Bayanan jinsin sun nuna cewa kwayar halittar nocturnal da kuma na linzamin kwamfuta sune tushen asalin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban mai samar da gamma-CoVs da delta-CoVs.
An gano wadannan tsuntsaye masu tsaron gida da kuma jerin kwayoyin SARS-Rh-BatCoV HKU3.
Wannan da sauran nau'ikan tsuntsayen da ke cikin dare suna da kashi 88-92% na tsarin nucleotide tare da SARS-CoV.
Wadannan binciken sun kafa sabon ka'ida game da kwayar cutar da ke daukar mutane a cikin tsuntsaye masu barci.
An gano wasu nau'ikan SARS-like (SL-CoVs) a cikin tsuntsayen dare, amma akwai wani nau'in kwayar cutar da ta bambanta da WIV1.
An san shi da mai karɓar SARS-CoV don enzyme mai canzawa na mutum na 2 (ACE2).
Gabatarwa WIV1 an bayyana shi azaman mai karɓar maraice, don amfani da kwayar halitta daga samfurin kwayar tsuntsaye da kuma ACE2 na mutum.
Abin mamaki, marasa lafiya da ke dauke da cutar SARS ba su da ikon kamuwa da cutar WIV1.
WIV1 shine mafi kusa da SARS-CoV wanda aka samo a cikin tsuntsaye na dare, wanda ke wakiltar kashi 95% na homologous na tsarin nucleotide.
Duk da cewa akwai bambancin homology tsakanin ƙwayoyin cuta biyu, ana ganin cewa WIV1 ba kwayar cutar SARS-CoV ba ce kai tsaye kuma tsuntsayen dare ba masu ɗaukar SARS-CoV kai tsaye ba ne.
Nazarin nau'in kwayar cutar zai kawo MERS-CoV tare cikin rukuni guda na Bat-CoV-HKU4 da Nightbird-CoV-HKU5.
Nightbird COVID-HKU4 da MERS-CoV suna amfani da mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar mai karɓa.
Ana iya samun jerin MERS-CoVs na RNA polymerization a cikin kwayoyin halitta zuwa lab na kwayar halitta, wanda ya faru a Turai da Afirka.
Har zuwa yanzu, ba a gano wani nau'in MERS-CoV mai rai a cikin tsuntsaye na daji ba.
MERS-CoV da kuma dangin sa na kusa CoV-HKU25 suna da kashi 87% na kwayar cutar nucleotide.
Saboda haka, tsuntsaye na iya zama masu ɗaukar MERS-CoV kai tsaye.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman Larabawa suna da kwayar cutar MERS-CoV, wanda ke hana ƙwayoyin cuta, wanda idan ya kasance daga Gabas ta Tsakiya, yana nufin cewa raƙuman da ke ƙasashe da yawa na Afirka.
Live MERS-CoV, wanda ya yi kama da kwayar cutar da aka gano a cikin mutane, ya bambanta da magudanar hanci na raƙuman Arabiya, wanda ya nuna cewa raƙuman sun kasance masu ɗaukar MERS-CoV.
Ya kamata a lura cewa a cikin binciken dakin gwaje-gwaje, raƙuman da aka yi wa allurar rigakafi da MERS-CoV sun nuna alamun rashin lafiya amma sun sami babban ƙwayar cuta.
Wani abu da ya kamata a yi la'akari da shi shi ne, raƙuman da aka yi wa cutar ba sa fitar da kwayar cutar ta hanyar numfashi kawai, amma kuma suna fitar da kwayar cutar ta hanyar fungi, wanda shine hanyar da ake fitar da kwayar cutar daga tsuntsayen dare.
Koyaya, har zuwa yanzu, ana zargin cewa asalin cutar ta MERS-CoV ba ta bayyana a raƙuma ba kafin gano cutar, ko kuma ta hanyar wucewa daga mutum zuwa mutum ko kuma ta hanyar da ba a san ta ba, kuma an gano cewa nau'in dabba ne ya haifar da cutar.
SARS-CoV-2 yana da kashi 96.2% na kwayar cutar nucleotide tare da RATG13 na kwayar cutar da aka ware daga Rhinolophus affinis.
Kamar SARS-CoV da MERS-CoV, jerin SARS-CoV-2 da RaTG13 suna da nisa sosai kuma yana da wuya a tantance dangantakarsu.
Wannan yana nufin cewa a nan gaba, ba za a iya samun nau'in SARS-CoV-2 a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Wataƙila, an sayar da dabbobin da ke dauke da SARS-CoV-2 kuma sun kashe su a cikin babban kantin sayar da abincin teku na Hunan, wanda ya danganci yawancin shari'o'in asalin COVID-19, wanda ke nuna cewa ba a iya yada shi daga dabbobi zuwa mutane.
Binciken da aka yi kwanan nan a kan binciken metagenomic ya nuna cewa wasu dabbobi masu shayarwa da ake kira pangolins (Manis javanica) na iya zama masu dauke da tsoffin beta-CoVs da ke da alaƙa da SARS-CoV-2.
Wadannan sabon nau'in pangolin CoV sun hada da SARS-CoV-2 a cikin kashi 85-92% na tsarin nucleotide.
Duk da haka, suna da dangantaka sosai da RTG13 a cikin kashi 90 cikin dari na tsarin su na nucleotide.
Ana rarraba ƙwayoyin cuta masu kama da SARS-CoV-2 a ƙarƙashin ƙananan ƙwayoyin cuta guda biyu, ɗayan wanda ke da kamanceceniya da SARS-CoV-2 mai karɓar mai karɓar mai karɓar (RBD) a cikin 97.4% amino acid sequence tag.
Kodayake tsarin kwayoyin sun fi na farko girma, amma ba kamar yadda aka bayyana ba, SARS-CoV-2 da RaTG13 RBDs sun bambanta.
Wani binciken da aka yi a baya a kan pangolins da ke da cutar ya gano kwayar cutar a cikin samfurori na huhu, wanda aka gano yana da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyin tattarawa da kuma gyaran hannu don samar da tsarin kwayar cutar da aka riga aka tsara wanda ya ƙunshi kusan kashi 86.3 cikin dari na tsawon kwayar cutar.
Ba za mu iya musanta cewa pangolin na iya zama mai watsa SARS-CoV-2 ba.
Amma, saboda bambancin tsari tsakanin SARS-CoV-2 da beta-CoVs da ke da alaƙa da pangolin SARS-CoV-2, a halin yanzu babu wani bayani game da SARS-CoV-2 kai tsaye daga pangolin.
Bugu da ƙari, nisa tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da nesa tsakanin SARS-CoV-2 da beta-CoVs masu alaƙa da pangolin SARS-CoV-2.
Tsarin juyin halitta na SARS-CoV-2 a cikin tsuntsaye masu barci, pangolins da sauran dabbobi masu shayarwa ya ci gaba da kasancewa.
Amma an sami babban tsari na homology a cikin RBDs, kuma ana raba babban tsari na genomic wanda ya danganci beta-CoVs, SARS-CoV-2 da pangolin SARS-CoV-2, tsakanin SARS-CoV-2 da RaTG13.
Babban daidaituwa tsakanin beta-CoVs da SARS-CoV-2 na RBDs (mai karɓar ƙarshen haɗuwa) na pangolin SARS-2 ana iya danganta shi da zaɓin canjin juyin halitta mai zurfi.
Shawarwarin da aka bayar na gaba ya duba sake haɗuwa tsakanin beta-CoV da RaTG13 na pangolin SARS-CoV-2.
Haɗin yana da tasiri sosai a tsakanin beta-CoVs a matsayin ƙarfin juyin juya hali.
Wannan shawarar ta shafi asalin cutar SARS-CoV-2.
Ana kuma nazarin HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1, wadanda ke haifar da cutar.
Shaidar falogenic ta nuna cewa HCoV-NL63 da HCoV-229E sun samo asali ne daga kwayar warts, kuma an gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin beraye.
ARCoV.2 (Appalachian Ridge Cove) wanda aka gano a cikin tsuntsun dare mai launin fata na Arewacin Amurka ya nuna kusancin HCoV-NL63.
A gefe guda, an gano cewa HCoV-229E yana da alaƙa da wani nau'in kwayar cutar da ake kira Hipposideros/GhanaKwam/19/2008 da aka samo a Ghana, yayin da raƙuma ma ta kasance mai ɗaukar hoto.
Don a bayyana, an bayyana fahimtarmu game da HCoVs daga dabbobi a hoto na 1 da tebur na 2.
Binciken ilimin halittu ya ba da tabbacin cewa an sami ciwon HPV a cikin tarihin.
A cikin shekarun 1890, an rubuta annobar cutar numfashi lokacin da HC43 ya watsa kwayar cutar daga dabbobi don cutar mutane.
Ba a san yadda HCoV-229E ke yaduwa tsakanin jinsuna ba.
An gano alpha-CoVs na bat da ke da alaƙa da HCoV-229E.
A cikin su akwai alpha-CoV na Alpaca.
Bayanai da dama sun goyi bayan kai tsaye daga tsuntsaye zuwa mutane.
Na farko: Alpacas (dabbobi masu dogon wuyansa da gashi a Kudancin Amurka) ba za su iya haɗuwa da tsuntsaye na dare ba, amma a cikin yanayin yanayin da mutane ke da shi.
Maimakon haka, mutane ba su taɓa yin hulɗa da alpacas ba.
Na biyu, alpha-CoVs na tsuntsaye masu haɗuwa da HCoV-229E sun bambanta a cikin tsuntsaye masu haɗuwa da kuma ba su haifar da cutar ba, yayin da alpha-CoVs na alpaca ya haifar da kamuwa da cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano alpha-CoV a cikin namun daji ba.
Saboda haka, bai kamata mu daina yin zato cewa alpacas na iya samun cutar HCoV-229E-da aka danganta da alpha-CoV a cikin mutane ba.
A gaskiya ma, tsuntsaye na dare sune tushen cututtukan da ke cutar da mutane, ciki har da cutar kare mai hauka, cutar Ebola, cutar Nipah, da kuma cutar Hendra.
Saboda haka, ba abin mamaki ba ne cewa tsuntsaye masu rarrafe suna iya kaiwa mutane cutar HCoV-229E kai tsaye.
A madadin haka, alpha-CoVs na tsuntsaye na dare suna amfani da su a matsayin tarin kwayoyin HCoV-229E, kuma suna iya ɗaukar ƙwayoyin cuta zuwa ga mutane kamar MERS-CoV, alpacas, da raƙuman Arabian.
Mears-CoV yana iya zama misali mai kyau na cutar da ke yaduwa daga nau'in tsuntsaye zuwa nau'in raƙumi, daga raƙumi zuwa mutum.
An fara gano asalin juyin halitta na Mars-Cov a cikin tsuntsaye na dare, kuma an tabbatar da shi ta hanyar binciken da aka samu.
"A bayyane yake cewa tsuntsayen dare suna samar da tarin kwayoyin cuta masu yawa a cikin musayar kwayoyin halitta da kuma watsawa zuwa kwayoyin halitta.
Tsawon lokaci, taro mai yawa, haɗuwa da juna da kuma iyawar tsuntsaye masu tashi da ƙarfi sun ba da yanayi mai kyau don yaduwar kwayar cutar.
A gefe guda kuma, Merse-Cove ya yi shekaru da yawa yana da raƙuma.
Ya dace da waɗannan raƙuman da suka canza daga matsakaiciyar ɗaukar kaya zuwa madaidaiciya da ɗakunan ajiya na halitta.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan canje-canje a cikin waɗannan dabbobin.
Rashin saurin kamuwa da cutar a cikin mutane ba zato ba tsammani ne, kuma har sai an sami damar hana yaduwar cutar, mutane za su kasance masu ɗaukar cutar mai haɗari ga wannan MERS-CoV.
Kasuwancin raƙuma a cikin yaduwar MERS-CoV idan aka kwatanta da na pangolins, yaduwar SARS-CoV-2 ta bambanta.
Musamman ma, beta-CoVs na pangolin suna da matukar damuwa ga lafiyar pangolin.
Za su iya zama masu watsa beta-CoVs na ƙarshe waɗanda ke hulɗa da SARS-CoV-2, kamar yadda ƙuda ke hulɗa da SARS-CoV.
Akwai yiwuwar kamuwa da SARS-CoV-2 daga dabbobi zuwa mutane a cikin binciken da zai biyo baya.
Da farko dai, tsuntsayen dare na iya zama masu ɗaukar kwayar cutar SARS-CoV-2 da kuma irin SARS-CoV-2.
'Yan Adam suna iya raba yanayin halittu kamar tsuntsaye, ta hanyar cin dabbobi ko hakar kwal.
Na biyu, sabbin kamuwa da cuta daga masu daukar kwayar cutar ta Pangolin da kuma SARS-CoV-2.
Mutane suna kamuwa da cutar ne ta hanyar farauta da cin dabbobi.
Yawancin dabbobi masu shayarwa, gami da dabbobin gida, na iya zama masu haɗari ga SARS-CoV-2.
An ba da izinin binciken dabbobi na gida da na daji don dalilai na rigakafi.
Na uku: Kamar yadda aka ambata a sama, sake dawowa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Ana ci gaba da binciken asalin SARS-CoV-2 a cikin dabbobi.
Ba kamar masu ɗaukar dabbobi ba, manyan abubuwan da ke haifar da cutar guda uku suna da mahimmanci don daidaita kwayar cutar a duk faɗin iyakokin kwayar.
Da farko, ana auna daidaito mafi girma a cikin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta masu haɗa RNA guda ɗaya, ƙimar canjin COVs, bisa ga matakin daidaitawa na COVID ga masu ɗaukar sabon abu, ana iya rarraba su daga  matsakaici zuwa  mafi girma, tare da matsakaicin canjin sau ~10-4 a ko'ina a shekara 2.
Cova suna da tabbacin-karatun exorbibolicles, wanda lalacewar sa ke haifar da canjin hali mai yawa da kuma rashin ƙarfi ko rashin iya ci gaba.
Abin mamaki, ana iya ganin samfurori na nucleotide na Remdesvir suna hana kwayar cutar ta COV ta hanyar riƙe wannan exoribonucleus da RNA mai dogara da RNA polymers.
Remdesivir yana daya daga cikin magungunan SARS-CoV-2 masu matukar tasiri da ake gudanar da gwajin asibiti.
Amma, iyawar haihuwar tsuntsayen da ke cikin teku ta ninka ta masu ɗauke da su sau miliyan.
Bugu da ƙari, yawan canjin da ake samu a cikin kwayar halitta yana da yawa idan kwayar ba ta daidaita da mai ɗaukar kwayar ba.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan yaduwar kwayar cutar, akwai tabbacin cewa SARS-CoV-2 yana da ƙananan yaduwar kwayar cutar, wanda ke nuna babban matakin daidaitawa ga mutane.
Wataƙila, idan yana kusa da mutane, ya riga ya saba da wani mai ɗaukar hoto.
Baya ga SARS-CoV-2, yana kuma da alaka da MERS-CoV, wanda aka tsara a kan raƙuman raƙuman ruwa guda.
A cikin yanayin ɗan adam, allurar rigakafin kwayar halitta da rigakafin cutar SARS-CoV-2 ba za su yi nasara da sauri ba.
Na biyu, babban kwayar RNA a cikin kwari yana ba da ƙarin filastik a cikin haɓakar kwayar halitta ta hanyar canzawa da sake haɗawa, don haka ƙara damar co-juyin halitta ga nau'ikan halittu, kuma yana ba da damar fitowar sabon coronavirus lokacin da yanayi ya dace.
Wannan yana da goyon baya ta hanyar tsarin karatun da aka tsara na musamman da kuma ayyukan sunadarai da aka tsara don shiga cikin ƙarshen 3′ na genomic.
"Na uku, yayin da RNA ta COV ta yi kwafi, tana iya kwafa da kuma canza kanta ba zato ba tsammani kuma a kai a kai ta hanyar "zabin kwafi" na musamman".
A cikin mai ɗaukar hoto, wanda ake amfani da shi azaman mai haɗawa, sauye-sauyen tsalle-tsalle yana faruwa sau da yawa yayin kwafin RNA na COVID.
RNAs masu cikakken tsawon lokaci da ƙananan genomic suna haɗuwa tare don ƙirƙirar sababbin Covi.
An gano masu sake dawo da kwayar halitta ta phylogenetic a cikin HCoV-HKU1 da HCoV-OC43 a cikin tsuntsayen dare SL-CoV da batCoV-HKU9, duka biyu na dabbobi.
A cikin wannan yanayin, ana iya samun cutar ta hanyar taɓawa.
Baya ga dalilai uku na kwayar cutar da aka ambata a sama, hulɗa da kwayar cuta ita ce wani muhimmin abu da ke haifar da yaduwar kwayar cutar ta hanyar nau'in mai ɗaukar hoto.
Misali na sake haɗuwa da SARS-CoV-2 shine, wanda ya nuna tabbataccen zaɓi a lokacin abubuwan da ke faruwa a cikin jinsin.
Bisa ga nazarin kwatancen, wani nau'i na SARS-CoV na mutum da na namomin kaza, SARS-CoV, ya ba da damar daidaitawa cikin sauri ga masu jigilar abubuwa daban-daban, musamman ma a cikin musayar S-protein RBD.
RBD, wanda aka samo a cikin furotin na COVID S, yana haɗuwa da mai karɓar ƙwayoyin cuta, kuma an fi zaɓar mai hana amsawar rigakafi.
A cikin SARS-CoV, RBD yana cikin sashin S1 na 318 zuwa 510 amino acid, wanda shine abin da ke haɗa ACE2 na mutum zuwa mai karɓar ƙwayar cuta.
SARS-CoV RBD (mai karɓar ƙarshen haɗuwa) yana da ikon gano masu karɓar ACE2 a cikin dabbobi, gami da tsuntsaye, dabbobin daji, beraye da karnukan raccoon, wanda ke ba da damar watsa kwayar cutar ta hanyar masu rarraba.
Hakanan, an gano nau'ikan amino acid guda 6 daban-daban daga kwayar cutar ɗan adam da ƙwayar cuta kuma 4 daga cikin waɗanda ke musayar mai karɓar ACE2 suna cikin mahallin mai karɓar mai karɓa.
Civet yana da K479 da S487T masu musayarwa a cikin SARS-CoV RBD (mai karɓar mai karɓar mai karɓar mai karɓa), kuma yana haɓaka haɗin haɗin haɗin ƙwayoyin cuta a cikin mai karɓar ACC2 na ɗan adam.
A wasu kalmomi, waɗannan canje-canjen amino acid guda biyu na iya zama mahimmanci don kwayar cutar ta iya shiga cikin mutum.
"Abin sha'awa shi ne cewa SARS-CoV-2 yana yaduwa a cikin kwayoyin da suke da cutar SARS-CoV".
Bambancin kashi 30% tsakanin SARS-CoV-2 da SARS-CoV-2 na iya dakatar da haɗin S protein na S1 tare da ACE2 na jini.
A gaskiya ma, binciken CRIO-EM ya nuna cewa wannan kwayar tana da dangantaka da sau 10 zuwa 20 fiye da yadda yake tsakanin ACE2 da SARS-CoV S a cikin mutane.
Ana buƙatar yanke shawara ko ana buƙatar sauran manyan masu karɓar SARS-CoV-2 don watsawa.
Abin mamaki, HCoV-NL63 yana da alaƙa da ACE2 amma yana da alaƙa da wani S.
Akwai wasu masu karɓar HCoVs da yawa, kamar su aminopeptides N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Bayan an yi amfani da su a cikin jinsin dabbobi masu dauke da su, ba su da wani muhimmin matsayi a cikin nasarar daidaita wannan kwayar cutar zuwa ga mutane.
Baya ga masu karɓar ƙwayoyin cuta, sakamakon yaduwar HCoVs yana haifar da wasu masu ɗaukar hoto da sauran dalilai.
Rarrabuwa tsakanin waɗannan sunadarai masu ɗaukar hoto tsakanin mutane da manyan masu ɗaukar su na halitta, kamar su tsuntsaye masu dare, raƙuman ruwa masu tsayi, da beraye masu dogon fuska, na iya haifar da ƙuntatawa ga watsawa tsakanin nau'ikan.
Don samun nasarar rarraba jinsuna, HCoVs dole ne su sami mafaka a cikin wuraren da ake buƙata kuma su bi iyakokin mai masaukin baki.
Suna da mahimmanci a wannan yanayin, suna ƙayyade, rarrabewa, da kuma rarraba kwayoyin da ke kewaye da haɗin ƙwayar cuta.
Yin amfani da fasahar CRISPR na zamani don bincika tushen mai ɗaukar SARS-CoV-2 da ƙuntatawa na ƙwayar cuta mai ƙarancin kwayar halitta na iya zama da amfani.
An sake gina sabon gidan da ake kira Novel Hskovch.
Daban-daban na tsuntsayen dare suna haifar da babban damar zuwa sabon nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
A wannan yanayin, tsuntsayen da suke yin dare suna zama wurin da ake yin taro.
Bugu da ƙari, sauyawa da sauri da kuma sake tsarawa suna ƙayyade tsarin HCoV kuma suna aiki a matsayin matakai biyu a cikin wannan tsari.
Alal misali, gano ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
A cikin sunadarai masu amfani da SARS-CoV, ORF8 ya zama dole don daidaitawa ga mutane, wanda aka gano don shigar da sunadarai daban-daban na ORF8, kamar yadda aka gano daga tsuntsayen dare masu alaƙa da SARS-CoV.
An gano ɓarnar fasalin SARS-CoV-29, a cikin gwajin da aka yi a farkon barkewar cutar a cikin mutane.
Wannan sokewar yana haifar da daidaitaccen haifuwa ta hanyar raba ORF8 zuwa ORF8a da ORF8b.
Bugu da ƙari, SARS-CoV-2 na iya samun alaƙa ta tarihi tare da SARS-CoV-2 da gamma-CoV-2.
An kuma gano wuraren sake haɗuwa a cikin nsp9, yawancin nsp10, da kuma sassan nsp14.
Hakazalika, wani binciken da aka yi a kan wani shayin Saudi Arabia ya nuna cewa akwai yiwuwar sake haɗuwa tsakanin nau'ikan nau'ikan MERS-CoV.
An lura da abubuwan da suka faru na sake haɗuwa a cikin wasu HCoVs, wanda ya yi daidai da SARS-CoV da MERS-CoVs, wanda shine yanayin da HCoVs ke sake haɗuwa da kwayoyin halittar su na wasu dabbobi.
Ya kamata a yi taka tsantsan, musamman ma a cikin nau'in rigakafin mai ɗaukar hoto, wanda zai iya haifar da sauye-sauye na ba zato ba tsammani a cikin nau'in kwayar cutar, wanda zai iya haifar da matsin lamba na zaɓi wanda zai iya haifar da keɓewar kwayar cutar.
Misali na irin wannan lalacewa shine raguwar tsawon ORF4 a cikin kwayar HCoV-229E, wanda ke nufin asarar nucleotides biyu.
An gano OARF4 a cikin kwayar cutar Nightbird da Camel da ke da alaƙa da HCoV-229E, wanda ya nuna shigar da kwayar cutar alpha-CoV guda ɗaya ta hanyar canza yanayin.
A ƙarshe, juyin halitta na Novell HCoVs kuma yana ƙarƙashin matsin lamba na zaɓi a cikin masu ɗaukar kaya.
Idan tsuntsaye suka kai hari ga tsuntsaye, ba su da wata alama ko kuma suna nuna alamar cewa suna da dangantaka mai kyau da tsuntsaye da tsuntsaye.
An nuna cewa tsuntsayen dare sun dace da COVID ta hanyar ilimin halittu da na jiki.
Alal misali, tsuntsaye da suke yin yawo da dare ba sa nuna alamun cutar kafin su kamu da cutar, kuma hakan yana rage yawan tsuntsaye da suke yin hakan.
Bugu da ƙari, a cikin tsuntsaye, mafi girman alamar alamar haɗuwa da ƙwayar cuta shine ƙananan matakan kwayoyin halitta na matakin I, wanda ke hana mai karɓar kwayar halitta mai kisa NKG2/CD94 daga haɓaka madaidaiciya.
Bugu da ƙari, yawan aikin hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan hawan.
Ƙarin ƙwayoyin cuta na COVID na iya haɗuwa da haɓaka, wanda ke haifar da samun sabbin sunadarai ko alamun sunadarai don daidaitawa ga mai ɗaukar hoto.
Saboda haka, ba daidaituwa ba ne cewa abubuwa uku na Novel HCs sun faru a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutarwa ko kuma suna haifar da ƙananan alamomi a kan manyan masu ɗaukar su, kamar tsuntsaye da raƙuma.
Ba tare da samun amsa mai ƙarfi na rigakafi ba, suna jin yunwa.
An bayyana abin da ya sa masu dauke da cutar ba tare da alamun cutar ba suka bayyana kuma suna haifar da mummunan kamuwa da cutar a cikin mutane.
Alamun cutar suna faruwa ne a lokacin da ake samar da sinadarin cytokine a wuraren da tsarin rigakafi ke da karfin gaske, wanda hakan ke haifar da lalacewar huhu.
A gefe guda, amsawar rigakafi a cikin masu ɗaukar sigina ta ragu daga yawan COVID.
Irin wannan dabarar kawar da rigakafin cutar na iya samun sakamako mai amfani ga maganin SARS-CoV-2.
Amsar da ke tsakanin jini da jini tana da ƙarfi sosai a tsuntsaye masu barci.
Saboda haka, bayar da maganin interferon na nau'in I zai zama da amfani aƙalla a farkon kamuwa da cutar SARS-CoV-2 a cikin mutum.
Bugu da ƙari, ba a fara farawa na NLRP3 a cikin tsuntsaye masu dare ba.
A cikin wannan tunanin, ana iya amfani da rigakafin cutar NLRP3 tare da MCC950 don magance COVID-19.
An gano asalin SARS-CoV-2 a cikin yanayin da aka samu na SARS-CoV da MERS-CoV.
An gano beta-CoVs da ke dauke da SARS-CoV kuma suna da kashi 95% na kwayar cutar, yayin da akwai SARS-CoV-2 da ke dauke da kwayar cutar da ke da kashi 96% na kwayar cutar.
Amma an gano wasu nau'ikan kwayar cutar SARS-CoV-2 a cikin kwari da sauran dabbobi da aka sayar, kuma ba a gano wanda ke watsa SARS-CoV-2 a kusa ba.
An gano beta-CoVs na pangolin a matsayin homologous ga SARS-CoV-2, wanda ke nuna cewa masu ɗaukar hoto na pangolin na iya ɗaukar nau'ikan SARS-CoV-2 na ƙarshe.
Duk da cewa akwai tambayoyi, babu wata hujja da ta nuna cewa SARS-CoV-2 ya kasance mai tunani ko kuma ya samo asali ne ta hanyar mutum.
An sake mayar da hankali kan Covts saboda barkewar cutar SARS-CoV-2 kwanan nan.
Nazarin kwayar cutar HCoVs a cikin tsuntsaye da sauran dabbobi ya canza fahimtarmu game da asalin kwayar cutar HCoVs da mahimmancin masu ɗaukar dabbobi a cikin yaduwar mutane.
Akwai tabbacin tabbatacce cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga tsuntsaye kuma ana iya watsa su ga mutane ta hanyar masu jigilar kayayyaki.
Idan da a ce an rufe kasuwanni kuma an kashe masu cin abinci, za a iya dakatar da barkewar cutar SARS-CoV saboda hulɗa da mutane da kuma kwari a kasuwa.
A cikin irin wannan tunanin, saboda akwai nau'ikan beta-CoVs na pangolin da ke da alaƙa da SARS-CoV-2, ya kamata a cire pangolin daga kasuwannin ruwa don hana yaduwar cutar.
Koyaya, ko SARS-CoV-2 zai iya yaduwa ga mutane ta hanyar pangolins da sauran dabbobi ko kuma yadda za a iya yaduwa, bincike na gaba ne.
A wani bangare kuma, ana iya samun Merck-Cov a cikin raƙumi mai tsayi na dogon lokaci.
Ana amfani da raƙuman don jigilar kaya, nama, madara, gashi da kayan fata ga al'ummomin yankin.
An yada su sosai daga Gabas ta Tsakiya zuwa Afirka.
Saboda haka, ba za a iya yin hadaya da dukkan raƙuma ba don hana Mersin, kamar yadda aka yi a kasuwar dabbobin daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar cutar ta MERS, ana buƙatar hanyar haɗin kai tare da sauran matakan sarrafa kamuwa da cuta don samun ingantattun alluran rigakafi daga MERS-CoV wanda ke cutar raƙuma.
Ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, saboda haka za a iya haifar da sabbin nau'ikan ƙwayoyin cuta da ke haifar da annoba.
An gano wasu nau'o'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Musamman, kwari na kwari, wanda ke iya kawo cututtuka, ya bambanta.
Akwai yiwuwar cewa wadannan nau'o'in cutar za su sake juyawa kuma su sake haɗuwa, kuma za su iya zama masu saurin kamuwa da cutar ko kuma su kashe jarirai a nan gaba.
A wasu yankunan kasar Sin, an hana cin naman daji don rage hulɗa tsakanin mutane da dabbobi.
Dangane da haɗarin SARS, MERS da COVID-19, ana buƙatar babban shiri da cikakken kulawa don kulawa da wuri.
A gaskiya, ƙwayoyin cuta da yawa sun daɗe a duniya.
Suna zama a cikin yanayin da suke ciki har sai an samar da yanayi mai kyau don yaduwa.
Ko da yake tsuntsaye suna da damar watsa ƙwayoyin cuta, idan mutane suka san cewa su guje su, hakan zai rage haɗuwa da tsuntsaye da sauran dabbobin daji.
Kulawa akai-akai da dabbobi masu shayarwa na da muhimmanci don fahimtar yanayin halittu na kwari da masu jigilar su na halitta, wanda zai tabbatar da mahimmancin su wajen hana yaduwar cututtuka daga dabbobi zuwa mutane da kuma cututtuka na gaba.
A takaice, hanya mafi inganci ga mutane don hana asalin kwayar cutar ita ce ta guje wa asalin halitta na kwayar cutar.
Akwai wasu abubuwa da yawa da suka bayyana a cikin hasashen tushen SARS-CoV-2.
Idan tsuntsun dare yana watsa SARS-CoV-2 zuwa pangolin, ya kamata a bincika abin da tsuntsun dare da pangolin suke da shi.
Na biyu, idan tsuntsaye na dare suna taka rawa kai tsaye a cikin yaduwar kwayar cutar zuwa ga mutane, za a gano yadda mutane za su iya hulɗa da tsuntsaye na dare.
Na uku, idan dabba mai shayarwa ta uku ta zama mai watsawa, ya kamata a bayyana yadda ta yi hulɗa da wasu nau'in, ciki har da mutane, tsuntsaye masu ba da dare, da pangolins.
A ƙarshe, ya kamata a yi bincike da kuma lura da kamuwa da cutar saboda dabbobi masu shayarwa da yawa, gami da dabbobin gida, na iya zama masu haɗari ga SARS-CoV-2.
Ana sa ran cewa tsuntsaye, pangolins, ko wasu dabbobi za su iya zama masu ɗaukar SARS-CoV-2 ko ƙwayoyin cuta masu alaƙa da su a nan gaba.
Bincike mai gudana a cikin wannan fannin yana ba da damar nazarin yanayin juyin halittar SARS-CoV-2 a cikin dabbobi, tare da shawarwari don hanawa da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta bukatun gwaji don waɗanda ake zargi da waɗanda ba a tabbatar da su ba na COVID-19
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar gaggawa don ganowa da magance kamuwa da cutar novel coronavirus (2019-nCoV) na 2019, kuma wannan jagorar tana ba da kwarewarmu kuma tana ba da kyakkyawan tunani don yaƙar wannan annobar a duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma tare da ci gaba da binciken bincike da ayyukan asibiti, iliminmu da wayewar kai suna ƙaruwa a hankali, don haka, hanyoyin ganowa da magani suna ci gaba da kasancewa kusa.
A cikin wannan wasikar, mun amsa shawarwarinmu game da jagorarmu kuma mun gabatar da sabon tsarin bincike bisa ga sabon jagorar bincike da magani na COVID-19 (na bakwai) bisa sabon tsarin bincike da magani wanda Kwamitin Kiwon Lafiya na Jama'ar Jamhuriyar Sin ya fitar.
A watan Disamba na 2019, sabon kwayar cutar coronavirus (2019-nCoV) ta haifar da annoba, wanda yanzu aka kira shi da sunan cutar coronavirus 2019 (COVID-19) kuma an sanya wa kwayar cutar sunan coronavirus mai saurin numfashi 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba ta duniya.
Don yaƙar cutar SARS-CoV-2, ƙungiyarmu ta shirya jagorar gaggawa kuma an buga ta ta yanar gizo ta Cibiyar Nazarin Likitocin Soja a ranar 06 ga Fabrairu, 2020.
Tun da aka wallafa shi, an yi masa ba'a sosai.
Ka tuna cewa COVID-19 sabon cuta ne, kuma fahimtarmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike na yanzu da ayyukan aikin asibiti, don haka hanyoyin ganowa da magani suna ci gaba da haɓaka.
Misali, Ka'idojin Ganowa da Kula da COVID-19 da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/), A.S., ya fitar da juzu'i bakwai daga 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, tare da wasu mahallin da aka canza sosai.
Yanzu da aka karɓi shawarwari daga masu ba da shawara, sun ba da shawarar sauƙaƙe sakamakon sakamakon bisa ƙwarewar asibiti.
Aikin su ya kawo sabon shaida don jagorarmu kuma yana ba da darajar wannan annobar a duk duniya.
Muna goyon bayan wannan muhimmin aiki kuma muna godiya.
Koyaya, aikin su ma yana buƙatar sabuntawa bisa ga sabbin hanyoyin bincike da magani na COVID-19 (na bakwai na gwaji) da kuma binciken da aka yi kwanan nan.
A cewar fitowar ta bakwai (Maris 3rd, 2020), dole ne wanda ake zargi ya cika bayanan asibiti guda uku, sai dai idan ya bayyana cewa ana buƙatar haɗa abubuwa biyu na bayanan asibiti don gudanar da cikakken bincike, ko kuma idan ba a bayyana ba:
Tarihin cututtukan cututtuka: (1) Tarihin tafiye-tafiye ko kasancewar wasu masu cutar COVID-19 a cikin garin Wuhan da kewaye, ko kuma a cikin wasu lokuta na COVID-19 da aka ruwaito a cikin kwanaki 14 kafin bayyanar bayyanar, (2) Tarihin hulɗa da masu cutar SARS-CoV-2 (tare da gwajin alumic acid), (3) Tarihin hulɗa da marasa lafiya da ke da zazzabi ko alamun numfashi a cikin garin Wuhan da ke kewaye, ko kuma sauran al'ummomin da ke da alaƙa da COVID-19, (4) Jerin ƙwayoyin cuta (≥ 2K) da aka tabbatar da su a cikin makonni 2 a cikin wuraren da aka gano (watau gida, ofis, wurin aiki, da sauransu).
Bayanan asibiti: (1) zazzabi da / ko alamun numfashi; (2) tare da manyan alamun gano hoto na kamuwa da COVID-19; (3) jimlar adadin ƙwayoyin farar jini waɗanda ke nuna daidaito, raguwa, ko ƙarancin lambobin lymphocyte a farkon matakin.
Binciken da aka tabbatar ya kamata ya dogara da abin da ake zargi: (1) tabbatacce a gwajin PCR na ainihi don SARS-CoV-2; (2) jerin kwayoyin halittar kwayar cutar da ke nuna babban aiki ga sabon kwayar cutar corona; (3) gwajin kwayar cutar ta IgM na musamman da gwajin IgG na SARS-CoV-2 a cikin kwayar halitta, ko kuma daga kwayar cutar SARS-CoV-2 ta musamman zuwa tabbatacce, ko sau 4 sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau sau
Ana iya ganin gwajin PCR na lokaci na ainihi don gwajin acid na nucleic a cikin kwayoyin numfashi ko samfuran jini a cikin na biyu (Janairu 18th, 2020) da na uku (Janairu 22nd, 2020).
An ƙara gwajin jini a cikin fitowar ta huɗu (Janairu 27, 2020) da ta biyar (Fabrairu 8, 2020). Bayan haka, an ƙara tabbacin serological a fitowar ta bakwai.
Wadannan gyare-gyare, bisa ga ci gaba da aikin masu bincike, sun dogara ne akan ingantaccen na'urar gano nucleic acid don saurin ganewa, da kuma kara samfurori daban-daban daga kwayoyin numfashi, gami da samfurin jini, da kuma samar da sakamako mai kyau na musamman na anti-mutum a cikin ma'aunin da aka tabbatar.
Bugu da ƙari, akwai ƙarin bayani da ke nuna cewa muna bukatar mu mai da hankali ga marasa lafiya da ke nuna alamun cutar da waɗanda ba su da alamun cutar.
Saboda haka, za a sabunta teburin aikin Zhou et al. saboda an yi la'akari da mutanen da ba su da alamun asibiti a matsayin masu ƙananan haɗari.
Hakanan za'a tabbatar da tsarin sakamako a cikin ayyukan asibiti da karatu.
A ƙarshe, za a sami tabbaci kai tsaye kuma za mu kira masu karatu su ba da ra'ayinsu.
"Don gudanar da bincike kan abubuwan da ba a zata ba da kuma tuhumar da ba a tabbatar da ita ba, muna ba da shawarar su bi sabbin ka'idoji na kasashensu.
Ƙungiyarmu tana sabunta jagorarmu a kai a kai don taimakawa.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar a rana
A jiya, Bangladesh ta tabbatar da sabbin mutuwar mutane biyar a wannan rana saboda COVID-19.
Wannan shi ne adadin mafi girma na mutuwar da aka samu a rana guda saboda cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta yi rikodin kuma ta ba da rahoton mutane 114 da ke jinya da kuma 33 da suka warke da kuma kewaye da gida.
An samu mutuwar mutane 17.
A wani rahoto na yanar gizo, Daraktan IEDCR, Dr. Mirjaddi Sabrina Flora, ya ce, wadanda suka mutu sun hada da maza hudu da mace daya.
"A cewar Dr. Merjadie, akwai marasa lafiya biyu da suka haura shekaru 60, biyu da ke tsakanin shekaru 51 zuwa 60, da kuma daya da ke tsakanin shekaru 41 zuwa 50.
"Bayan wannan, sai aka yi wa wasu mutane barazana.
A ranar 11 ga watan Maris ne Hukumar Lafiya ta Duniya ta ayyana cutar ta COVID-19 a matsayin annoba.
A cikin wadanda suka mutu akwai Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta kasar Bengal, wanda ake sa ido a asibitin Maitree na Kuwait, in ji jami'an asibitin ga kamfanin dillancin labarai na Anadolu.
A ranar Asabar, Ministan Sufuri da Bridges na Bangladesh Obaidul Quader ya sanar da sanarwar bidiyo cewa za a rufe jigilar jama'a fiye da yadda aka tsara a farkon Asabar.
An fara wannan rufewar jigilar jama'a ne a ranar 26 ga Maris kuma an shirya za ta kare a ranar Asabar, 4 ga Afrilu.
Har yanzu an ba da izinin jigilar kayayyakin rayuwa - magani, mai da abinci.
An fara samun rahoton cutar COVID-19 a Bangladesh a ranar 8 ga Maris, wanda ya shafi mutane biyu da suka dawo daga Italiya, tare da matar daya.
Tun daga ranar 19 ga watan Maris, ukun sun riga sun warke.
Yawan wadanda suka kamu da cutar SARS-CoV-2 a duniya ya wuce miliyan daya
Rahotanni daga Jami'ar Johns Hopkins sun nuna cewa jimillar adadin wadanda suka kamu da cutar SARS-CoV-2 a duniya sun zarce miliyan daya a ranar Alhamis.
Akalla 52 daga cikin mutuwar sun danganci cutar coronavirus.
Malawi ta samu mutuwar farko da ke da nasaba da cutar korona a Zambia, inda ta tabbatar da kamuwa da cutar ta farko.
Koriya ta Arewa ta ce tana daya daga cikin kasashen da suka fi 'yancin kamuwa da cutar coronavirus tun ranar Alhamis.
Hukumar Lafiya ta Duniya ta sanar jiya cewa jimillar mutane 1,051,635 ne suka kamu da cutar, ciki har da 79,332 a cikin awanni ashirin da huɗu bayan karfe 10 na ranar 4 ga Afrilu (0800 UTC).
An samu sama da mutane 244,000 da suka kamu da cutar coronavirus a Amurka, tare da mutuwar mutane akalla 5,900.
CBS News ta ruwaito cewa, fiye da mutane 1,000 ne suka mutu a Amurka sakamakon kamuwa da cutar coronavirus a ranar Laraba, ta nakalto bayanan jami'ar Johns Hopkins.
A duk duniya, kasashe sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
A matakin kasa, shugaban kasar Vladimir Putin ya sanar da cewa 'yan kasar Rasha za su ci gaba da karbar albashi ba tare da zuwa aiki ba har zuwa ranar 30 ga watan Afrilu.
Majalisar dokokin Portugal ta yanke shawarar tsawaita dokar ta baci na kwanaki 15 da kuri'u 215, 10 a kan 1 a kan.
Saudiyya ta tsawaita dokar hana fita a Makka da Madina, inda a baya ta kasance tsakanin karfe 3 na yamma zuwa karfe 6 na safe.
Thailand na shirin aiwatar da dokar hana fita da karfe 10 na dare da 4 na dare.
Gwamnan Ohio Mike DeWine ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga watan Mayu.
A Ostiraliya, kantuna sun rage yawan takardar bayan gida da suke sayarwa
A ranar Lahadi da Asabar, manyan shagunan Australia na Wellworth da Coles sun rage iyakar siyar da takardar bayan gida guda daya a duk shagunan su na kasa zuwa biyu da daya.
ALDI ya gabatar da dokar hana fita a ranar Litinin.
An sanya wadannan takunkumin a kan shafukan yanar gizo na Facebook da kuma na kudi.
An bayar da rahoton cewa masu amfani sun adana kayayyaki saboda tsoron COVID-19 da yiwuwar keɓewa.
A ranar Laraba, Woolworths ta yi odar takarda ta gida da kayan wanka a cikin fakiti.
Waɗannan canje-canjen sun biyo bayan iyakar musayar da aka gabatar a baya ta Woolworths da Coles a ranar 4 da 5 ga Maris, bi da bi.
A cikin wata sanarwa da ya fitar ga manema labarai a ranar 8 ga watan Maris, Coles ya ce, "Kasuwanci da yawa suna sayar da kaya a cikin awa daya da aka aika" kuma bukatar "ba a taɓa ganin irinta ba" a cikin wani sakon ALDI a shafin Facebook a ranar Talata.
A makon da ya gabata, mai magana da yawun Woolworths ya ce tallace-tallace sun nuna karuwar da ta yi yawa.
Costco a Canberra ya rage adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ta ba da umarnin manyan fakiti daga masu samarwa kuma ta ƙara yawan isar da su; Walworths ta ba da umarnin ƙarin kayan da aka shirya don siyarwa, kuma ALDI ta shirya tallace-tallace na musamman a gaba don ranar Laraba da aka tsara.
Russell Zimmerman, darektan zartarwa na kungiyar 'yan kasuwa, ya ce 'yan kasuwa na son kara yawan tallace-tallace, amma dokar majalisar karamar hukuma kan lokacin isar da motoci ta sanya hakan ya zama da wahala.
Yana tsammanin farashin kayayyaki zai ragu yayin da muke jiran masu samar da kayayyaki da sauran abubuwan da suka fi dacewa.
ALDI ta sanar a ranar Litinin cewa wasu shagunan ba za su gudanar da ranar musamman ta ranar Juma'a ba, bayan da aka saki Stock.
A cikin rahoton News.com.au, Dr Gary Mortimer, masanin sayar da kayayyaki daga Jami'ar Fasaha ta Queensland, ya ce shagunan suna cike da kayayyakin da aka shirya don siyarwa kowane dare.
Tsabtace takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda takarda
"A cewar ABC, Russell Zimmerman ya ce, "Ra'ayin Coles da Woolworths shi ne, idan akwai abubuwa da yawa a kan ɗakunan ajiya, za a iya rage yawan ƙura da za a iya samu ta hanyar samun kayan tsabta da tawul da za a yi amfani da su wajen wankewa".
Masu samar da takardar bayan gida mai jujjuyawar takarda sun ce a ranar Laraba da ta gabata cewa sun kusan ƙarewa.
Kimberly-Clark, Knex Toilet Soft, da Solaris Paper, wanda ke aiki da kayan shara, sun nuna cewa suna aiki 24/7 don tallafawa wadatar, kamar yadda News.com.au ta ruwaito.
Shafin yanar gizo na dukiya mai suna Domain.com ya ruwaito wasu dillalai na gidaje a Melbourne suna ba da takardar bayan gida kyauta ga mai nema na farko a gwanjo, saboda 'yan gwanjo kaɗan ne kawai a lokacin da masu siye ke hutu a ranar ma'aikata na dogon mako.
Jaridar NT News ta ranar Alhamis, wadda Darwin ke wallafawa kullum, ta ƙunshi shafuka takwas da za a iya amfani da su a matsayin takarda na bayan gida da kuma takarda.
A farko, shagunan sun yi watsi da takunkumin, suna mai cewa ba su da wani shiri na gabatar da takunkumin sayayya, kamar yadda rahoton ABC Australia ya nuna a ranar 3 ga Maris.
Russell Zimmerman ya kara da cewa akwai bukatar kayayyaki da dama, ciki har da abin rufe fuska, na'urar tsabtace jiki, kayan bushewa, wanke hannu da kuma foda.
Hakazalika, babban kantin sayar da kayayyaki na Okado na Burtaniya a waje da Ostiraliya ya sanar a ranar Lahadi cewa za a sayar da takardun wanki 12 na Andres.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta sanar da yaduwar COVID-19 a matsayin annobar duniya da coronavirus SARS-CoV-2 ke haifarwa.
"Pan-Mexican" ba ya nufin yadda cutar ta fi tsanani a yankin, amma yadda ta yaɗu a yankin, kuma yana nuna cewa gwamnatocin Amurka sun ɗauki matakin gaggawa.
"Dukkanin kasashe na iya canza yanayin annobar".
"Darakta Janar na WHO Tedros Adhanom Ghebreyesus ya ce ""idan kasashe suka gwada, suka adana, suka ware, suka nemi, kuma suka amsa wa jama'a""".
"Muna mai da hankali sosai ga yadda za a magance wannan mummunar cuta.
"Dokar kula da rigakafin cutar ta Amurka, Dr. Tom Frieden, ta ce annobar ta zama "ba a taɓa ganin irinta ba".
"A cikin wani jawabi da aka wallafa a CNN a watan Fabrairu, ya ce, ""Babu wani kwayar cutar numfashi da ta faru sai cutar mura tun lokacin da ta fara zuwa duniya gaba daya"."
"Gertrude Yesu ya bayyana ra'ayi iri daya cewa ba mu ga barkewar cutar ba kamar yadda cutar coronavirus ta gani".
"Sai ya ce, ""kuma ba mu taɓa ganin annobar da za a iya sarrafawa a lokaci guda ba"."
Wannan sabon yanayi ya biyo bayan shawarar da Hukumar Lafiya ta Duniya ta yanke na ayyana yaduwar cutar a matsayin babbar barazana ga lafiyar jama'a a duniya.
Darakta na Cibiyar Kula da Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar C C C C C C C C C C C C C C C C C C C C
Tun daga ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ruwaito cewa akwai mutane 126,000 da suka kamu da cutar COVID-19 a duniya, kuma sama da mutane 4,600 sun mutu sakamakon cutar.
Cutar cutar coronavirus ta 2019/20 ita ce cutar coronavirus ta 2019 (COVID-19) da ke yaduwa, wanda ke haifar da cutar coronavirus mai saurin numfashi ta 2 (SARS-CoV-2).
An sanar da annobar a matsayin annoba a ranar 11 ga Maris, 2020, bayan da aka sanar da annobar a matsayin gaggawa ta duniya ga lafiyar jama'a a cikin watan Disamba, 2019, Janairu 30, 2020.
A ranar 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe 210, tare da mutuwar mutane kusan 97,000.
Kusan mutane 364,000 sun warke.
An kiyasta cewa wannan adadin mutuwar cutar a China ya kai kashi 4%, yayin da sauran sauran kasashen duniya suka kiyasta cewa ya kai 13.04% a Aljeriya zuwa 0.08% a New Zealand.
Alamun farko sune zazzabi, tari, da kuma rashin numfashi.
Abubuwan da ke damun sun hada da ciwon huhu da kuma ciwon numfashi mai saurin ragewa.
Lokaci daga bayyanar cutar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma wannan na iya zama daga kwana biyu zuwa goma sha huɗu.
Babu maganin rigakafi ko maganin rigakafin cutar da aka tsara don wannan.
Babban maganin shi ne maganin alamomi da tallafi. Matakan kariya da aka ba da shawarar sun haɗa da wanke hannu, rufe baki yayin yin hancin, nisantar mutane, da kuma lura da kai da keɓe kai ga waɗanda suke tsammanin an yi musu hari.
Hukumomi a duniya sun mayar da martani ta hanyar aiwatar da takunkumin tafiye -tafiye, keɓewa, ƙuntatawa, kula da haɗarin aiki, da rufe wuraren aiki.
Cutar ta haifar da matsanancin matsin tattalin arziki na duniya, jinkirta da soke wasannin wasanni, abubuwan addini, siyasa da al'adu, da kuma karancin kayayyaki a cikin fargaba.
A kasashe 193 an rufe makarantu da jami'o'i na gida ko na duniya, wanda ya shafi kusan kashi 99.4 na dalibai.
Bayanai na rashin gaskiya game da cutar sun haifar da nuna bambanci da keɓewa ga 'yan ƙasa daga China, kudu da gabashin Asiya da sauran ƙasashe da cutar ta ɓarke.
Sakamakon rage tafiye-tafiye da rufe manyan masana'antu, gurɓataccen iska da iskar carbon sun ragu.
Jami'an kiwon lafiya a Wuhan, China (babban birnin lardin Yubei), sun sanar da cewa ba a san asalin cutar huhu ba a ranar 31 ga Disamba, 2019, kuma an fara binciken a watan Janairu, 2020.
Yawancin abubuwan da suka faru suna da alaƙa da kasuwar cin abincin teku ta Hunan, kuma ana tsammanin cutar ta samo asali ne daga zoonotic.
Kwayar cutar da ta haifar da yaduwar cutar, wacce aka sani da SARS-CoV-2, sabuwar kwayar cutar da aka gano wacce ke da alaƙa da kwayar cutar tsuntsaye, kwayar cutar pangolin, da SARS-CoV. An gano mutumin da ya fara nuna alamun cutar a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da alaƙa da rukunin kasuwar ruwa.
Kashi biyu bisa uku na wadanda suka kamu da cutar a farkon watan Disamba na 2019 ba su da alaka da kasuwa.
A ranar 13 ga Maris, 2020, South China Morning Post ta ruwaito cewa, an gano mutum na farko mai dauke da cutar a ranar 17 ga Nuwamba, 2019, wanda ke zaune a lardin Hubei, wanda ke da shekaru 55. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, sabbin cututtukan cutar sun ragu a China, kuma a cikin Italiya, Iran da Koriya ta Kudu, sun fara ƙaruwa.
Akwai yiwuwar karamin adadin mutane da suka kamu da cutar, musamman a cikin wadanda ba su da wata cuta.
A ranar 26 ga Afrilu, an sami karancin masu kamuwa da cutar a tsakanin matasa 'yan kasa da shekaru 19, wanda ya kai kashi 2.4% na masu kamuwa da cutar a duniya. Babban mai ba da shawara kan ilimin kimiyyar Burtaniya, Patrick Valance, ya yi kiyasin cewa ana bukatar a sanar da kashi 60% na yawan jama'ar Burtaniya kafin a sami ingantaccen rigakafi.
"Masu cutar sun hada da mutanen da aka gwada wa cutar COVID-19 da kuma wadanda suka tabbatar da cewa sun kamu da cutar bisa ka'idojin gwamnati.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada sama da kashi 3 cikin ɗari na yawan jama'arta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain, da Switzerland, sun riga sun sami umarnin hukuma don ba da izinin gwada waɗanda ke da alamun rashin lafiya.
A cewar wani bincike da aka buga a ranar 16 ga Maris, kimanin kashi 86% na yaduwar COVID-19 a cikin kasar Sin ba a san su ba har zuwa ranar 23 ga Janairu.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin wadanda suka kamu da cutar a Italiya zai fi adadin wadanda aka samu.
Hasashen farko na ƙimar sake haifuwa (R0) don COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amurka ta wallafa ya kammala da cewa za a iya samun cutar 5.7.
Yawancin mutanen da ke da COVID-19 suna murmurewa.
Ga wadanda ba su sani ba, tsawon lokacin da ake bukata kafin mutum ya mutu daga alamun cutar shine kwanaki 6 zuwa 41, mafi yawan kwanaki 14 ne.
Ya zuwa ranar 10 ga Afrilu, 2020, an yi kusan mutuwar 97,000 da ke da alaƙa da COVID-19.
"Kamar yadda ya zuwa ranar 5 ga watan Fabrairu, kashi 80 cikin 100 na mutuwar da aka samu a kasar Sin sun kasance sama da shekaru 60, kuma kashi 75 cikin 100 ba su da cutar zazzabin jini ko ciwon sukari.
"Yawan mutuwar COVID-19 zai iya ƙaruwa, ba tare da haɗa da waɗanda suka mutu ba tare da an gwada su ba, misali, a gida, a asibitin gida, da sauransu".
Wani rahoto na Italiya ya nuna cewa adadin mutuwar COVID ya ninka na hukuma sau 4-5 a lokacin annobar.
"Mai magana da yawun Cibiyar Kula da Cututtuka da Rigakafin cuta ta Amurka (CDC) ya ce, "Mun san cewa an yi watsi da [yawan mutuwar da aka ruwaito]", "Ba a taɓa samun irin wannan rahoton ba a cikin Amurka, kamar yadda ya faru a lokacin annobar cutar, kamar yadda ya faru a cikin cutar mura ta alade ta H1N1 a shekarar 2009.
Mutuwa ta farko daga babban yankin kasar Sin ta faru ne a Philippines a ranar 1 ga watan Fabrairu, sannan ta farko daga kasashen waje a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Janairu, an samu karin mutuwar a kasashen waje kamar Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga watan Maris, sama da kasashe da yankuna arba'in sun ce an samu mutuwar mutane a kowace nahiya, sai dai Antarctica.
Wadannan lambobi sun bambanta a yankuna daban-daban, amma a tsawon lokaci, yawan gwaje-gwaje da aka tsara, ingancin kiwon lafiya, likitoci da shugabannin, lokacin da cutar ta fara, da kuma yanayin lafiyar jama'a, kamar shekaru, jinsi, da kuma lafiyar jama'a.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutanen da suka mutu a duniya ya kai 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Wannan adadin ya bambanta daga lardi zuwa lardi.
A kasar Sin, yawan mutanen da suka kamu da cutar ya ragu daga kashi 17.3 cikin dari (U.S. wadanda suka kamu da cutar daga ranar 1 zuwa 10 ga Janairu, 2020) zuwa kashi 0.7 cikin dari (U.S. wadanda suka kamu da cutar bayan ranar 1 ga Fabrairu, 2020). Sauran matakan sun hada da yawan mutanen da suka kamu da cutar (CFR), wanda ke nuna yawan mutanen da suka kamu da cutar a rayuwarsu, da kuma yawan mutanen da suka kamu da cutar (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar a rayuwarsu (waɗanda aka gwada da waɗanda ba a gwada su ba).
Waɗannan ƙididdigar ba su da iyakance lokaci, kuma ana bin su ta hanyar takamaiman yanayin yanayin yanayin cutar a cikin ƙididdigar yawan jama'a.
Masana da yawa sun yi ƙoƙari su ƙididdige waɗannan adadi don ƙididdigar yawan jama'a.
Cibiyar Lafiya ta Oxford, bisa ga shaidar, ta kiyasta cewa cutar za ta iya haifar da mutuwar kashi 0.1% zuwa 0.39%.
Kwanan baya na wannan zangon ya kasance ne bisa binciken kididdiga da aka yi a Jamus game da gwajin COVID-19 da kuma kimantawar CFR.
Hukumar Lafiya ta Duniya ta ce za a iya shawo kan annobar.
Yana da wahala a faɗi daidai lokacin da annobar za ta kai ga matsakaicin matsayi da tsawon lokacin da za ta ci gaba, kuma yana iya bambanta daga wuri zuwa wuri.
Jami'ar Jihar Penn ta ce cutar ta kasance a cikin yanayi mai tsawo kuma cutar ta ci gaba da yaduwa.
Amma ba za a iya sanin lokacin da hakan zai faru ba.
"Zhong Nansheng, babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, ya yi ta cewa, "za a iya dakatar da cutar a watan Yuni, idan duk kasashe suka bi shawarar Hukumar Lafiya ta Duniya kan matakan da za a dauka don hana yaduwar cutar".
"A ranar 17 ga Maris, Adam Kucharski na London Hygiene and Tropical Medicine ya ce SARS-CoV-2 zai "yi maimaitawa na tsawon shekara daya ko biyu".
"A cewar wani binciken kwalejin Imperial wanda Neil Ferguson ya gudanar, ana bukatar tsauraran matakan zaman lafiya da sauran matakan (watakila watanni 18 ko sama da haka) har sai an samu rigakafin".
"William Schaffner na Jami'ar Vanderbilt ya ce: "Wannan kwayar cutar korona tana da saurin yaduwa, saboda haka yana da wuya a ce za ta halaka gaba daya, kuma ina tsammanin za ta iya dawowa kowace shekara kuma ta zama sabon yanayi".
An ƙaddara lalacewar sake dawowa bisa ga haɗin gwiwa na rigakafi da canjin DNA.
Alamun cutar COVID-19 ba su da bambanci kuma waɗanda aka kamu da cutar ba za su iya nuna alamun cutar ba.
Alamun da suka fi kowa su ne zazzaɓi (88%) da tari mai bushe (68%).
Alamun da ba su da yawa sun haɗa da gajiya, rashin numfashi (acne), rashin jin ƙanshi, rashin numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, rawar jiki, ɓacin rai, tari mai haushi, ciwon hanci ko kumburi. Kusan mutum ɗaya cikin shida na iya yin rashin lafiya mai tsanani kuma yana da wahalar numfashi, in ji Hukumar Lafiya ta Duniya.
Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka (CDC) sun lissafa alamun gaggawa kamar su wahalar numfashi, ciwon kirji ko matsin lamba, tashin hankali, wahalar tafiya, da kumburi na fuska ko lebe, kuma ana ba da shawarar neman kulawa ta gaggawa. Ƙarin yaduwar cutar na iya haifar da ciwon huhu, matsalar matsin numfashi, lalacewa, kamuwa da cuta, da mutuwa.
Masu bincike sun ba da shawarar cewa duk wanda ya yi hulɗa da mutanen da suka kamu da cutar, waɗanda wasu daga cikinsu ba su da alamun cutar, waɗanda ba su da alamun asibiti amma sun nuna tabbatacciyar kamuwa da cutar, ya kamata a kula da su sosai kuma a gwada su don kawar da cutar.
Sinawa sun kiyasta rashin nuna alama daga kadan zuwa kashi 44 cikin dari.
Lokacin haifuwa na al'ada (tsakanin kamuwa da cuta da bayyanar cututtuka) yana cikin kewayon kwana 1 zuwa 14, yawanci kwanaki biyar. Misali na rashin tabbas, kashi 30% na mutanen da ke da COVID-19 sun rasa ƙanshin su da farko, kuma daga baya ya ragu zuwa 15%.
Za a bayyana cikakken bayani game da yadda cutar ke yaduwa nan gaba.
Ana yaduwar cutar ne ta hanyar kusanci da kuma ƙananan ɗigo da ke faruwa yayin tsotsa, hancin, ko magana, kusanci ya zama tsakanin mita 1-2 (daga ƙafa 3 zuwa ƙafa 6).
Bincike ya nuna cewa idan ba a rufe hanci ba, zai iya haifar da rigar da ta kai tsawon mita 4.5 zuwa mita 8.2.
Wasu sun kammala da cewa za a iya yada cutar ta hanyar ɗigon da za a iya samu a lokacin magana, kuma waɗannan ɗigon za su iya zama a cikin iska na dogon lokaci. Ƙofofin numfashi za su iya zama a lokacin numfashi, ciki har da magana, amma cutar ba ta da iska.
Za su iya sauka a bakin mutane ko kuma a hanci ko kuma a cikin huhu.
Yin tiyata na numfashi ta hanyar karshopulmonary recovery (CPR) na iya sa mutum ya kamu da cututtukan da ke yaduwa ta hanyar iska.
Idan mutum ya taɓa wani abu da ke da cutar, har da fata, zai iya yaɗuwa ta wurin taɓa idanunsa, hanci, ko kuma bakinsa.
Duk da cewa akwai barazanar cewa za a iya yada ta hanyar kwayar cutar, wannan barazanar ba ta da yawa.
Gwamnatin kasar Sin ta musanta cewa SARS-CoV-2 ya yadu ta hanyar baki.Yana da matukar yaduwa a cikin kwanaki uku na farko da bayyanar cutar, duk da cewa ba a nuna alamun cutar ba kuma ana iya yada ta ta hanci da kuma hanci.
An gano cewa mutane suna da cutar kwanaki uku kafin su fara nuna alamun cutar, wanda ke nuna cewa ana iya kamuwa da cutar kafin bayyanar da alamun.
Labaran da aka tabbatar sun nuna cewa ba a yadu ba, amma kuma an samu irin wannan yaduwar a wasu kasashen da aka yi nazarin cutar Nicki.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ba a bayyana yadda cutar ke yaduwa cikin sauƙi ba, ta hanyar yadda mutum ɗaya zai iya yada cutar daga mutane biyu zuwa uku.
Kwayar cutar na iya rayuwa har tsawon kwanaki uku, musamman a kan filastik (polypropylene) da karfe 304 da kuma tsawon sa'o'i huɗu a kan jan ƙarfe.
Amma wannan ya bambanta dangane da zafi da zafin jiki. Dabbobi da sauran dabbobi sun sami tabbataccen COVID-19.
Babu tabbacin cewa dabbobi na iya yada cutar zuwa ga mutane, amma jami'an Birtaniya sun ba da shawarar wanke hannu bayan sun taba dabbobi kamar yadda mutum mai cutar zai yi bayan ya taba wani abu.
Cutar coronavirus 2 (SARS-CoV-2) wani sabon kwayar cuta ce ta numfashi, wanda ya fara bayyana a cikin mutane uku da ke fama da ciwon huhu wanda ke da alaƙa da yanayin cutar numfashi mai tsanani a Wuhan.
Dukkanin halayen kwayar cutar SARS-CoV-2 na faruwa ne a yanayi kamar yadda yake tare da kwayar cutar coronavirus. A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu a gida, saboda sabulu yana kawar da murfin kariya na kwayar cutar. SARS-CoV-2 yana da alaƙa da ainihin SARS-CoV.
An yi imanin cewa akwai asalin Zenotec.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar coronavirus ta samo asali ne daga kwayar cutar betacoronavirus, kwayar cutar serbevirus (lineage B) da kuma wasu nau'ikan kwayoyin halitta guda biyu daga wani nau'in halittu.
A duk matakin kwayoyin halitta, samfurin kwayar cutar coronavirus na BatCov RaTG13 ya yi kama da kashi 96 cikin dari.
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambancin amino acid guda daya ne kawai a wasu sassan jerin kwayoyin halittar mutum da na pangolin.
A halin yanzu, kwatancen cikakken kwayoyin halitta ya gano cewa kimanin kashi 92% na kayan halittar jini suna cikin bangolin coronavirus da SARS-CoV-2, wanda ya isa ya tabbatar da cewa pangolins sune matsakaitan masu jigilar kaya.
Ana iya magance kamuwa da cutar ta hanyar alamun cutar, amma ana iya tabbatar da cutar ta hanyar maganin polymerase chain reaction (rRT-PCR) ko CT.
Wani bincike a Wuhan wanda ya kwatanta PCR da CT ya nuna cewa CT ya fi PCR rauni, amma ya nuna rashin haske da yawa na gani wanda ya yi kama da sauran cututtukan huhu da hanyoyin cutar.
Har zuwa Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT don yin gwajin COVID-19 ko a matsayin gwajin layin farko.
Hukumar Lafiya ta Duniya ta fitar da takardar farko ta hanyar gudanar da bincike kan cutar SARS-CoV-2 a ranar 17 ga watan Janairu.
Gwajin yana amfani da amsawar sarkar polymerase-reverse-reverse (rRT-PCR) na lokaci na ainihi.
Ana iya yin gwajin ne ta hanyar yin amfani da jini ko kuma ta hanyar yin amfani da jini.
Sakamakon yana samuwa daga 'yan sa'o'i zuwa kwana ɗaya.
Ana yin gwajin ne ta hanyar shafa hanci, kuma ana iya yin gwajin hanci. Dakunan gwaje-gwaje da kungiyoyi da yawa suna yin gwajin ƙwayar cuta, wanda ke gano ƙwayoyin cuta.
Ya zuwa ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka amince da su don amfani da su a ko'ina.
Gwajin maganin da aka samar a Amurka da Selx an amince da shi ne kawai ta hanyar dakunan gwaje-gwaje da aka amince da su don amfani da gaggawa.
Radiographs da computational tomography (CT) da kuma halayyar mutanen da ke da alamun sun hada da gilashin da aka narkar da su wanda ba shi da siffar da kuma ruwa tsakanin tsakiya da tsakiya.
Kungiyar Radiology ta Italiya tana aiki da bayanan hotuna na duniya akan layi wanda ke nuna abubuwan da suka faru.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, ƙarancin gano COVID-19 ta hanyar hoto wanda ba a tabbatar da shi ta hanyar PCR ba.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya yi la'akari da shi azaman kayan aikin gano cututtukan cututtuka, mai sauri da hankali, kodayake hoton ya nuna ɗan bambanci ga cutar.
An tsara hanyoyin sadarwa na kwakwalwa masu amfani da hankali don gano abubuwan da ke cikin hoto da CT na cutar.
Hanyoyin watsa cutar, ciki har da kiyaye tsabtace jiki, wanke hannu, guje wa taɓa idanu, hanci ko baki ba tare da wanke hannu ba, da kuma shafawa da hancin kayan wanka da jefa kayan wanka kai tsaye cikin shara.
An shawarci mutanen da suka riga sun kamu da cutar da su sanya abin rufe fuska kafin su shiga wuraren jama'a.
Ana kuma ba da shawarar nisantar jiki don hana yaduwar cutar. Gwamnatoci da yawa sun dakatar da duk tafiye -tafiye marasa mahimmanci daga ƙasashe da ƙasashe inda yaduwar cutar ta yadu.
Koyaya, cutar ta kai matakin yaduwa a cikin al'ummomi a yawancin sassan duniya.
Ma'aikatan kiwon lafiya da ke kula da mutanen da ke da cutar suna ba da shawara cewa su yi amfani da matakan tsaro na yau da kullum, su yi amfani da hanyoyin kula da mutane, kuma su yi amfani da idanu.
Amfani da bayanan gidaje ta hanyar wayoyin hannu ta hanyar gwamnati don wannan dalili ya haifar da fargabar mutum, Amnesty International da kungiyoyi sama da 100 sun yi kira da a takaita irin wannan sa ido.
An gabatar da aikace-aikacen hannu da yawa a cikin filagogo, kuma a ranar 7 ga Afrilu, 2020, masana da yawa suna jiran wani sabon abu da zai zo tare da amfani da Bluetooth.
Idan masu amfani sun kasance tare da mutumin da ya sami tabbataccen cutar COVID-19, za a aika musu da saƙo. An yada ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cuta, misali, wanke hanci da wanke baki da kayan wanke baki ba su da tasiri.
Ko da yake kungiyoyi da dama suna aiki don samar da maganin COVID-19, babu wani maganin da aka gano.
Ana ba da shawarar wanke hannu don rage yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na akalla sakan ashirin, musamman bayan sun je bayan gida ko kuma bayan sun wanke hannayensu a fili; kafin cin abinci; da kuma bayan sun taɓa hanci, hancin, ko hancin.
Wannan saboda safa da wanka ne ke kashe kwayar cutar a waje da jiki.
CDC ta ba da shawarar amfani da maganin tsabtace hannu wanda ke dauke da kashi 60% na barasa a wuraren da sabulu da ruwa ba su da isasshen.
Hukumar ta WHO ta ba da shawarar kada mutane su taɓa idanunsu, hanci, ko bakinsu ba tare da sun wanke hannayensu ba.
Za a iya tsabtace fuska ta hanyar bayani da yawa (mai tsabtace bakin karfe a cikin minti daya), daga 6271% ethanol, 50100% propepelol, 0.1% sodium hypochloride, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran hanyoyin warwarewa, kamar su benzalkonium chloride da crohexidine gluconate, sun rage inganci.
CDC ta ba da shawarar cewa, inda ake zargin ko tabbatar da cutar ta COVID a wuraren da ake yin sabis, ofis ko wurin wanka, wanka, wuraren amfani da jama'a, da wuraren amfani da wutar lantarki, tebur, kwamfutar da ake amfani da ita, ATM, da sauransu, ya kamata a tsabtace su da maganin kashe cutar.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hanci da sutura ko sutura yayin yin tsotsa ko numfashi kuma su zubar da duk wani sutura nan da nan.
Ana ba da shawarar yin tiyata ne kawai ga mutanen da cutar ta kama, saboda yana hana yaduwar kwayar cutar da kuma hana yaduwar kwayar cutar yayin magana, numfashi da hancin mutum.
Hukumar Lafiya ta Duniya ta ba da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
"A cewar Stephen Griffin, masanin ilmin cututtuka a jami'ar Leggs, ""Samun abin rufe fuska na iya rage mutane su taba fuskokinsu, wanda hakan ke hana su kamuwa da cuta ta hanyar rashin wanke hannayensu"." Masks na iya hana mutane da ke da cutar daga kamuwa da cutar".
"Masu lafiya ba za su sa abin rufe fuska da hanci ba, sai dai idan suna da nicky da kuma rashin jin daɗi tare da masu tallafawa COVID-19, ko da yake sun san cewa yana da kyau a sanya abin rufe fuska da hanci".
Kasashe da dama sun fara karfafawa 'yan kasashensu amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na masana'anta wanda ba na likita ba. A China kuma, an ba da shawarar yin amfani da abin rufe fuska na likita na lokaci guda (mita 1 (ƙasa 3) ko ƙasa da haka) ga mutanen da ke da lafiya, musamman lokacin da suke hulɗa da wasu mutane.
Ana ba da shawarar sanya abin rufe fuska yayin amfani da sufuri na jama'a ko kuma kasancewa a wuraren da mutane ke da yawa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su sanya abin rufe fuska da aka yi da tufafi kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ba ko rufe hanci da hanci.
A ranar 16 ga Maris, Vietnam ta bukaci duk wani dan kasa da ya fita daga gida zuwa wuraren taruwar jama'a ya sanya abin rufe fuska don kare kansa da sauran mutane.
Gwamnatin Austria ta bukaci duk wanda ya shiga kantin sayar da kayayyaki ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan 'yan kasarta da su sanya abin rufe fuska da kuma rufe baki yayin fita waje.
Taiwan, wacce ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci fasinjojin jirgin kasa da na birni da ke amfani da motocin bas su sanya abin rufe fuska daga ranar 1 ga Afrilu.
Panama ta bukaci duk wanda ya fita waje ya sanya abin rufe fuska, kuma ta karfafa wa waɗanda ba su da ikon sayan abin rufe fuska su yi aiki a gida.
An kuma kara sanya abin rufe fuska a Japan, Koriya ta Arewa, Malaysia, da Singapore.
Nisa nesa da jama'a ko kuma (wanda aka fi sani da nisantar jiki) ya ƙunshi kiyaye yanayin yaduwar cutar, rage hulɗa tsakanin mutane, da rage yaduwar cutar.
Hanyoyin sun hada da keɓewa, hana zirga-zirga, rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo da cibiyoyin kasuwanci.
Mutane na iya aiwatar da matakan nisantar zamantakewa ta hanyar zama a gida, rage tafiye tafiye, guje wa wuraren taruwa, gaishe da juna ba tare da taɓa juna ba, da kuma nisantar kansu daga wasu.
Gwamnatoci da dama a halin yanzu suna ba da shawarar nisantar da jama'a kuma sun sanya shi tilas a jihohin da cutar ta shafa.
Hukumar gwamnati ta Amurka da Hukumar Lafiya ta Amurka sun ba da shawarar rage yawan tarurrukan mutane daga 250 (idan babu alamun cutar COVID-19 da aka sani) zuwa 50, sannan zuwa 10.
"A ranar 22 ga Maris, 2020, Jamus ta hana kowa saduwa da mutane sama da biyu. CDC WHO ta ba da shawarar cewa tsofaffi da masu kula da lafiyar jiki, waɗanda ke da ciwon sukari, cututtukan zuciya, cututtukan numfashi, ƙwayoyin cuta, ƙarancin garkuwar jiki, da kuma wasu abubuwan da ke iya haifar da cututtuka, su fita daga gidajensu a yankunan da cutar ta ɓarke. A ƙarshen Maris, WHO da sauran kungiyoyin kiwon lafiya sun fara haɗa kalmar ""yankewar zamantakewa"" tare da ""yankewar jiki"", saboda manufar ita ce rage hulɗa ta jiki ta hanyar rufe hanyoyin sadarwar jama'a ta hanyar Intanet ko ƙofar.
Amfani da kalmar nesa da jama'a yana nufin mutanen da dole ne su shiga cikin keɓewar jama'a, maimakon ba da shawarar ci gaba da hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i don amfani yayin annobar duniya.
Wannan ya hada da bayar da shawarar yin jima'i kawai tare da wanda ke zaune tare da wanda ke da kwayar cutar ko kuma wanda ba shi da alamun cutar.
An ba da shawarar a ware mutane daga gida ga waɗanda ake zargin suna da cutar kuma suna da COVID-19.
Hukumomin kiwon lafiya sun ba da cikakkun umarnin keɓewa. Gwamnatoci da yawa suna ba da shawarar keɓewa ga mutanen da ke cikin wuraren da cutar ta ɓarke.
An ba da umarnin keɓe kai mai ƙarfi ga waɗanda ke cikin manyan ƙungiyoyin haɗari.
Mutanen da ke iya fuskantar cutar COVID-19 da waɗanda suka yi tafiya zuwa ƙasar da cutar ta bazu, an shawarce su da su keɓe kansu na tsawon kwanaki 14 daga ranar ƙarshe da suka kamu da cutar.
Hanyoyin da za a iya sarrafa yaduwar cutar su ne hana ko hanawa da ragewa.
Ana sanya takunkumin hana zirga-zirga a farkon barkewar cutar kuma ana nufin gabatar da wasu sabbin hanyoyin sarrafa kamuwa da cuta don ganowa da kebe mutanen da suka kamu da cutar ta hanyar saka idanu da kuma rage yaduwar cutar ga sauran al'umma.
Idan ba za a iya hana yaduwar cutar ba, za a ci gaba da gwaji zuwa matakin juriya, kuma za a ɗauki matakai don rage yaduwar cutar da kuma magance tasirin da ke tattare da tsarin kiwon lafiya da al'umma.
Za a iya ɗaukar matakan kamawa da na rigakafi tare.
"Yin amfani da tsarin da aka sani da maganin cututtuka na cutar, don rage yaduwar cutar, yana buƙatar ƙarin matakai masu ƙarfi don juya cutar ta duniya zuwa ƙasa da 1.
Wannan zai ba da ƙarin lokaci don shirya allurar rigakafi da magani, ba tare da yin aiki da yawa a cikin masu ba da sabis na kiwon lafiya ba.
Matakan rigakafin kai da suka hada da tsaftace hannu da rufe baki da hanci da keɓewa, da kuma matakan zamantakewa na nisantar jiki, kamar rufe makarantu, soke tarurrukan jama'a, da kuma sa jama'a su shiga cikin aiwatar da irin wannan takunkumin, da kuma tsaftacewa.
Sauran kasashe sun dauki matakai daban-daban don hana yaduwar cutar.
Koriya ta Kudu ta gabatar da gwajin kamuwa da cutar da ke ware mutane, kuma tana ba da sanarwar lokacin da mutane masu kamuwa da cutar suka yi aiki.
Singapore ta sake hukunta wadanda suka yi hakan, yayin da ta keɓe tallafi ga wadanda suka keɓe kansu na wani lokaci.
Taiwan ta kara samar da abin rufe fuska da kuma rarraba kayayyakin kiwon lafiya. Binciken Birtaniya da Amurka ya nuna cewa akwai manyan kalubale wajen rage (rage yaduwar cutar amma ba a dakatar da ita) da kuma sarrafa (dawo da ci gaban cutar) ba.
Amfani da manufofin da suka fi dacewa ya rage yawan cututtukan farko na rashin lafiya da kashi biyu cikin uku kuma ya rage mutuwar da rabi. Amma dubban mutuwar da hanyoyin kiwon lafiya sun nuna cewa akwai matsala sosai.
"Yayin da cutar ke yaduwa a cikin mutane, zai fi dacewa a yi amfani da ta'addanci amma ya kamata a jira (ko har sai an sami rigakafi, idan hakan ya fara), yayin da yanayin ya dace, watsawar zai dawo da sauri".
"Hanyoyin da za a yi amfani da su na dogon lokaci wajen shawo kan annobar za su haifar da rikici na zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19 da aka amince da shi, amma ba a gudanar da kokarin ci gaba ba, gami da gwajin magungunan da ake da su.
Shan magunguna, shan ruwa, da hutawa na iya taimakawa wajen rage alamun cutar.
Dangane da nauyin jikinsa, ana iya buƙatar maganin oxygen, maganin jini, da taimakon numfashi.
Yin amfani da kwayoyin steroid na iya haifar da sakamako mafi muni.
Ana gudanar da bincike kan wuraren da aka amince da su don maganin cutar COVID-19.
"Kungiyar Lafiya ta Duniya ta kuma ce wasu ""magungunan gargajiya da na gida"" na iya taimakawa wajen rage alamun cutar SARS-CoV-19".
WHO ta ce, inganta iya aiki da kuma inganta kulawar lafiya ga bukatun marasa lafiya na COVID-19 shine matakin farko da za a dauka don hana yaduwar cutar.
ECDC da Ofishin Yankin WHO na Turai sun ba da umarni ga asibitoci da sabis na kiwon lafiya na farko, gami da mai da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, soke hanyoyin duk lokacin da zai yiwu, gano marasa lafiya masu cutar COVID-19 da keɓewa da horar da ma'aikata, da haɓaka ƙarfin kulawa da marasa lafiya masu tsanani da haɓaka adadin injunan numfashi da gadaje.
Akwai hasashe da yawa game da asalin abin da ya fara faruwa (marasa lafiya zero).
An fara gano cutar coronavirus a watan Disamba 1 na 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin wadanda suka kamu da cutar coronavirus a Hubei ya ragu a hankali.
Yawancin waɗannan suna da alaƙa da kasuwar cin abincin teku ta Hawai'i, wanda ban da sayar da dabbobi masu rai, kuma ra'ayi ɗaya shine cewa cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi, ko kuma asalin zoonotic.
"A ranar 30 ga watan Disamba, wata tawagar likitoci a asibitin Wuhan ta sanar da ma'aikatansu cewa an samu wani sabon kwayar cutar korona mai kama da SARS".
An gargadi takwas daga cikin likitocin, ciki har da Li Wenliang, da 'yan sanda saboda yada jita-jita, yayin da wani mai suna Ai Fen ya sha horo daga shugabansa saboda yada jita-jita.
Hukumar Lafiya ta Wuhan ta ba da sanarwar hukuma a ranar 31 ga Disamba kuma ta sanar da WHO.
An kai rahoto ga jami'an kiwon lafiya a Wuhan game da isassun cututtukan cutar huhu da ba a gano ba a farkon watan Janairu.
A farkon da tsakiyar watan Janairu na 2020, kasancewar shi ne cibiyar sufuri da kuma manyan hanyoyin sadarwa na jirgin kasa a lokacin da ake bikin sabuwar shekara ta kasar Sin, ya taimaka wajen yada cutar zuwa wasu lardunan kasar Sin.
A ranar 20 ga watan Janairu, kasar Sin ta bayar da rahoton kusan sabbin mutane 140 da suka kamu da cutar a cikin kwana daya, ciki har da mutane biyu a birnin Beijing da kuma mutum daya a birnin Shenzhen.
A ranar 26 ga Maris, Amurka ta wuce China da Italiya a yawan wadanda suka kamu da cutar. A ranar 9 ga Afrilu, 2020, an sami sama da mutane miliyan 1.61 da suka kamu da cutar a duniya, tare da mutane sama da 97,000 da suka mutu, kuma sama da 364,000 sun warke.
Kusan kasashe da yankuna 200 suna da akalla mutum daya da ya kamu da cutar.
Kasashe da dama a yankin Schengen sun fara sanya takunkumi a kan iyakokinsu saboda annobar a Turai.
Matakan kasa sun hada da hana fita daga gida, tsare gida ko rufewa, da kuma hana zirga-zirga.Zuwa ranar 2 ga Afrilu, kusan mutane miliyan 300 ko kashi 90% na Amurka suna karkashin dokar hana fita, miliyan 50 a Philippines, miliyan 59 a Afirka ta Kudu, da kuma mutane biliyan 1.3 a Indiya.
A ranar 26 ga watan Maris, mutane biliyan 1.7 ne ke zaune a gidaje ko kuma a wasu hanyoyi, daga mutane biliyan biyu zuwa biliyan 2.6. Wannan yana nufin cewa kusan kashi ɗaya bisa uku na yawan mutanen duniya suna cikin gidaje.
An gano mutum na farko da ya kamu da cutar COVID-19 a ranar 1 ga Disamba, 2019, a Wuhan, yayin da rahoto da ba a tabbatar da shi ba ya nuna cewa an gano mutum na farko a ranar 17 ga Nuwamba.
Dokta Zhang Jixian ya gano wani hali na ciwon huhu wanda ba a san asalinsa ba a ranar 26 ga Disamba, kuma ya sanar da CDC (Cibiyoyin Kula da Cututtuka da Rigakafin Cutar) a asibitin Wuhan Jianghan a ranar 27 ga Disamba.
Disamba 27th, 2019 Gwajin kwayar halitta a kan samfuran marasa lafiya ya nuna cewa akwai kwayar cutar coronavirus irin ta SARS.
An fitar da sanarwar a ranar 31 ga watan Disamba a hukumar kiwon lafiya ta birnin Wuhan.
An sanar da Hukumar Lafiya ta Duniya a ranar.
A lokacin da aka sanar da su, likitocin ruwa sun sami gargadi daga 'yan sanda saboda yada "Allubala".
Hukumar Lafiya ta kasar Sin ta ce, a farko, babu wata hujja ta tabbatacciyar cutar da ke yaduwa daga mutum zuwa mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na dakile yaduwar cutar, inda ta bayyana shi a matsayin yakin mutane, kamar yadda babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping ya bayyana.
A cikin abin da aka bayyana a matsayin mafi girman keɓewa a tarihin ɗan adam, an sanya dokar hana zirga-zirgar ruwa a ranar 23 ga Janairu, an kuma aiwatar da ita a cikin birane 15 a Hubei, wanda ya shafi mutane miliyan 57.
An haramta amfani da motocin masu zaman kansu a cikin birnin.
An soke bikin Sabuwar Shekarar kasar Sin (Janairu 25) a wurare da dama.
Jami'an sun kuma ce za a gina asibitin wucin gadi a cikin kwanaki 10 daga asibitin Hwaseongsan.
An gina wani asibiti da ake kira Lechenshun don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitoci, kasar Sin ta maida wurare 14 na musamman a Wuhan, kamar wuraren shakatawa na jama'a da filayen wasa, zuwa asibitocin gargajiya. Gwamnati ta dauki karin matakai don hana barkewar cutar COVID-19 a ranar 26 ga Janairu, gami da sabon sanarwa da sanarwa ga matafiya da kuma tsawaita ranakun bukukuwan musamman.
Jami'o'i da makarantu a fadin jihar sun rufe.
An dauki matakai da yawa a yankunan Hong Kong da Macau, musamman game da makarantu da jami'o'i.
An fara aiwatar da matakan aiki daga nesa a yankuna da dama na kasar Sin.
An dakatar da zirga-zirga a cikin Hubei da waje.
An rufe gidajen tarihi na wani dan lokaci saboda sauya hanyoyin sufuri a duk fadin kasar Sin.
"An sanya dokar hana zirga-zirgar jama'a a birane da dama, kuma kusan mutane miliyan 760 (kusan rabin yawan jama'ar kasar Sin) sun shiga cikin dokar hana fita. Bayan yaduwar cutar ta kai matakin duniya a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana cutar " shiga "China daga wasu kasashe".
A ranar 23 ga watan Maris, an samu cutar nan da nan a kasar Sin, kwanaki biyar da suka gabata, sakamakon wani matafiyi da ya zo daga Istanbul zuwa Baganshu.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an dakatar da cutar a cikin gida kuma an sami damar sarrafa yaduwar cutar a cikin kasar Sin.
A ranar ne aka sassauta takunkumin tafiye-tafiye a Hubei, a cikin watanni biyu da aka sanya takunkumin a wajen Wuhan. Ma'aikatar Harkokin Wajen kasar Sin ta sanar a ranar 26 ga Maris, 2020 cewa duk da cewa masu da takardar izinin shiga ko izinin zama ba za su iya shiga ba tun daga ranar 28 ga Maris, ba a bayyana lokacin da wannan manufar za ta sake ba.
Wadanda ke son shiga kasar Sin dole ne su nemi biza a ofisoshin jakadancin kasar Sin ko ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta yi kokarin dawo da kamfanoni da masana'antu daban-daban da aka rufe saboda COVID-19 zuwa ayyukansu tun daga ranar 21 ga Maris, 2012, kuma ta ba da tallafin kudi don karfafawa da kuma farfado da waɗannan kungiyoyi. Ko da yake ya yi daidai da bikin Qingming na shekara-shekara, jami'an kasar sun ayyana ranar 26 ga Maris, 2012, a matsayin ranar makoki ta kasa, da karfe 4:00 na safe, kuma an yi addu'ar minti 3.
An ba da rahoton yaduwar COVID-19 daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar kiwon lafiya ta kasa ta bayar da rahoton karuwar wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wanda ya fi dacewa da taron da ake yi a wani sabon addini na Daegu da ake kira Shincheonji Church of Jesus.
Shincheonji ya ziyarci Wuhan, ya sa a yi shakku kan ko za a iya samun yaduwar cutar.
A ranar 22 ga watan Fabrairu, kimanin kashi 13 cikin dari na masu bin addinin 9,336 sun kamu da cutar, wanda ya nuna alamun 1,261. Koriya ta Kudu ta ba da sanarwar matakin gaggawa a ranar 23 ga watan Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu sama da mutane 2,000 da suka kamu da cutar, inda a ranar 29 ga watan Janairu, adadin ya kai 3,150.
An rufe dukkan sansanonin sojojin Koriya ta Kudu zuwa kwantaragi bayan sojoji uku sun kamu da cutar.
Koriya ta Kudu ta gabatar da shirin da ya fi girma kuma mafi tsari a duniya don bincika jama'a daga cutar da gano duk wani mutum da ke da cutar da kuma ganowa da kuma ware mutanen da suka sadu da su.
Hanyoyin tantancewa sun hada da tilastawa na sanar da kai ga alamun cutar a cikin sabbin masu shigowa duniya ta hanyar manhajar wayar hannu, gwajin kwayar cutar ba tare da sauka daga mota ba inda za a ba da sakamakon a rana mai zuwa, da kuma kara karfin gwajin mutum 20,000 a kowace rana.
Ko da yake ba a rufe birane gaba daya ba, shirin Koriya ta Kudu ya nuna cewa yana da tasiri wajen shawo kan annobar.
Yawancin 'yan Koriya suna tattara sa hannu don neman a gurfanar da Shugaba Moon ko kuma a yaba masa saboda amsar da gwamnatin ta ba da game da cutar.
A ranar 23 ga watan Maris, Koriya ta Arewa ta bayar da rahoton mafi karancin cutar a rana guda cikin makonni hudu.
A ranar 29 ga Maris, da kuma farkon 1 ga Afrilu, duk sabbin masu shigo da kayayyaki za a ware su na tsawon makonni biyu.
Rahotanni sun nuna cewa, a ranar 1 ga Afrilu, Koriya ta Kudu ta nemi taimakon gwajin kwayar cutar daga kasashe 121.
Iran ta bayar da rahoton kamuwa da cutar SARS-CoV-2 a Kwai a ranar 19 ga Fabrairu, kuma a cewar Ma'aikatar Lafiya da Ilimi na Lafiya, mutane biyu sun mutu a wannan ranar.
Matakan da gwamnati ta dauka sun hada da rufe bukukuwa da sauran tarurrukan al'adu, wasanni, ibadar Juma'a, jami'o'i, makarantun firamare da sakandare.
Iran ta ware tiriliyan biyar na Riyal don yaki da cutar.
Shugaban kasar Hassan Rouhani ya bayyana a ranar 26 ga watan Fabrairun 2020 cewa babu wani shiri na rufe wuraren da cutar ta addabi, amma kawai a ware mutane.
Ko da yake ana ci gaba da zirga-zirgar ababen hawa tsakanin biranen da ke gab da Nuwruz na Sabuwar Shekarar Farisa, an sanar da shirin dakile zirga-zirgar ababen hawa a cikin birane a watan Maris.
An bude wuraren ibada na Shia a Kouk ga masu yawon bude ido har zuwa ranar 16 ga Maris, 2020. Bayan China, Iran ta zama cibiyar yaduwar cutar a watan Fabrairu.
Da yake nuni da zargi kan yadda Iran ke rufe annobar, sama da kasashe goma sun danganta makomarsu da Iran a ranar 28 ga Fabrairu, inda suka nuna cewa za a iya samun karuwar yaduwar cutar fiye da wadanda suka kamu 388 da gwamnatin Iran ta ruwaito a wannan rana.
An rufe majalisar dokokin Iran a ranar 3 ga watan Maris, bayan da aka gano cewa mambobi 23 daga cikin 290 na majalisar sun kamu da cutar.
A ranar 12 ga watan Maris, masu sa ido kan kare hakkin dan adam sun bukaci jami'an gidan yarin Iran da su gaggauta sakin wadanda aka tsare ba tare da wani sharadi ba saboda adawa da hakkin dan adam, da kuma sakin duk wadanda aka yanke wa hukuncin da ya dace.
An bayyana cewa, wurare kamar gidajen yari, inda ba a samun isasshen taimakon likita, su ne wuraren da cutar ke da matukar hadarin yaduwa.
A ranar 15 ga watan Maris, gwamnatin Iran ta bayar da rahoton mutuwar mutane 100 a rana daya, wanda shine mafi girma a kasar tun lokacin da cutar ta barke.
Akalla 'yan siyasa 12 na yanzu da na baya da jami'an gwamnati sun mutu sakamakon cutar a ranar 17 ga watan Maris.
23 ga Maris Iran tana samun sabbin mutane 50 a kowace awa daya saboda cutar coronavirus, kuma mutum daya na mutuwa a kowane minti goma.
A cewar hukumar lafiya ta duniya WHO, adadin wadanda suka kamu da cutar a Iran ya ninka na wadanda suka kamu da cutar sau biyar.
Ya ce takunkumin da Amurka ta kafa kan Iran na iya lalata karfin kudin kasar wajen magance annobar cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a dage takunkumin tattalin arziki kan kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da yaduwar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu 'yan yawon bude ido biyu na kasar Sin suka gwada tabbatacciyar cutar SARS-CoV-2 a Rome.
Gwamnatin Italiya ta sanar da dokar ta baci, ta dakatar da zirga-zirgar jiragen sama daga China zuwa Italiya da Italiya zuwa China saboda karuwar cutar.
A ranar 22 ga watan Fabrairu, majalisar ministocin ta sanar da sabon umarnin da za ta sarrafa yaduwar cutar, ciki har da keɓe mutane sama da 50,000 a cikin kananan hukumomi 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce babu shiga ko fita daga yankunan da cutar ta bulla.
A ranar 4 ga watan Maris, lokacin da mutuwar ta kai 100 a Italiya, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar.
Duk manyan wasannin wasanni, ciki har da wasannin kwallon kafa na Serie A, ya kamata a rufe su har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni na akalla wata guda.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da umarnin dakatar da duk ayyukan kasuwanci a kusa da wurin, sai dai manyan kantuna da kantunan magani. A ranar 6 ga watan Maris, Kwalejin Kula da Magungunan Rashin Jiki, Anaesthesia, Resuscitation and Intensive Care (SIAARTI) ta wallafa shawarwarin ɗabi'a na likita game da ƙa'idodin kulawa na gaggawa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China tare da yin rahoton mutuwar mutane 3,405 sakamakon cutar coronavirus.
A ranar 22 ga watan Maris, Rasha ta aika da jiragen sama tara na soja dauke da kayan aikin kiwon lafiya zuwa Italiya.
Ya zuwa ranar 5 ga Afrilu, an sami mutane 128,948 da suka kamu da cutar a Italiya, 15,887 sun mutu, kuma 21,815 sun warke, mafi yawan waɗannan sun faru ne a yankin Lombardy.
Rahoton CNN ya ce, yawan mutanen Italiya da suka tsufa da rashin iya gwada duk wanda ke da cutar sun haifar da yawan mutuwar.
Amsar Burtaniya ga cutar ta kasance mai sassaucin ra'ayi a matsayin ɗayan ƙasashe da suka fi fama da cutar, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta ɗauki kowane matakin nisantar da jama'a ko keɓewa ga 'yan ƙasa ba.
A sakamakon haka, an soki gwamnati da rashin kulawa da kulawa wajen amsa barazanar da jama'a suka gabatar. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar cewa kowa ya guji tafiye -tafiye da hulɗa da jama'a, mutane su ci gaba da aiki a gidajensu gwargwadon iko, kuma su guji zuwa wurare kamar mashaya, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, ya sanar da rufe dukkan wuraren shakatawa kamar mashaya da wuraren motsa jiki, tare da rufe kashi 80% na albashi na masu karbar albashi har zuwa £2,500 a wata. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewar jama'a, hana mutane sama da biyu kasancewa tare da iyakance tafiye -tafiye, da kuma hana ayyukan waje, tare da ba da izini ga ayyukan da ake buƙata kawai.
Sabanin matakan da aka dauka a baya, 'yan sanda ne ke tilasta wa' yan sanda su aiwatar da wannan dokar ta hanyar biyan tarar da kuma tarwatsa tarurruka.
"An umarci yawancin kasuwancin da suka hada da manyan kantuna, kantunan magani, bankuna, shagunan kayan aiki, kantuna da kuma gidajen ajiye motoci su rufe, sai dai kasuwancin da aka amince da su a matsayin ""masu amfani"".
An gano mutum na farko da aka tabbatar da cutar COVID-19 a ranar 20 ga Janairu a cikin Pacific Pacific na arewa maso yammacin Washington, wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar White House ta yaki da cutar korona a ranar 29 ga watan Janairu.
A ranar 31 ga Janairu, ya ba da sanarwar gaggawa ta kiwon lafiya ga jama'a kuma ya sanya takunkumi ga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta Amurka ta sanar da cewa sun kirkiro nasu na'urar gwaji.
Duk da haka, Amurka ta fara jinkirin gwajin, wanda ya hana fahimtar ainihin yaduwar cutar a lokacin.
A watan Janairu, an dakatar da bincike saboda gwamnatin tarayya ba ta samar da kayan aikin bincike masu inganci ba. Gwamnatin tarayya ta iyakance don amincewa da kayan aikin bincike da ke hannun kungiyoyi masu zaman kansu (makarantu, kamfanoni da asibitoci) har zuwa karshen watan Janairu, tare da hana mutane yin gwaji har zuwa farkon Maris (bayan haka ana buƙatar umarnin likita).
A ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa, kasa da mutane 4,000 ne aka gwada a Amurka.
Atlantic ta ruwaito cewa an yi gwaje-gwaje kasa da 14,000 har zuwa ranar 13 ga Maris.
"A ranar 22 ga Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa, "'Yan kasar da ke da alamun cutar da kuma umarnin likita sun jira sa'o'i ko kwanaki don yin gwaji. "Bayan an fara samun mutuwar farko a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, kuma sauran jihohi sun bi sahun nan ba da jimawa ba".
An dakatar da makarantun da ke yankin Seattle a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantun da ke cikin garinsu sun rufe. A ranar 6 ga Maris, 2020, Imperial College London na Amurka ta yi shawarwari da kungiyoyin masu ilimin cututtuka game da tsinkayen rikicin da sabon coronavirus ke haifar wa kasar.
A wannan ranar, Shugaba Trump ya sanya hannu kan sanarwar shirye-shiryen karawa juna sani game da shirye-shiryen cutar coronavirus da kuma amsawa don samar da asusun gaggawa na dala biliyan 8.3 ga jami'an tarayya don magance annobar.
Kamfanoni sun hana ma'aikatansu tafiya, sun soke tarurruka, kuma sun karfafa ma'aikatansu su yi aiki daga gida.
An soke abubuwan wasanni da shirye-shirye. A ranar 11 ga Maris, Trump ya sanar da dakatar da jiragen sama daga Turai, sai dai Ingila, wanda zai fara aiki na tsawon kwanaki 30 daga ranar 13 ga Maris.
Kashegari, an kara wa Isra'ila da Burtaniya takunkumi.
A ranar 13 ga watan Maris, Amurka ta ayyana dokar ta baci, wanda ya haifar da sakin kudaden tarayya don magance matsalar.
A farkon ranar 15 ga watan Maris, kamfanoni da dama a Amurka sun rufe ko rage lokutan aiki domin rage yaduwar cutar.
A ranar 17 ga watan Maris, cutar ta bazu a jihohi 50 da jihar Columbia. A ranar 23 ga watan Maris, an samu mutane 10,700 da suka kamu da cutar a birnin New York, wanda ya fi adadin da aka samu a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya bayyana cewa yana aiki ne a kan nisantar zamantakewar jama'a, inda ya ce adadin da ake tsammani zai karu ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an samu mutane 32,308 da suka kamu da cutar a birnin New York kadai, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga watan Maris, Amurka, China da Italiya sun sami mutane da suka kamu da cutar a duk duniya.
Rahotanni na kafofin watsa labarai na ranar 30 ga Maris sun ce, shugaban Amurka Trump ya yanke shawarar tsawaita dokokin nisantar jama'a har zuwa ranar 30 ga Afrilu.
A wannan rana, jirgin asibiti na USNS Comfort, wanda ke dauke da gadaje kusan 1,000, ya isa New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 a cikin awanni 24 sakamakon cutar coronavirus.
A ranar 3 ga Afrilu, cutar ta zarge mutane sama da 100,000 a jihar New York, tare da sukar fadar White House kan rage barazanar da kuma jagorantar jami'an kiwon lafiya da kuma sanyawa masana kimiyya damar daidaita maganganun jama'a da kuma sanya takardu masu alaƙa da cutar a ƙarƙashin ofishin mataimakin shugaban kasa Mike Pence.
Gwamnatin Trump ta yi watsi da rikicin, kuma hakan ya haifar da rarrabuwa tsakanin magoya bayan jam'iyyar.
Wasu jami'an Amurka da masu sukar Amurka sun soki Amurka kan dogaro da shigo da kayan aiki masu mahimmanci, gami da kayan kiwon lafiya masu mahimmanci daga China.
An yi amfani da nazarin hanyoyin zirga-zirgar jiragen sama a kan taswira da kuma hasashen hanyoyin watsawa kuma an buga shi a cikin Jaridar Tafiya da Magunguna a tsakiyar Janairu 2020 na EA.
Bangkok, Hong Kong, Tokyo, da Taipei sun karbi bakuncin mafi yawan fasinjoji daga ruwa bisa ga bayanan da Cibiyar Kula da Sufurin Jiragen Sama ta Duniya ta bayar a shekarar 2018.
Dubai, Sydney da Melbourne manyan wurare ne ga mutanen da ke zuwa daga Wuhan.
Bali ita ce ƙaramar birni a cikin biranen da aka fi so 20 don shirye-shirye, kuma an yi niyyar zama biranen Australiya. Australia ta ba da sanarwar shirin gaggawa na gaggawa ga sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
An ce har yanzu akwai ƙarin bincike game da COVID-19, kuma Australia za ta mai da hankali kan kula da kan iyakoki da sadarwa a cikin martani ga annobar.
An sanar da gaggawa ta kare lafiyar dan adam a Australia a ranar 21 ga Maris.
Don samar da ingantaccen keɓewar sufuri na jama'a a Wuhan da Hubei, ƙasashe da yawa suna shirin fitar da 'yan ƙasa da ma'aikatan diflomasiyya daga yankin ta hanyar izinin hukumomin China, musamman don wannan dalili, ta hanyar jiragen sama na musamman.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand na daga cikin manyan kasashen da ke shirin ba da izinin tafiya ga 'yan kasarsu.
Pakistan ta ce ba za ta fitar da 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko kuma danginsu tare da' yan Poland hudu, Sin daya da Indiya.
'Yan kasar Poland, China da Indiya sun sauka a Poland kafin jirgin Brazil ya tashi zuwa Brazil.
An ware 'yan Brazil da suka tafi Juan daga sansanin soja da ke kusa da Brazzaville.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga cikin jirgin, da 39 daga jirgi na biyu da gwamnatin Amurka ta yi izini) daga cikin ruwa zuwa CFB Trenton kuma an keɓe su na tsawon makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama dauke da 'yan Kanada 185 ya sauka a CFB Trenton.
Hukumomin Australiya sun kai mutane 277 zuwa Cibiyar Tsare-tsare ta Tsibirin Kirsimeti a ranar 3 da 4 ga Fabrairu, inda suka yi kwanaki 14 a cikin wani wuri da aka canza zuwa keɓewa.
Jirgin saukar jiragen sama na New Zealand ya isa Auckland a ranar 5 ga Fabrairu, kuma fasinjojin (ciki har da wasu Australiya da Pacific) an keɓe su a sansanin sojin ruwa na Wan Gaparua, arewacin Auckland.
A ranar 15 ga watan Janairu, Amurka ta sanar da cewa za ta kwashe 'yan kasarta daga jirgin Diamond Princess Yasher.
Jirgin da ke dauke da fasinjoji 129 na Kanada da ya sauka daga Diamond Princess a ranar 21 ga Fabrairu ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga watan Maris, jirgin saman kamfanin jiragen sama na Afirka ta Kudu ya mayar da 'yan Afirka ta Kudu 112.
An yi wa 'yan Afirka ta Kudu da dama da suka nuna alamun cutar coronavirus gwajin likita kafin a sake su, kuma an sake su don a rage hadarin.
Sai dai 'yan Afirka ta Kudu da suka samu sakamako mara kyau ne kawai aka mayar da su gida.
Sakamakon gwajin ya nuna cewa dukkan 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, ma'aikatan otal, 'yan sanda da sojoji, wadanda suka shiga aikin agaji da kuma wadanda aka sanya su keɓewa na tsawon kwanaki 14 a wurin shakatawa na Ranch don yin kariya, sun sami sakamako mai kyau.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da agaji ga kasar Sin.
An bayar da rahoton cewa wasu daliban kasar Sin da ke jami'o'in Amurka sun hada kai tare da aika kayan rufe fuska da hanci 50,000 N95 zuwa asibitocin Wuhan a lardin Hubei a ranar 30 ga Janairu, don taimakawa yankunan da cutar ta shafa.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da tallafin dala miliyan 100 ga WHO don tallafawa bincike kan allurar rigakafi da magani a Afirka da Kudancin Asiya.
A ranar 6 ga watan Fabrairu, kasar Sin ta tura kayan rufe baki da hanci 200,000 zuwa Philippines, kamar yadda Interaction ta ruwaito.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska da abin rufe fuska miliyan goma sha biyu ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta ba da gudummawar kayan aikin likita na musamman na tan 13 ga Wuhan, Malaysia ta sanar da cewa ta mayar da safar hannu miliyan 18 ga China ga Wuhan, Jamus ta ba da gudummawar kayan aikin likita daban-daban na 10,000, kuma Amurka ta ba da gudummawar tan 17.8 na kayan aikin likita ga China, tare da alƙawarin ba da dala miliyan 100 ga ƙasar da ke fama da cutar.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da kwararru don taimakawa Italiya da cutar coronavirus ta shafa.
Dan kasuwa Jack Ma ya aika da kayan bincike miliyan 1.1, da abin rufe fuska miliyan shida, da kuma riguna na kariya dubu 60,000 zuwa Addis Ababa, Habasha, don rarraba wa kungiyar tarayyar Afirka.
Daga baya, ya aika da kayan gwaji 5,000, abin rufe fuska 100,000, da kuma na'urorin sanyaya iska guda biyar zuwa Panama.
Ma ya ba da gudummawar kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan gwajin da aka yi a China.
Misali, Spain ta fitar da kayan gwajin cutar coronavirus 58,000 da aka yi a China, saboda ingancin su ya kai 30%. Hakazalika, Netherlands ta sanya kayan rufe baki 600,000 da ba a tabbatar da ingancin su ba, waɗanda aka yi a China.
Belgium ta mayar da abin rufe fuska 100,000 da aka yi zaton an sayo su ne daga China, amma a zahiri daga Colombia ne.
A wani bangare kuma, tallafin da China ke bayarwa ya samu karbuwa a wasu sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya fara bayar da tallafin gaggawa ga kasashe masu tasowa.
Hukumar Lafiya ta Duniya WHO ta yaba wa jami'an kasar Sin kan matakin da suka dauka na shawo kan annobar.
"WHO ta lura da kwatancen tsakanin barkewar cutar SARS ta 2004 da 2004, inda jami'an kasar Sin suka yi ta kokarin hanawa da kuma sarrafa cutar, kuma rikicin na yanzu shine gwamnatin tsakiya ta "ba da cikakken bayani kan yanayi don kaucewa fargaba kafin bikin sabuwar shekara ta wata".
A ranar 23 ga watan Janairu, wakilin Majalisar Dinkin Duniya, Goden Gale, wanda ya amsa shawarar da hukumomi suka yanke na aiwatar da takunkumin hana zirga-zirga a Wuhan, ya ce, "duk da cewa ba shawarar Hukumar Lafiya ta Duniya ba ce, amma kuma muhimmiyar manufa ce ta kama inda cutar ta fi yaduwa, kuma ba a taɓa ganin irinta ba a tarihin lafiyar jama'a".
"Darakta Janar na Hukumar Lafiya ta Duniya Tedros Adhanom PHEIC ya ce, "yana da matukar damuwa game da yaduwar cutar a duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya".
"Dangane da amsa buƙatun ƙuntatawa na tafiye-tafiye, Tedros ya bayyana cewa ""babu wani dalili da zai sa a tsoma baki cikin balaguron balaguro da kasuwanci na duniya"" da kuma ""WHO ba ta ba da shawarar hana kasuwanci da motsi ba"."
A ranar 5 ga watan Fabrairu, WHO ta nemi taimakon dala miliyan 675 daga kasashen duniya don tallafawa kasashen da ke da karancin kudi, don taimakawa kasashen da ba su da tsarin da zai iya gano wadanda suka kamu da cutar, ko da yake cutar ta fara fitowa.
Tedros ya kara da cewa "mu masu rauni ne, kamar yadda muke da karfi", kuma ya yi kira ga kasashen duniya da su "saka hannun jari a yau ko kuma su biya ƙarin a baya".A ranar 11 ga Fabrairu, a cikin sanarwar manema labarai, WHO ta sanya sunan cutar COVID-19.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya, António Guterres ya amince da duk rundunar Majalisar Dinkin Duniya ta mayar da martani.
Ƙungiyar Gudanar da Bala'i ta Majalisar Dinkin Duniya, wadda aka kafa, ta ba da damar hadin gwiwar amsawar Majalisar Dinkin Duniya don mayar da hankali kan amsawar kiwon lafiya, yayin da sauran hukumomi ke amfani da iliminsu don gano tasirin annobar cutar da ci gaba a kan zamantakewar jama'a, tattalin arziki.
A ranar 14 ga watan Fabrairu, an gudanar da wani aiki tare da kungiyar lafiya ta duniya tare da kasar Sin don taimakawa masana na cikin gida da na duniya a kasar Sin wajen taimakawa wajen gudanar da gudanar da bita da tarurruka. Ya ce, ya kamata a gudanar da ziyarar filin don kimanta tasirin ayyukan mayar da martani a yankuna da larduna, ciki har da manyan cibiyoyin matakin kasa da yankuna da yankunan karkara, a ranar 25 ga watan Fabrairu, don shirya duniya yadda ya kamata.
"A cikin martani ga barkewar cutar a Iran, WHO ta aika da tawagar hadin gwiwa don kimanta matsalar. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara kimanta hadarin kwayar cutar ta corona daga ""mai tsanani"" zuwa ""mai tsanani"" a duniya.
"Wannan gwaji ne na gaske ga kowace gwamnati a duniya", in ji Mike Ryan, babban daraktan shirye-shiryen gaggawa na WHO.
"Wannan kwayar cutar na iya zuwa, kuma kuna buƙatar kasancewa a shirye,  ɗaukar matakan kariya masu dacewa zai taimaka wa duniyarmu ta shawo kan mafi munin yanayi. "
"Ryan ya kara da cewa, bayanan na yanzu ba su tabbatar da cewa jami'an kiwon lafiyar jama'a za su iya yin gargadin barkewar cutar ba, cewa irin wannan sanarwar na nufin "mun yarda cewa duk ɗan adam a duniya zai iya kamuwa da cutar".
Hukumar Lafiya ta Duniya WHO ta ayyana cutar coronavirus a matsayin annoba ta duniya a ranar 11 ga watan Maris.
"Darakta Janar na WHO ya ce ya damu matuka game da "matakan da ake damuwa da yaduwar cutar da kuma rashin daukar mataki". An soki WHO sosai saboda rashin kula da cutar, gami da jinkirin sanar da dokar ta baci ta kiwon lafiya da kuma jinkirin ayyana cutar a matsayin annoba ta duniya.
An tattara sa hannun babban daraktan Hukumar Lafiya ta Duniya Theodore Adhanom don yin murabus, wanda ya kai mutane 733,000 sun sanya hannu a ranar 6 ga Afrilu.
26 Maris 2020 Masana 'yancin dan adam da dama na TCDD sun yi kira ga kowa da kowa da ya kula da hakkin dan adam a wannan lokacin na annobar COVID-19.
Masana sun ce, kowa ya kamata ya yi aiki don ceton rayuka, kuma gwamnati tana da alhakin jagorantar hakan.
Kungiyar ta ce kada a yi amfani da rashin wadata ko rashin lafiya don kai hari ga wata kungiya mai rikitarwa.
Masana sun jaddada cewa kowa yana da 'yancin samun lafiya, ciki har da nakasassu, wadanda ba sa cikin 'yan tsirarun kungiyoyi, tsofaffi, 'yan gudun hijira, marasa gida, wadanda ke cikin matsanancin talauci, wadanda ke cikin kurkuku, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a bayyana su ba da ke bukatar tallafin gwamnati.
Kasashen duniya na kokarin magance matsalar tattalin arziki da zamantakewar da COVID-19 ta haifar.
Kungiyar Hadin Kai da Ci Gaban Tattalin Arziki ta kafa wani dandamali na samar da martani kan manufofin da suka dace da kuma cikakke ga kasashe a duk duniya, tare da bayar da shawarwari da shawarwari.
Ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya ta hanyar manufofi don magance matsalolin da ke haifar da sakamakon kulle-kulle da ƙuntatawa na tafiye-tafiye, magance cibiyar dijital ciki har da bin diddigin manufofin ƙasa da kuma ba da damar ƙasashe su koya daga juna don magance ayyukan cutar coronavirus da kuma sauƙaƙe haɗin kai na duniya.
Michelle Gove, dan kasar Burtaniya da kuma dan shugaban kasar Brazil Jar Jar Borsano, ya zargi gwamnatin China da cewa cutar ta samo asali ne daga lardin Hubei na kasar Sin, inda kasar Sin ta kamu da cutar.
An kori wasu jami'an gudanarwa na matakin yanki (CPC) a tsakiyar kasar Sin saboda kula da kokarin killace mutane a tsakiyar kasar, a wani bangare na yadda hukumomin siyasa suka mayar da martani ga annobar a wadannan yankuna.
Wasu masu sukar sun yi imanin cewa an dauki matakin ne don hana fushin jama'a kan babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping kan yaduwar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun musanta cewa cutar ta farko ta COVID-19 ta samo asali ne daga ruwa, suna mai da hankali kan cewa COVID-19 ya samo asali ne daga Amurka ko Italiya.
"Gwamnatin Donald Trump ta Amurka ta ambaci coronavirus a matsayin ""kwayar cutar Sin"" ko ""kwayar cutar Wuhan"" yayin da wasu masu sukar suka ce, "Suna nuna wariyar launin fata da kuma rashin iya sarrafa cutar".
The Daily Beast ya ce duk wani batun da ya shafi sadarwa a majalisar tsaron kasa, shi ne batun kasar Sin.
An gaya mana mu yada wannan sakon ta kowace hanya da za mu iya, ciki har da sanarwar manema labarai da shirye-shiryen talabijin. Kasashen waje kamar su siyasa, manufofin kasashen waje da kuma Bloomberg sun ce kokarin da China ke yi na aika da agaji ga kasashen da cutar ta shafa na daga cikin matsin lamba na duniya.
Shugaban manufofin kasashen waje na Tarayyar Turai Joseph Borili ya yi gargadin cewa akwai shirin yin tasiri a fannin siyasa ta hanyar azurfa da kuma manufofin alheri.
"Borrell ya ce, ""China tana yada sakon cewa ita ce abokiyar hulda mai aminci da kuma alhakin daban da Amurka"."
China ta yi kira ga Amurka da ta sauƙaƙa takunkumi kan Syria, Venezuela, da Iran, kuma ta yi ta ba da taimako ga Venezuela da Iran.
A ranar 3 ga watan Afrilu, Amurka ta dakatar da tallafin da aka yi wa Jack Ma na kayan rufe fuska 100,000 da ya bayar ga Cuba.
An zargi jami'an Amurka da kashe kudaden tallafin da aka yi niyyar bayarwa ga wasu kasashe don mallakar kasarsu.
An samu rikici tsakanin Jamus, Austria, Switzerland, Jamhuriyar Czech da Italiya dangane da rufe fuska da goshi.
Turkiyya ta kuma kwace daruruwan na'urorin numfashi da ake kaiwa Spain.
A farkon watan Maris, Tarayyar Turai ta soki gwamnatin Italiya kan rashin hadin kai da ita a cikin rikicin cutar coronavirus.
"Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce, "Shayina ce kawai ta ba da amsa ta biyu".
Hakika, wannan ba misali mai kyau ba ne na haɗin kan Turai.
A ranar 22 ga watan Maris, Shugaban Rasha Vladimir Putin ya tattauna ta waya da Firayim Ministan Italiya Giuseppe Conte, inda ya shirya isar da likitocin tsaro, kayan aikin likita, motocin fesa magunguna zuwa Italiya.
Jaridar La Stampa ta Italiya ta ruwaito wani babban dan siyasa wanda ya nemi a sakaya sunansa, cewa kashi 80 cikin 100 na taimakon da Italiya ke bayarwa ba shi da amfani ko kuma ba shi da amfani.
"Wadannan kafofin sun soki Rasha a matsayin mai tayar da hankali a kan ""yanayin siyasa da diflomasiyya"".
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Waje na Italiya Luigi Di Maio sun yi godiya ga yadda suka yi watsi da rahoton da kafofin yada labarai suka fitar.
Rasha ta kuma aika da jirgin sama mai dauke da kayayyakin magani zuwa Amurka.
"Mai magana da yawun Kremlin Dmitry Peskov ya ce, "Lokacin da ya ba da tallafi ga abokan huldar Amurka, [Putin] ya yi tunanin cewa idan masana'antun kayan aikin likitanci na Amurka sun sami saurin, za su iya dawo da su idan ya zama dole".
Aikin sojin NATO Defender 2020 na shirin gudanarwa a Jamus, Poland da kasashen Baltic, wanda shine mafi girma tun karshen yakin sanyi, za a gudanar da shi a wani karamin mataki.
"Sakatare Janar na Kungiyar Kare Makaman Nukiliya Kate Hudson ta soki ayyukan Defender 2020. ""A cikin rikicin kiwon lafiyar jama'a na yanzu, ba wai kawai rayukan sojoji daga Amurka da na kasashen Turai da yawa ba ne ke cikin hadari, har ma da rayukan mazauna kasashen da suke aiki"." Gwamnatin Iran ta sha wahala sosai daga cutar, tare da sha biyu 'yan majalisa da goma sha biyar na yanzu ko tsoffin' yan siyasa.
A ranar 14 ga Maris, 2020, Shugaban Iran Hassan Rouhani ya rubuta wasikar hukuma zuwa ga gwamnatocin duniya, yana mai cewa takunkumin tattalin arzikin Amurka a kan kasarsa babban cikas ne ga kokarin da ake yi na hana barkewar cutar. Cutar ta sa Amurka ta aiwatar da manufofin zamantakewa na gaggawa, wanda ya dace da sauran kasashe masu arziki (ci gaba da kula da lafiya, rashin kare yara, kasafin kudi mai yawa ga lafiyar jama'a, da sauransu).
Masu sharhi a harkokin siyasa sun yi hasashen cewa hakan na iya shafar damar da Donald Trump zai samu na sake zabarsa a zaben shugaban kasa na 2020.
"Bayan Japan ta sanar da cewa, "Duk wani dan kasar Koriya ta Kudu da ya shigo zai zauna a wurin da gwamnati ta shirya na tsawon makonni biyu", Koriya ta Kudu ta zargi Japan da "ba ta da hankali kuma ba ta da hankali".
A farkon, an hana al'ummomin Koriya ta Kudu yin aiki sosai saboda matakin da Shugaba Moon Jae-in ya dauka na magance matsalar.
Yawancin 'yan Koriya suna sa hannu kan takardar neman hukunta wata a sama, ko kuma suna yaba wa matakin da gwamnati ta dauka na hana barkewar cutar.
Wasu manazarta sun nuna damuwa cewa zai iya taimaka wa gwamnatoci su karfafa ikonsu.
A Hungary, Firayim Minista Viktor Orbán ya ba da izinin gudanar da majalisar dokoki ba tare da wani lokaci ba, dakatar da majalisar dokoki da kuma gudanar da zabe, da kuma daukar mataki kan wadanda ke yada karya game da cutar da kuma yadda gwamnati ke kokarin shawo kan matsalar.
An zargi cutar ta coronavirus da rashin wadatar kayayyaki da yawa, karuwar amfani da duniya don yaƙar cutar, sayen gaggawa, da kuma katsewa a masana'antu da ayyukan dabaru.
Hukumar Abinci da Magunguna ta Amurka ta yi gargadin cewa za a iya samun karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kuma rashin wadatar kayayyaki.
"Yawancin mutanen yankin sun yi ta fama da matsalar samar da kayayyaki, inda aka rasa kayayyakin da ake bukata kamar abinci, takardar wanka, da kuma ruwan kwalba.
Masana fasahar zamani sun yi gargadin cewa za a iya samun jinkiri a jigilar kayayyakin lantarki.
A cewar babban daraktan WHO Tedros Adhanom, bukatar kayan kariya ta mutum ya ninka sau 100.
Wannan bukatar ta haifar da hauhawar farashin sau ashirin fiye da yadda aka saba, kuma an jinkirta jigilar kayayyakin kiwon lafiya daga watanni hudu zuwa shida.
Hukumar Lafiya ta Duniya ta yi gargadin cewa rashin kayan kariya na sirri na iya sanya ma'aikatan kiwon lafiya cikin hadari a duniya.
A Ostiraliya, annobar ta duniya ta samar da sabuwar dama ga masu sayen Daegu don sayar da kayayyakin Australiya zuwa China.
Gwamnatin Australia ta yi gargadi kan matsalar rashin abinci a cikin babban kanti, bayan da ta yi watsi da matsalar. Ko da yake cutar COVID-19 ta fi yawa a arewacin Italiya da yankin Wuhan, duk da haka, an sami mafita daga rashin abinci a yankunan biyu, sakamakon bukatar abinci na farko.
Matakan da China da Italiya suka dauka na hana adana kayayyakin da suka fi muhimmanci da kuma hana cinikayya sun kasance masu tasiri, wanda ya kawar da matsalar karancin abinci da ke damun Turai da Arewacin Amurka.
Arewacin Italiya ba ta bayar da ragi mai yawa ba saboda yawan amfanin gona, amma idan wakilan masana'antu suna da shi, zan iya ƙara farashin.
A Wuhan kanta, jami'an gwamnatin kasar Sin sun saki kayan naman alade domin tabbatar da cewa akwai isasshen abinci ga jama'a.
A Italiya, irin wannan doka ta bukaci masana'antun abinci su sanya ajiyar lokaci don irin wannan bala'in.
An kuma ga tasirin tattalin arzikin duniya a kasar Sin: A cewar wani rahoto na kafafen yada labarai na ranar 16 ga watan Maris, tattalin arzikin kasar Sin ya yi matukar rauni kuma tallace-tallace na kiri ya ragu da kashi 20.5% a cikin watanni biyu na farko na shekarar 2020 sakamakon matakan da gwamnati ta dauka na rage yaduwar cutar.
Kasar Sin ta kasance cibiyar bunkasa tattalin arziki da masana'antu kuma cutar ta haifar da koma bayan tattalin arziki a duniya.
Agathe Demarais na sashen bincike na tattalin arziki ya ce har sai an samu karin bayani, kasuwannin za su ci gaba da canzawa.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa annobar za ta iya haifar da koma bayan tattalin arziki a duniya fiye da yadda cutar SARS ta 2002-2004 ta yi.
Masana a Jami'ar Washington da ke St. Louis sun kiyasta cewa sarkar samar da kayayyaki ta duniya za ta yi kasa da dala biliyan 300 a cikin shekaru biyu.
An ruwaito cewa Syracuse na neman kasuwa saboda bukatar man fetur da farashin mai na kasar Sin.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin masu cutar COVID-19 a wajen kasar Sin.
A ranar 27 ga watan Fabrairu, saboda fargabar yaduwar cutar coronavirus, wasu alamomin kayayyaki na Amurka, ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average, sun buga mafi ƙarancin ragowar su tun shekara ta 2008, inda suka yi kasa da maki, wanda shine mafi girman faɗuwar rana tun bayan rikicin kuɗi na 2007-08.
Dukkanin alamomin guda uku sun kammala makon da raguwa sama da 10%.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da cewa kasar Sin kasa ce mai 'yancin yin hukunci da kanta game da batun bashi.
Hannun jari sun sake faduwa saboda barazanar cutar coronavirus, tare da babban koma baya a ranar 16 ga Maris.
Mutane da yawa suna tunanin cewa tattalin arziki zai iya rushewa.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa manyan bankuna da jihohi kan matakan gaggawa na wucin gadi.
Bankunan tsakiya na amsawa cikin sauri fiye da yadda suka yi a lokacin rikicin kuɗi na 2008.
Yawon shakatawa na ɗaya daga cikin fannonin da suka fi fama da takunkumin tafiye -tafiye, rufe wuraren taruwar jama'a, ciki har da wuraren shakatawa, da kuma shawarwarin gwamnatoci na dakatar da duk wani tafiya a duk duniya.
Sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, China Eastern Airlines da Cantonese sun soke jirage saboda karancin bukatar, kuma kamfanin jirgin sama na yankin na Burtaniya, Flame, ya fadi.
Ba a taɓa ganin irin tasirin da jirgin ruwa ya yi wa masana'antar jirgin ruwa ba.
An kuma rufe tashoshin jiragen kasa da tashoshin jiragen ruwa da dama.
Cutar ta yadu a Chongun, babban wurin da ake yin tafiye-tafiye da bikin sabuwar shekara ta kasar Sin.
Gwamnatocin kasa da na kananan hukumomi sun soke bukukuwa da dama da suka hada da bukukuwan Sabuwar Shekara, yayin da kamfanoni masu zaman kansu ke rufe shagunan su da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe wuraren shakatawa da wuraren shakatawa na bikin Lunar New Year don hana taron jama'a a birnin Beijing na Forbidden City, inda aka gina gidan ibada na gargajiya na Carnival Beta.
Hukumomi a larduna 31, kananan hukumomi da yankuna 24 na kasar Sin sun ba da umarnin tsawaita bikin ranar murnar ranar 10 ga watan Fabrairu, tare da hana bude wuraren aiki da yawa har zuwa ranar.
Wadannan yankuna suna wakiltar kashi 80% na GDP na kasar da kuma 90% na fitarwa.
Hong Kong ta kara matakin mayar da martani ga cutar, kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bikin Sabuwar Shekara a ranar Alhamis.
Ziyarar 'yan kasuwa a Turai da Latin Amurka ta ragu da kashi 40%.
'Yan kasuwa daga Arewacin Afirka da Gabas ta Tsakiya sun fuskanci ragin kashi 50-60%.
Wannan ya haifar da raguwar zirga-zirgar ƙafa zuwa cibiyoyin cin kasuwa da kashi 33.43% a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da manyan kantuna a duniya sun aiwatar da ƙarin matakan kamar ƙarin tsaftacewa, sanya gwajin zafin jiki don bincika yanayin zafi na masu amfani, da soke abubuwan da suka faru.A cewar Hukumar Tattalin Arzikin Latin Amurka ta Majalisar Dinkin Duniya, rufewar cutar ta iya jefa mutane tsakanin miliyan 14 zuwa 22 cikin talauci a Latin Amurka fiye da waɗanda ba su shiga cikin yanayin cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, kimanin mutane miliyan biyar ne suka rasa ayyukansu a kasar Sin a lokacin da annobar ta barke a birnin Wuhan.
Kimanin ma'aikata 'yan gudun hijira na karkara miliyan 300 na kasar Sin sun kasance a gida ko kuma sun kasance a cikin tsakiyar yankin lardin Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Yaduwar cutar coronavirus ta lalata ayyuka miliyan 47 a Amurka kuma bankin tarayya na St. Louis ya kiyasta cewa yawan rashin aikin yi zai iya kaiwa 32%.
A rabin watan Maris, ma'aikatan Faransa miliyan 4 ne suka nemi amfanin rashin aikin yi na wucin gadi, kuma ma'aikatan Burtaniya miliyan 1 sun nemi tsarin bashi na duniya, yayin da kusan kamfanoni miliyan rabin Jamus suka tura ma'aikatansu zuwa tsarin rage aikin wucin gadi na gwamnati da ake kira Kurzarbeit.
Shirin biyan diyya na ɗan gajeren lokaci da aka aiwatar a Jamus an fara aiwatar da shi a Faransa da Ingila.
Tarihin fasaha da al'adu sun sami mummunan rauni sakamakon cutar, wanda ya shafi ayyukan kamfanoni da ma'aikata da masu zaman kansu a duniya.
Kungiyoyin fasaha da al'adu sun yi ƙoƙari su ba da gudummawar al'adun gargajiya ga al'umma (wanda galibi gwamnati ke tallafawa), don kare lafiyar ma'aikatansu da jama'a, da kuma tallafawa 'yan wasan kwaikwayo a duk inda zai yiwu.
An dakatar da ko kuma an jinkirta nunawa a dakunan karatu, gidajen tarihi, wuraren shakatawa da sauran cibiyoyin al'adu na duniya, amma girman ya bambanta a watan Maris na 2020.
Wani sabon abu da ke ci gaba da ƙaruwa na cutar shi ne soke ayyukan addini, manyan abubuwan wasanni, da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide da wake-wake, taron fasaha, da nunin tufafi.
Vatican ta sanar da soke azumin tuba na Krista a karshen mako mai tsarki a Rome.
Da yawa daga cikin majami'u sun shawarci dattawan su zauna a gidajensu, ba tare da yin taro a ranar Lahadi ba, wasu majami'u suna ba da sabis na coci ta hanyar rediyo, watsa shirye-shirye ta kan layi ko talabijin, wasu kuma suna ba da sabis na mota.
Tun bayan da cocin Roman Catholic ya ba da izinin yin taro don yin sujada kuma an ba da yardar yin sujada a St. Peter's Square, sauran kungiyoyin addinai sun hana taron jama'a a cikin majami'u da kuma hana taro a wuri guda.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a wuraren da cutar ta yadu kuma an rufe wuraren ibada daga baya, yayin da Saudiyya ta hana masu yawon bude ido na kasashen waje shiga da kuma wuraren ibada na Makka da Madina.
Wannan annoba ta sanya matsin lamba a kan wasanni da shirye-shiryen da ake yi a duniya bayan yakin duniya na biyu.
An soke wasannin wasanni da dama, ciki har da gasar zakarun Turai ta 2019/20 da gasar Premier ta 2019/20 da UEFA Euro 2020, da kuma kakar NBA ta 2019/20 da kuma kakar NHL ta 2019-20.
"Cutar ta kawo cikas ga shirin gasar Olympics ta bazara ta 2020, wanda aka shirya a karshen watan Yuli, amma kwamitin wasannin Olympics na duniya ya sanar a ranar 24 ga watan Maris cewa za a sake shirya gasar "bayan shekarar 2020, amma ba sai lokacin bazara na 2021 ba". An rufe gidajen caca da wuraren wasanni a duniya, kuma an jinkirta ko soke wasannin karta kai tsaye. "
"A cikin shekara ta 2007, an yi wa 'yan wasan caca da yawa a duniya, kuma an yi wa masu yin caca a kan layi, da yawa daga cikinsu sun yi rajista a kan layi.
Yawancin manyan gidajen wasan kwaikwayo, kamar su Broadway, sun dakatar da duk abubuwan da suka faru.
"Wasu masu zane-zane sun bincika yanayi don shirya da raba ayyukan su ta hanyar yanar gizo a matsayin madadin damar watsa shirye-shiryen gargajiya, kamar kide-kide na raye-raye ko kuma "bikin" na yanar gizo, don masu zane-zane su yi, su rarraba da buga aikinsu".
An yada nishaɗin Intanet da yawa na coronavirus a kan layi, yawancin su ba zato ba tsammani sun zama abin dariya da nishaɗi.
Tun bayan barkewar cutar COVID-19, an lura da yawan keɓewa, ƙiyayya da wariyar launin fata tsakanin Sinawa da Asiya, mutanen asalin Gabashin Asiya da waɗanda suka fito daga Turai, Amurka da sauran ƙasashe waɗanda ke da manyan abubuwan da ke faruwa.
An samu rikice-rikicen tsoro, shakku, da kuma adawa a kasashe da dama, da kuma a Turai, Gabashin Asiya, Arewacin Amurka da yankin Asiya ta Pacific.
Rahotanni na watan Fabrairu (wanda yawancin masu cutar da aka samu a yanzu suna cikin China) sun nuna cewa kungiyoyi daban-daban a duniya sun yi imanin cewa mutanen China sun kamu da cutar ko kuma cewa wannan ya zama fansa.
An ga tashin hankalin adawa da China a wasu biranen Afirka.
Ya ce Wuhan da Hubei suna fuskantar wariya saboda sun kasance wuraren da cutar ta samo asali.
Ka yi amfani da wannan hanyar don taimaka wa mutanen da suke yaren Caina da ke yankunan da ake ciwon.
A cikin sabon wuri mai zafi, kamar Italiya, wanda ya ga farkon yaduwar cutar COVID-19 a Turai, ana iya samun shakku da ƙiyayya bayan wannan lamarin. Kasashen Malaysia, New Zealand, Singapore da Koriya ta Kudu suna tattara sa hannu don hana mutane shiga ƙasarsu daga China don rage yaduwar cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a shafin Twitter.
An samu karuwar yawan cin zarafin da ake yi wa mutanen kasar Sin da kuma wasu mutanen Asiya a Burtaniya da Amurka.
Shugaban Amurka Donald Trump ya fuskanci zargi da yawa saboda kiran cutar coronavirus da cutar Sin, yana mai nuna wariyar launin fata da adawa da China.
Masu zanga-zanga a Ukraine sun kai hari kan wani bas da ke jigilar 'yan Ukraine da wasu' yan kasashen waje daga Wuhan zuwa Novi Sanzari.
Dalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, da kuma ɗalibai da ke karatu a manyan biranen Indiya, an ba da rahoton cewa sun fuskanci zalunci dangane da annobar cutar coronavirus.
"A bangaren yammacin Bengal, Dilip Ghosh, shugaban jam'iyyar Bharatiya Janata na jihar, ya ce, "China ta lalata yanayi kuma ""saboda haka Allah yana rama musu"."
"A baya, ofishin jakadancin kasar Sin da ke Kolkata ya yi tir da maganganun, inda ya ce, ""ba daidai ba ne. A kasar Sin, tsanar baƙi da nuna wariyar launin fata sun yadu a kan mazauna kasashen waje saboda annobar, kuma an bayyana 'yan kasashen waje a matsayin ""ƙazamar ƙasa"" da kuma ""abin da za a kawar da shi"".
Jaridu da dama da ke da sassan biyan kuɗi kawai sun cire waɗannan sassan saboda wasu ko duk ɗaukar hoto na cutar coronavirus.
Masu wallafa kimiyya da yawa sun ba da takardun kimiyya game da barkewar cutar.
Wasu masana kimiyya sun raba sakamakon binciken su a kan sabobin kamar bioRxiv don saurin Preprint.
Cutar da ke shigowa  Cutar da ke shigowa da cuta sau da yawa sabon abu ne, a cikin annobar ko kuma a cikin yaduwa
Duniya da cuta Gajerar bayani game da duniya da kuma yadda ake yaduwar cuta.
Jerin annoba da annoba na duniya  yawan mutuwar da ke tattare da cutar shita
Cutar da ke tattare da sayar da dabbobin daji da kuma cututtuka da ke yaɗuwa daga dabbobi zuwa mutane ko kuma sayar da dabbobin daji da ba a saba gani ba
Gwajin gwaji na amfani da hanyoyin da za su iya gano cutar coronavirus na numfashi 2019 (COVID-19) da kuma cutar SARS-CoV-2 mai alaƙa da kuma ƙwayoyin cuta masu amsa wannan kamuwa da cuta.
Za a iya gano kwayar cutar a cikin samfuran ta hanyar RT-PCR, wanda ke iya gano RNA na kwayar cutar corona.
Wannan gwajin yana da iyaka kuma yana da amfani wajen gano SARS-CoV-2.
Wannan zai taimaka wajen gano cutar da ta riga ta faru ko kuma wadda ta riga ta fara.
Ana iya yin amfani da maganin rigakafi (serology) don yin gwaji da kuma lura da jama'a.
Gwajin rigakafin yana nuna yawan mutanen da ke da cutar, har da adadin mutanen da ke da alamun cutar amma ba su da alamun cutar ko kuma ba su da alamun cutar.
Za a iya sanin ainihin adadin mutuwar cutar da kuma ƙarfin rigakafin jama'a ta hanyar wannan gwajin.
Saboda iyakantaccen aikin bincike, babu wani tabbataccen bayani game da yadda yaduwar cutar ta kasance a cikin yawan jama'a a kowace ƙasa a watan Maris na 2020.
Har zuwa ranar 23 ga Maris, babu wata ƙasa da ta gwada sama da kashi 3 cikin ɗari na yawan jama'arta, kuma akwai bambancin da ke tsakanin ƙasashe a cikin gwajin.
Wannan bambancin yana da babban tasiri a kan yawan mutuwar, saboda ƙididdigar da aka yi a wasu ƙasashe sun fi daidai.
Yin amfani da gwajin lokaci na lokaci na juyawa na juyawa (rRT-PCR) zai ba da damar bincika samfurin da aka samo ta hanyar amfani da ruwa mai narkewa ko ta hanyar amfani da sutura.
Ana samun sakamako daga 'yan sa'o'i zuwa kwanaki 2.
Gwajin RT-PCR wanda aka yi ta hanyar daukar samfurin ruwa a cikin makogwaro zai zama tabbatacce ne kawai a makon farko na kamuwa da cutar.
Bayan haka, kwayar cutar za ta iya ɓace daga makogwaro kuma ta ninka a cikin hanci.
Ga mutanen da suka kamu da cutar a mako na biyu, za a iya amfani da wani na'urar daukar samfur daga Deep Airwaves ta hanyar yin amfani da catheter ko kuma hanyar yin numfashi.
An fara yin gwajin PCR a watan Janairun 2020 a Berlin, kuma mai yinsa Charité ne. A lokacin, an yi gwajin polymer chain reaction (rRT-PCR) na baya, wanda aka rarraba ta Hukumar Lafiya ta Duniya (WHO) don yin gwajin 250,000.
Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da na'urar bincike ta SARS-CoV-2 mai tushen PCR mai matakin asibiti (PowerChek Coronavirus) a ranar 28 ga Janairu, 2020.
"Yana neman kwayar ""E"" da ake samu a cikin dukkan kwayar cutar korona, kuma yana neman kwayar cutar RdRp, wacce take da cutar SARS-CoV-2. A China, ƙungiyar BGI tana ɗaya daga cikin ƙungiyoyi na farko da suka sami fa'idar gaggawa daga Hukumar Kula da Samfuran Lafiya ta China, kuma kayan aikin ganowa ne na PCR-based SARS-CoV-2. Cibiyar Kula da Cututtuka da Rigakafi (CDC) a Amurka tana rarraba sabon kwayar cutar coronavirus (2019-nCoV) ta 2019 a lokaci guda a cikin allon bincike na RT-PCR don gwajin dakunan gwaje-gwaje na kiwon lafiya ta hanyar tushen wakilin duniya".
Daga cikin gwaje-gwaje guda uku na kwayoyin halitta, sakamakon da ba daidai ba ya haifar da ganowa a cikin tsofaffin kayan aikin bincike, kuma ya haifar da rikici a gwajin a CDC a Atlanta, wanda aka gudanar da shi cikin nasara tare da matsakaicin samfuran 100 a rana a cikin watan Fabrairu 2020.
Har zuwa ranar 28 ga Fabrairu, 2020, ba a tantance cewa ana iya amincewa da gwajin da ake amfani da shi a cikin raka'a biyu ba, kuma har zuwa yanzu ba a ba da izinin yin gwajin a dakunan gwaje-gwaje na ƙasa da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin ne bisa ga izinin amfani da gaggawa. Laboratoriyoyin kasuwanci a Amurka sun fara gwajin a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa akwai gwajin COVID-19 na ƙasa wanda ya dogara da RT-PCR.
Quest Diagnostics ta shirya gwajin COVID-19 na ƙasa a ranar 9 ga Maris, 2020.
Babu iyakancewar adadin, kuma ana buƙatar tattara samfurin da kuma yin amfani da shi bisa ga ƙa'idodin CDC.
A Rasha, an tsara gwajin COVID-19 kuma an samar da shi ta Cibiyar Bincike ta Kiwon Lafiyar Kwayoyin cuta da Fasaha ta Halitta ta VECTOR.
A ranar 12 ga Maris, 2020, Clinic na Mayo ta bayar da rahoton cewa ta samar da gwajin da zai iya gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami izini daga FDA don yin gwajin da zai iya ba da sakamako a cikin mafi yawan sa'o'i 3.5, wanda ke ba da damar yin gwaji 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories, wanda ke gwada tsarin Abbott m2000, kuma FDA ta ba da izini iri ɗaya ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta sami EUA iri ɗaya daga FDA, wanda ke ɗaukar mintuna 45.
FDA ta ba da shawarar yin amfani da fasahar isotermal nucleic acid amplification a kan lasisi a matsayin madadin PCR.
Wannan ba ya buƙatar sake zagayowar zafin jiki, saboda yana samar da sakamako mai kyau a cikin ɗan gajeren lokaci na minti biyar, kuma har zuwa minti 13 yana samar da sakamako mara kyau.
A halin yanzu akwai na'urori 18,000 a Amurka, kuma Abbott yana hanzarta samarwa don yin gwaje-gwaje 50,000 a kowace rana. Ana sa ran gwajin da ke amfani da maganin rigakafin monoclonal zai haɗu kai tsaye da furotin nucleocapsid (N-protein) na sabon kwayar cutar corona, kuma kamar yadda ake sa ran gwajin mura zai nuna sakamakon cikin mintuna 15 zuwa 20.
A watan Maris na shekarar 2020, bita na wallafe-wallafen ya kammala da cewa farashin daukar hoto na kirji a matakin farko ba shi da yawa, amma sakamakon CT \[computed tomography] na iya kasancewa tun kafin a nuna alamar a wurin.
Abubuwan da aka saba gani a kan CT sun haɗa da nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan.
Rashin bambancin yanayi, rashin daidaito, da kuma hada baki suna ƙaruwa yayin da cutar ke canzawa.
Wani bincike da ya kwatanta PCR da CT a cikin ruwan da aka fara, ya nuna cewa CT ya fi karɓar PCR, amma tare da ƙarancin iyakancewa, yawancin abubuwan da ke cikin hoton suna kama da ciwon huhu da kuma yanayin cututtuka.
A watan Maris na 2020, Kwalejin Kula da Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT don gwajin COVID-19. A watan Maris na 2020, CDC ta ba da shawarar yin amfani da PCR don gwajin farko.
Amsar rigakafi shine samfurin rigakafi wanda ya ƙunshi IgM da IgG.
Ana iya yin gwajin a cibiyar bincike ta tsakiya (CLT) ko kuma a wurin kulawa (PoCT).
Tsarin sarrafa kansa mai suna High-Suprut zai iya yin waɗannan gwaje-gwajen a yawancin dakunan gwaje-gwaje na asibiti, kuma yawan abubuwan da ke ciki ya dogara da yawan kayan da ake samarwa a kowane tsarin.
Ana amfani da samfurin jini guda don CLT, amma ana iya amfani da samfurin jini don ganin yadda rigakafi ke amsawa.
Ana samun jinin da aka yi amfani da shi a PoCT ta hanyar allura.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakan motsa jiki kafin a fitar da su. A ranar 26 ga Maris, 2020, an bayyana cibiyoyi 29 da suka sanar da hukumar cewa suna da bukatar, kuma yanzu suna iya rarraba gwajin anti-human.
A ranar 7 ga Afrilu, 2020, FDA ta ba da izini ne kawai don gwajin gaggawa. A ƙarshen Maris 2020, FDA ta sami izinin Turai don gano ƙwayoyin cuta a cikin samfuran jini.
Wannan gwajin zai iya yin gwajin daruruwan samfurori a cikin awa daya, wanda ya fi saurin gano kwayar cutar RNA ta PCR.
Antibodies yawanci suna bayyana a cikin kwanaki 14 na kamuwa da cutar. A farkon watan Afrilu, babu wani kayan aikin gwajin antibody da aka saya a Burtaniya da ya taimaka.
A Hong Kong, an kafa tsarin da zai ba marasa lafiya da ake zargi damar zama a gida, inda sashen gaggawa ke ba marasa lafiya bututun samfurin, wanda za su yi musu allurar rigakafi, su kuma dawo da shi, kuma su sami sakamakon binciken daga baya. NHS na Ingila tana gudanar da tsarin da zai ba da damar gano abubuwan da ake zargi a gida, don hana masu zargi kamuwa da cutar idan sun je asibiti, da kuma tsabtace kamuwa da cuta idan an yi amfani da motar asibiti.
A Jamus, likitoci na Ƙungiyar Kula da Lafiya ta Ƙasa sun ce a ranar 2 ga Maris, an yi gwaji 10,700 a makon da ya gabata, wanda ke da damar yin gwaje-gwaje 12,000 a kowace rana a cikin motar asibiti.
Inshorar lafiya tana biyan kuɗin da ake kashewa a lokacin da ake bukatar likita ya duba lafiyar.
A cewar shugaban Cibiyar Robert Koch, Jamus na da damar yin gwajin 160,000 a mako.
A ranar 19 ga Maris, an kafa dokar gwadawa a manyan birane da yawa.
Ba a san adadin gwajin da aka yi a Jamus ba a ranar 26 ga Maris, 2020, saboda ana bayar da rahoton sakamako mai kyau ne kawai.
"Binciken farko na dakin gwaje-gwaje ya nuna cewa an gwada aƙalla samfuran 483,295 daga makon kalanda na 12/2020 zuwa 12/2020 kuma an sami tabbataccen SARS-CoV-2 a cikin samfuran 33,491 (6.9%). Masu bincike a Isra'ila a asibitocin Technion da Rambam sun gwada hanyar da za su gwada samfuran marasa lafiya 64 a lokaci guda, kawai idan samfurin da aka haɗa ya sami sakamako mai kyau. Hyu-ya " (çœœœœœœœœœ, ko "idanun wuta") wanda zai iya gudanar da samfuran 10,000 a rana an buɗe shi a ranar 5 ga Fabrairu 2020 a GBI".
Tare da aikin da ya kasance a karkashin kulawar Wang Jian, wanda ya kafa BGI, kuma ya ɗauki kwanaki 5, aikin samfurin zai iya ƙaruwa da kashi 47% a Hubei, kuma farashin keɓewa zai ninka idan ba a fara yanayin bincike ba.
Bayan dakin gwaje-gwaje na Wuhan, an buɗe a birane 12 a duk faɗin China, ciki har da Shenzhen, Tianjin, Beijing da Shanghai.
A ranar 4 ga Maris, 2020, ana yin gwaje-gwaje 50,000 a kowace rana. An saki Open Source Multiplex Designs ta Origami Assays, wanda ke ba da damar yin amfani da gwaje-gwaje 93 kawai don bincika samfuran marasa lafiya na COVID1122. Waɗannan ƙirar daidaitaccen tsari za a iya yi a ƙananan dakunan gwaje-gwaje kuma ba sa buƙatar kwantena na robotic.
A watan Maris, karancin kayan gwaji da rashin su sun zama babban abin damuwa ga tsarin gwajin taro a Tarayyar Turai, Burtaniya da Amurka.
Wannan ya sa wasu marubuta suka bincika wasu hanyoyin bincike, kamar dumama samfurori zuwa 98 °C (208 °F) na tsawon minti 5 don sakin kwayoyin RNA da kuma ƙarin bincike. A ranar 31 ga Maris, an sanar da cewa Hadaddiyar Daular Larabawa tana yin gwaji a kan kowacce mutum fiye da kowace ƙasa, kuma tana kan hanyar kai shi ga jama'a.
"Wannan shi ne gwajin da aka yi a kan motoci, wanda ya hada da dukan jama'a, da kuma BGI (wanda aka kafa a cikin dakin gwaje-gwaje na gaggawa na "Huo-Yan" a kasar Sin).
Labarin da aka gina cikin kwanaki 14 zai iya yin dubban gwaje-gwajen RT-PCR a rana, kuma shine na farko a duniya wanda zai iya yin irin wannan aikin a wajen kasar Sin.
An yi amfani da jerin gwaje-gwaje daban-daban don niyya ga nau'ikan kwayar cutar corona da aka samar a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta dauki tsarin girke-girke na kayan aikin Jamus don ƙasashe masu ƙarancin kuɗi waɗanda ba za su iya yin nasu ba.
An shirya tsarin girke-girke na Jamus a ranar 17 ga Janairu, 2020, yayin da yarjejeniyar da Cibiyoyin Kula da Cututtuka na Amurka suka tsara ba ta kasance a shirye ba har zuwa 28 ga Janairu, wanda ya haifar da jinkiri a gwajin a cikin Tarayyar Sin, kuma Amurka ta fuskanci matsaloli game da amincin kayan aikin bincike a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aikin bincike don biyan buƙatu ba kuma ba su iya ba da shawarwari daga ƙwararrun likitocin.
Akasin haka, masana sun ce, samun damar yin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta yi shekaru tana gina damar bincike, galibi a dakunan gwaje-gwaje na masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta bukaci a gaggauta gwajin don rage yaduwar cutar COVID-19. Karuwar bukatar kayan bincike saboda yaduwar cutar ta haifar da karancin daruruwan dubban kayan bincike na kwayar cuta da kuma bukatar sinadarai.
A watan Maris na shekarar 2020, kasar Sin ta bayyana cewa tana da matsaloli game da ingancin kayan aikin bincikenta.
A Amurka, binciken CDC ya kasance mai rikitarwa, kuma gwamnati ta kawar da takunkumin da ke hana gwajin mutum. Spain ta sayi masu binciken daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na kasar Sin, amma sakamakon ba daidai ba ne.
Kamar yadda hukumar ta bayyana, sakamakon da ba daidai ba na iya kasancewa saboda rashin tattara samfurori ko rashin amfani da kayan aikin.
A cewar ma'aikatar Spain, za a mayar da kayan aikin da suka samar da sakamako mara kyau kuma a maye gurbin su da na'urar bincike daban da Shenzhen Bioeasy. Jamhuriyar Czech ta samar da kashi 80% na kayan aikin da ta saya daga China. Slovakia ta sayi na'urorin gwaji miliyan 1.2 daga China, waɗanda suka samar da bayanan da ba daidai ba.
A cewar Ateş Kara, wani ma'aikacin ma'aikatar lafiya ta Turkiyya, Turkiyya ta sayi kayan aikin bincike daga China "saboda suna da babban kuskuren".Duk da cewa Burtaniya ta sayi kayan aikin bincike miliyan 3.5 daga China, a farkon watan Afrilu 2020 ta sanar da cewa ba za a iya amfani da su ba.
Bincike, gano mutanen da suka kamu da cutar, da kuma bin diddigin mutanen da ke dauke da cutar SARS-CoV-2 sun haifar da sakamako mai kyau.
Masu bincike a birnin VÃ2 na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a cikin mutane 3,400 a tsakanin kwanaki goma.
Rabin mutanen da suka kamu da cutar ba su da wata alama kuma duk abubuwan da aka sani suna cikin keɓewa.
An dakatar da sabbin cututtuka saboda takunkumin tafiye -tafiye zuwa al'umma.
Ta hanyar neman babban layin tuntuɓar, ƙuntatawa na tafiya da keɓewa, annobar cutar coronavirus ta 2020 ta bazu a cikin Singapore a hankali fiye da sauran ƙasashe masu tasowa, amma ba a ɗauki matakan da suka dace ba kamar rufe gidajen cin abinci da shagunan sayar da kayayyaki.
An soke al'amuran da yawa, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida har zuwa 28 ga Maris, amma makarantu sun sake buɗewa a ranar 23 ga Maris bayan hutun.
Yawancin sauran ƙasashe sun sami damar sarrafa cutar ta hanyar sa ido sosai, ƙuntata tafiye -tafiye, gwaji, keɓewa, amma kaɗan ta hanyar ƙuntata motsi na ƙasa, kamar yadda aka yi a Iceland da Koriya ta Kudu.
"A cewar kididdiga, kasashe da suka yi gwaji fiye da yadda suka yi a kan yawan mutuwar, wataƙila ba su da wata matsala, watakila saboda waɗannan ƙasashe suna iya gano waɗanda ba su da alamun cutar ko kuma ba su da alamun cutar".
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da damar gwaji da kuma dakunan gwaje-gwaje na ƙasa waɗanda ke da ƙarancin ƙwarewar gwajin COVID-19 su aika da samfuran COVID-19 guda biyar na farko da samfuran COVID-19 guda goma zuwa ɗayan cibiyoyin gwajin 16 na WHO don yin gwajin tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16 da aka ba da shawarar, 7 suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Kudancin Amurka, da 1 a Ostiraliya.
A cikin jadawalin da ke gaba, kashi na mutanen da aka bincika, ginshiƙin tabbatacce yana ƙarƙashin tasirin manufofin gwaji na ƙasar.
Kasashen da ke gwada marasa lafiya a asibiti suna da kashi mafi girma na masu cutar a cikin yawan jama'arsu, wanda ke nufin cewa duk abin da ya faru, ko da kuwa suna da alamun cutar ko a'a, ba zai canza ba.
Wanke hannu, wanda ake kira tsabtace hannu, yana nufin tsabtace hannu don kawar da ƙura, mai, ƙwayoyin cuta, ko wasu abubuwa da ba su da amfani.
Wanke hannu a wasu lokatai na rana tare da sabulu yana hana yaduwar cututtuka da yawa, kamar su ciwon zazzaɓi da kwalara, waɗanda ke kaiwa bakin mutum idan ba a wanke hannayensu ba.
Misali: Idan mutum bai wanke hannayensa ba kafin ya taɓa idanunsa, hanci ko bakinsa (watau, ƙwayoyin mucous) zai iya kamuwa da cututtukan numfashi kamar mura ko mura.
Muhimman lokatai biyar da ya kamata a wanke hannu da sabulu a ƙarshen rana sun haɗa da: kafin da bayan wanka, bayan wanke jariri ko canza diaper, kafin ciyar da jariri da kuma cin abinci, da kuma kafin da bayan dafa abinci ko taɓa naman kaza, kifi, ko kaza.
Idan babu ruwa da sabulu, ana iya wanke hannaye da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu.
Kafin mu ci abinci, sa'ad da muke ci abinci da kuma bayan mun ci.
Kafin ka kula da marar lafiya da kuma bayan ka yi hakan.
Bayan ka canja mayafi ko kuma ka wanke yaron da ya fita bayan gida.
Bayan ka yi ta shanye hanci, ka yi sumba, ko ka yi ta tsotsa.
Bayan ka yi wa dabba amai ko ka ci abinci ko kuma ka taɓa ƙashin dabba.
Tsabtace hannu na asibiti yana nufin ayyukan tsabtace jiki da ke da alaƙa da hanyoyin kiwon lafiya.
Wanke hannu kafin shan magani ko kula da lafiya zai iya hana ko rage yaduwar cututtuka.
Manufar wanke hannu a asibiti ita ce kawar da ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko ƙwayoyin cuta) da kuma wasu abubuwa masu guba da za su iya jawo lahani ko cuta.
Wannan yana da muhimmanci musamman ga masu dafa abinci ko masu aikin kiwon lafiya, amma yana da amfani ga jama'a.
Wanke hannu yana da fa'idodi da yawa ga lafiyar mutum, ciki har da rage yaduwar mura, kwayar cutar corona da sauran cututtukan da ke yaduwa, hana cututtukan da ke haifar da tari, da kuma rage kamuwa da cututtukan numfashi.
Kuma tana da shirin rage yawan mutuwar jarirai a cikin haihuwa.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa wanke hannu zai iya taimaka wa yara 'yan shekara biyar su yi girma.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke da nasaba da cututtukan numfashi da na zazzaɓi ta hanyar gabatar da canje-canje a halayyarsu, kamar su wanke hannu da sabulu.
Wannan mataki mai sauƙi zai rage yawan mutuwar da ke faruwa saboda waɗannan cututtuka da kusan kashi 50%.
"Samun hanzari da ke inganta wanke hannu zai iya rage yawan masu kamuwa da cutar da kashi daya bisa uku, idan aka kwatanta da samar da ruwa mai tsafta a yankunan da ke da karancin kudi".
Rage yawan shan hanci da shan ruwa da kashi 48 cikin 100 na iya danganta da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da sauƙi na hana kamuwa da cututtukan numfashi na hanci da ciwo (ARI) a gida, a makarantu, da kuma a cikin al'ummomi a duniya.
Cutar huhu ita ce babbar hanyar cutar ARI kuma ita ce sanadin mutuwar yara miliyan 1.8 a shekara a karkashin shekara biyar.
Yara kusan miliyan 3.5 ne ke mutuwa kowace shekara saboda cutar zazzaɓi da ciwon huhu.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma bayan amfani da bayan gida na iya ceton rayuka fiye da duk wani allurar rigakafi ko kuma magani, rage mutuwar da ke haifar da tari da rabi, da kuma rage mutuwar cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana wanke hannu tare da wasu matakan tsafta kamar su ruwa, tsabtace muhalli, da kuma tsarin tsabtace jiki (WASH).
Wanke hannu yana kuma kāre mutum daga cututtukan fata da ake samu ta wurin jima'i.
Rashin lalacewa a wanke hannu, wanke hannu sau da yawa zai iya haifar da lalacewa ta fata saboda bushewar fata.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu yana iya sa mutum ya kamu da cutar fata da ake kira hand-numbing, wadda ta fi yawa a tsakanin ma'aikatan kiwon lafiya.
Wanke hannu sau da yawa kuma yana cikin alamun cutar OCD.
Akwai muhimman lokuta guda biyar da ya kamata a wanke da sabulu a rana don rage yaduwar cutar: bayan amfani da wanka (urin, wanka), bayan wanke jariri (canja tsabta), kafin ciyar da jariri, kafin ciyar da abinci, da kuma kafin ko bayan dafa abinci ko kuma taɓa naman da ba a shayar ba, kifi, ko kaza.
Yin amfani da hanyoyin wanke hannu da suka dace don hana yaduwar cuta, ciki har da kafin da kuma bayan kula da wani ciwo ko rauni; bayan yin tari, yin hanci ko hanci; bayan taɓawa da ƙurar dabbobi ko dabbobi da kuma bayan taɓawa da ƙura.
A ƙasashe da yawa, ana amfani da sabulu a wanke hannaye.
Wani bincike da aka yi a shekara ta 2015 a ƙasashe 54 ya nuna cewa, a matsakaita, kashi 38.7 na iyalai suna wanke hannayensu a gida. Wani bincike da aka yi a shekara ta 2014 ya nuna cewa, Saudi Arabiya ce ke da kashi 97 bisa ɗari na masu wanke hannayensu.
A cikin Philippines, an gabatar da shirin "Safarin Kula da Lafiya" na Ma'aikatar Ilimi a matsayin abin koyi na inganta lafiyar yara da ilimi.
Babban manufar wannan shirin na kasa shine sanar da mutane sau biyu a shekara game da motsin wanke hannu da sabulu, goge haƙoranku da fluoride, kashe ƙwayoyin cuta.
An yi amfani da shi sosai a Indonesia.
Ana iya kawar da ƙwayoyin cuta daga fata ta ƙara ruwa a sabulu ko sabulu mai ruwa.
Babban aikin sabulu da wanke ruwa shine rage shingen maganin da kuma kara narkewa.
Ruwa kaɗai ba zai iya tsabtace fata ba domin mai da furotin da suke cikin ƙasa ba za su iya kawar da su da ruwa ba.
Amma tsaftacewa yana taimakawa ta hanyar isar da ruwa mai dacewa ..
Za a iya sake yin amfani da sabulu da ya bushe, kuma zai iya ɗauke da ƙwayoyin cuta da suka ɓace.
Wasu 'yan nazarin da suka yi game da yaduwar ƙwayoyin cuta a cikin sabulu mai ƙamshi sun kammala cewa ba su da matsala sosai saboda suna kawar da ƙwayoyin cuta daga kumfa.
CDC ta ce har yanzu ana amfani da sabulu mai ruwa don rarraba kayan aikin hana taɓawa.
Ana amfani da sabulun rigakafin ƙwayoyin cuta a cikin al'umma da ke da kyakkyawar dabi'ar kiwon lafiya.
Har zuwa yau, akwai tabbaci cewa amfani da maganin rigakafi ko kuma maganin rigakafi zai fi dacewa da kwayoyin da ke da kariya ga maganin rigakafi.
Duk da haka, sabulun antibacterial suna dauke da kayan aiki na antibacterial kamar tricone, wanda ke dauke da jerin kwayoyin halitta masu yawa.
Saboda haka, ko da yake ba za a iya amfani da maganin rigakafi kamar yadda ake tsammani ba, idan ba a zaɓi sabulun rigakafin ƙwayoyin cuta ba.
Ƙari ga maganin hana ƙwayoyin cuta, ana iya samun wasu abubuwa da ke hana ƙwayoyin cuta su yi aiki, kamar su mai kula da pH, maganin rigakafi, sinadarin benzoic acid, da kuma wasu abubuwa da ake amfani da su wajen sanyaya fata (aloevera, bitamin, almond, kayan lambu).
Ruwan zafi da ke da kyau don wanke hannu yana da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma da sauri a lokacin da jiki ya yi zafi sosai (37°C).
Amma, ruwan zafi da sabulu sun fi ruwan sanyi da sabulu kyau wajen kawar da ƙura da kuma ƙwayoyin cuta.
Amma, ba kamar yadda mutane da yawa suke tunani ba, bincike na kimiyya ya nuna cewa ruwan zafi ba ya rage matsin lamba na kwayoyin halittar da ke hannayenmu.
Wani zaɓi kuma shi ne tsabtace hannu ba tare da ruwa ba.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, zaɓuɓɓukan tsabtace hannu marasa giya da ruwa (wanda aka fi sani da wanke hannu mara giya, wanke hannu mai hana kumburi, ko kuma masu tsabtace hannu) sun fara samun shahara.
Yawancin su an kafa su ne don amfani da mai mai daɗi kamar carbomer (polymer na ocularic acid) a cikin gel, ko a matsayin ruwan glycerin, ko a cikin ƙura, da kuma rage tasirin amfani da busassun giya.
Ƙara hydrogen peroxide mai haɗuwa yana ƙara aikin rigakafi fiye da na kwayoyin cuta. Sanitise na hannu da ke da aƙalla kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta.
Maganin tsabtace giya yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu ƙin magani (MRSA da VRE), ciwon fuka, da wasu ƙwayoyin cuta (HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura, da hepatitis) da fungi.
Bayan dakika 30 na wanke hannu, ruwan wanke hannu mai barasa mai kashi 70 cikin 100 yana kawar da kwayoyin cuta daga hannu (rage ƙwayoyin cuta 3.5, daidai da decibel 35) da kashi 99.97% (rage ƙwayoyin cuta daga kashi 99.99% zuwa 99.999% (rage ƙwayoyin cuta 4 zuwa 5) 7 a cikin minti ɗaya.
Maganin wanke hannu da ke dauke da barasa ba shi da inganci sosai wajen kawar da ƙwayoyin cuta na cutar da ke saurin yaduwa (ko Norweck) wanda ke haifar da ciwon hanji. Ana iya amfani da maganin kashe ƙwayoyin cuta ko wanke hannu da giya don bushewa ko rufe hannaye duka.
Ruwan, kumfa ko gel na gaba da na baya da ƙarshen dukkan yatsun hannu suna shafawa na kimanin dakika 30 har sai sun bushe.
Dole ne a wanke yatsun hannu da kuma hannayen hannu sosai. Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar yin amfani da kayan tsabtace hannu musamman idan an san cewa hannu yana da ƙazanta.
An ƙara amfani da waɗannan kayan saboda sauƙin amfani da su da kuma saurin kashe ƙwayoyin cuta, amma bai kamata su zama madadin wanke hannu ba, sai dai idan sabulu da ruwa ba su da yawa.
Yin amfani da kayan wanke hannu na giya a kai a kai zai iya haifar da bushewar fata idan ba a haɗa man shafawa da / ko kayan shafa fata a cikin kayan aikin ba.
Za a iya rage ko kuma a kawar da sakamakon bushewar giya ta wajen ƙara glycerin da/ko wasu kayan shafawa.
A gwajin asibiti, kayan tsabtace hannu masu dauke da barasa sun haifar da rage zafin fata da bushewa fiye da sabulu ko sabulun antibacterial.
Ba a yawan samun cutar da ke sa mutum rashin lafiya ta wurin shan giya, ko kuma ta wurin shan giya da ke sa mutum rashin lafiya.
"Yana da matukar muhimmanci a wanke hannayenmu da sabulu da ruwa domin a iya kamuwa da cututtukan fata".
Ko da yake suna da tasiri, masu amfani da ruwa ba sa tsabtace kayan aiki, amma suna kashe su da sauƙi.
Wannan shine dalilin da ya sa sabulu da ruwa ba su dace da tsabtace hannu ba don hana yaduwar ƙwayoyin cuta da yawa, saboda ƙwayoyin cuta na iya kasancewa a hannu.
Ingancin tsabtace hannu mai tsabtace hannu ya dogara ne da kayan aiki da kayan shafawa, kuma yana da inganci - mai rage barasa da kuma ƙafafun giya.
A kwanan nan, an nuna cewa maganin da ake amfani da shi ya rage ingancinsa bayan an yi amfani da shi sau da yawa, ba kamar giya ba.
Mutane da yawa a cikin ƙananan al'ummomin da ke da ƙarancin kuɗi ba za su iya sayan sabulu ba kuma su yi amfani da tukunya ko ƙasa a maimakon haka.
Ash ko ƙasa na iya zama mafi inganci fiye da ruwa kawai, amma ba shi da inganci fiye da sabulu.
Wani abin damuwa shi ne, maimakon rage cututtuka da ke tattare da ƙwayoyin cuta, ƙasa ko kuma ƙasa na iya ƙara yaduwar cututtuka.
Kamar sabulu, toka yana kashe kwari domin yana samar da maganin alkaline a cikin ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin sabulu.
Cibiyoyin Kula da Cututtuka na Amurka sun ba da shawarar yin wanka da hannu yadda ya kamata don hana yaduwar cututtuka, ya haɗa da waɗannan matakan:
Ka wanke hannunka da ruwan zafi ko sanyi.
Ana ba da shawarar ruwa mai ruwa saboda ana iya gurɓata wuraren wanka, kuma a halin yanzu yanayin zafin ruwan bai yi tasiri ba.
Ka yi amfani da sabulu sosai a hannunka, har da bayan hannunka, tsakanin yatsanka, da kuma ƙarƙashin yatsunka.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan suna wanke hannu da sabulu maimakon ruwa kawai.
Ka yi bincike na akalla sakan 20.
Yin shafa yana sa a sami hanyar kawar da ƙwayoyin cuta daga fata, kuma yin shafa na dogon lokaci yana kawar da ƙwayoyin cuta da yawa.
Ka wanke su da ruwa mai tsabta.
Wanke hannu a cikin wanka zai iya sake gurɓata hannaye.
Ka yi amfani da tawul mai tsabta ko ka bar shi ya bushe.
Hannun da suka yi rigar da kuma wanda aka yi musu rauni suna iya sake kamuwa da cutar. Wuraren da aka fi manta da su su ne babban yatsan hannu, wuyan hannu, tsakanin yatsun hannu, da kuma ƙarƙashin yatsun hannu.
Na'urar ƙusa da kuma ƙusa mai ƙusa na iya haifar da ƙwayoyin cuta.
Ana ba da shawarar yin amfani da ruwan wanka don hana bushewar hannu, saboda bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
"Za a iya yin zaɓuɓɓuka masu tsada don sauƙaƙe wanke hannu a inda babu ruwan famfo da/ko sabulu, misali: ɗebo ruwa daga wani rami mai rataye ko rami mai dacewa da kuma/ko amfani da kayan aiki idan ya cancanta a ƙasashe masu tasowa. A yanayin da babu isasshen ruwa (a ƙasashe masu tasowa, kamar makarantu ko yankunan karkara), akwai zaɓuɓɓukan "Tip-Taps" da sauran zaɓuɓɓukan da ba su da tsada kamar su ceton ruwa. "
TPE-TAP fasaha ce mai sauki da ake yi da hannu ta amfani da ƙugiya da aka yi da igiya da kuma ruwa kaɗan da ganga na sabulu.
Ko da yake bushe hannu yana da muhimmanci a tsaftace hannu, akwai wasu muhawara game da yadda za a bushe hannu a cikin gidan wanka na jama'a.
Karin bincike ya nuna cewa tawul din takarda ya fi na lantarki tsabtace hannu a yawancin gidajen wanka.
A shekara ta 2008, an gudanar da bincike a Jami'ar Westminster da ke Landan, kuma an tallafa wa masana'antar takarda ta Turai ta Tassus Symposium na bushewar hannu don kwatanta ingancin tsabtace takarda, bushewar hannu mai iska mai zafi da kuma mafi kyawun iska mai iska.
Bayan wanke hannu da bushewa da na'urar bushewa, adadin kwayoyin cuta a yatsunsu ya karu da kashi 194 cikin dari da kuma 254 cikin dari a hannayensu.
Gogewar iska ta iska ta nuna karuwar kwayoyin cuta a matsakaita na 42% a kan kayan shafawa da 15% a kan kayan shafawa.
Bayan wanke hannu da bushewa da tawul ɗin takarda, adadin ƙwayoyin cuta ya ragu zuwa kashi 76% na matsakaicin adadin yatsun hannu da kashi 77% a kan dabino. Masana kimiyya sun gudanar da gwaje-gwaje don gano yiwuwar gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka saboda kowane irin bushewa.
Mai bushewa da iska, yana da karfin iska mai saurin 180 m / s (650 km / h / 400 mph) wanda zai iya kawar da kwayoyin cuta daga hannaye da na'urar kuma ya gurɓata sauran masu amfani da gidan wanka da kuma yankin gidan wanka har zuwa mita 2.
Yin amfani da na'urar bushewa mai zafi yana iya sa ƙwayoyin cuta su yi nisa har zuwa mita 0.25 daga na'urar bushewa.
A shekara ta 2005, an bincika hanyoyin bushe hannu dabam dabam a wani bincike da TÃœV Produkt und Umwelt ya yi.
An lura da canje-canje a ƙididdigar ƙwayoyin cuta bayan an bushe hannaye.
Akwai masana'antun bushe-bushe hannu da yawa, kuma ana iya kwatanta bushe-bushe hannu da bushe-bushe da takarda.
Wani zaɓi kuma shi ne wanke hannu da kayan wanki idan sabulu da ruwa ba su da isasshen.
Ya kamata a yi amfani da kayan wanke hannu da ke dauke da barasa aƙalla kashi 60 cikin dari.
An sanya wanke hannu ya zama tilas na likitoci tun bayan likitan Hungary Ignaz Semmelweis ya gano tasirin rigakafin cutar a cikin asibiti (1846).
Masu aikin asibiti suna amfani da na'urorin lantarki don tunatar da su cewa su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa, ana samun karancin kamuwa da cutar idan aka yi amfani da su.
Ana yin wanke hannu na likita na aƙalla dakika 15 ta amfani da sabulu da ruwa ko gel don shafawa da shafa kowane ɓangaren hannu.
Dole ne a shafa hannaye tare da yatsunsu.
Idan akwai datti a cikin kusoshi, ana iya amfani da goga don cirewa.
Saboda haka, yana da muhimmanci a goge hannu sosai kuma a bushe da tawul mai tsabta domin ƙwayoyin cuta suna iya zama a hannaye.
Bayan an bushe, ka rufe ruwa da tawul (kuma ka buɗe kofa idan ya cancanta).
Wannan zai hana hannayen sake kamuwa da wannan ɓarna.
"A wuraren kiwon lafiya, manufar wanke hannu ita ce kawar da ƙwayoyin cuta ("" ƙwayoyin cuta ") da ke da alaƙa da su kuma hana su yaɗuwa".
Jaridar New England Journal of Medicine ta ruwaito cewa wanke hannu ya zama abin da ba a yarda da shi ba a yawancin fannonin kiwon lafiya, kuma saboda haka, likitoci da ma'aikatan jinya da yawa sun manta da wanke hannayensu kafin su taɓa marasa lafiya, saboda haka suna yada ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu daidai da sauran hanyoyin da ba su da wahala sun rage yawan zubar da jini da ke da nasaba da cataract da kashi 66 cikin dari. Hukumar Lafiya ta Duniya ta wallafa wani labarin da ke nuna yadda ake wanke hannu a kai a kai da kuma tsabtace hannu a bangarorin kiwon lafiya.
Za a iya samun takardar shawarwarin da aka tsara na tsabtace hannu a dandalinmu.
Wani muhimmin bita da Whitby et al.
Idan ana buƙatar sanarwar bin ƙa'idodin sarrafawa, kayan aikin kasuwanci suna iya auna da tabbatar da tsabtace hannu.
"Kungiyar Lafiya ta Duniya ta ce wanke hannu yana da "shekaru biyar".
Bayan sun kamu da jini ko ruwan da ke fita daga jiki
kafin aikin da ba shi da gurɓataccen iska, da kuma
Bayan kulawar mai haƙuri. Ƙara sinadarai masu ƙin ƙwayoyin cuta zuwa sabulu (ko sabulu masu ƙwayoyin cuta ko masu ƙwayoyin cuta) yana nuna wakili na wanke hannu.
Ana iya buƙatar irin wannan cirewa kafin tiyata ko kuma a cikin yanayin ciki, inda ƙwayoyin cuta masu tsayayya da kwayoyin cuta suka fi yawa. Yin tiyata na iya buƙatar 'yanke hannuwanku, bututun wanka wanda zai iya buɗewa da rufewa ba tare da taɓa hannu ba, tawul mai bushe don bushe hannayenku bayan wanka, wanke tare da wasu chlorhexidine ko iodine, da kuma shafawa tare da goga mai bushe, da kuma tsabtace yatsan yatsan hannu da sauran kayan aikin da ba su da ƙwayoyin cuta.
Dole ne a cire dukan kayan ado.
Wannan aikin yana bukatar a wanke hannuwanka da kuma wuyanka na minti 2,6.
Ba a buƙatar tsawon lokacin gwaji (minti 10).
Idan aka yi amfani da igiya, ya kamata a hana ruwa daga sake zubowa a hannaye.
Bayan an gama wanka, sai a bushe hannayen da takarda mai tsabta kuma a saka masa rigar tiyata.
Wanke hannu ko amfani da kayan wanke hannu kafin da kuma bayan kula da wani marar lafiya zai rage yaduwar ƙwayoyin cuta.
A asibitoci, an gano cewa mafi girman fa'idar tsabtace hannu shine 20% na wankewar farko, kuma mafi ƙarancin fa'idar wanke hannu shine sama da 35% na yawan wanke hannu.
Yin wanka da sabulu na yau da kullun yana haifar da kamuwa da cuta fiye da sau uku idan aka kwatanta da wanke sabulu mai hana ƙwayoyin cuta. Yin amfani da kayan maye da ke dauke da barasa a hannu na matsakaici na sakan 30 idan aka kwatanta da wanke sabulu mai hana ƙwayoyin cuta, wanke hannu da barasa ya rage gurɓataccen ƙwayoyin cuta da kashi 26% fiye da sabulu mai hana ƙwayoyin cuta.
Amma sabulu da ruwa sun fi tsabtace hannu na barasa tasiri wajen rage kwayar cutar H1N1 da kuma Clostridium difficile a hannu. Matsaloli a cibiyoyin kiwon lafiya don inganta tsabtace hannu na iya haɗawa da koyar da ma'aikatan wanke hannu, ƙara wanke hannu na barasa, da rubutu da kuma bayanan sirri ga ma'aikata.
Ana buƙatar ƙarin bincike don gano waɗanne daga cikin waɗannan hanyoyin shiga tsakani ne suka fi tasiri a cikin saitunan kiwon lafiya daban-daban.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin hanya mai mahimmanci don rage kuɗi, inganta lafiyar jiki, da inganta abinci mai gina jiki.
Koyaya, rashin amintaccen samar da ruwa, sabulu ko kayan wanke hannu a gidaje, makarantu da wuraren aiki yana haifar da ƙalubale don cimma ƙa'idodin wanke hannu na duniya.
Alal misali, duk da cewa akwai hanyoyin da za a iya amfani da su wajen gina wuraren wanke hannu, a yawancin yankunan karkara na Afirka, akwai wuraren wanke hannu kaɗan kusa da kowane gidan wanka na jama'a ko na masu zaman kansu.
Amma, rashin wanke hannu da yawa ya fi saurin saurin wankewa da sabulu ko ruwa.
Sanarwa da koyarwa game da wanke hannu da sabulu na iya tasiri kan yanke shawara, fadakar da jama'a game da fa'idodin wanke hannu, da kuma haifar da canjin hali na dindindin.
Don yin wannan yadda ya kamata, ana buƙatar kulawa da kimantawa.
Wani nazari na nazari 70 ya gano cewa hanyoyin da al'umma ke bi wajen kara wanke hannu a LMICs sun yi tasiri, amma kamfen na tallatawa a kan kafofin sada zumunta bai yi tasiri ba. Wani misali shi ne gabatar da wanke hannu a makarantu, wato tsarin tauraro uku na UNICEF, wanda ke karfafa wa ɗalibai horo su ɗauki matakai masu sauƙi da kuma masu tsada don tabbatar da wanke hannayensu da sabulu, a tsakanin sauran bukatun tsabta.
Idan an cika mafi ƙarancin ƙa'idodi, makarantu na iya samun taurari ɗaya zuwa uku.
Gina wuraren wanke hannu zai iya zama wani bangare na kamfen na inganta wanke hannu don rage cututtuka da mutuwar yara.
Wani misali kuma shine yakin wayar da kan jama'a na wanke hannu na duniya wanda ke kokarin kawo sauyin hali. Saboda annobar cutar coronavirus ta 2019-2020, UNICEF ta karfafa yada emoji na wanke hannu.
Wasu 'yan karatu sun yi la'akari da yawan farashin wanke hannu a kasashe masu tasowa dangane da DALYs.
Amma wani bincike ya nuna cewa wanke hannu da sabulu ya fi sauran hanyoyin tsaftacewa da ruwa tasiri.
Mafarta tsabtace hannu biyu ne suka fara bayyana muhimmancin wanke hannu ga lafiyar ɗan adam, musamman ga waɗanda ke cikin yanayi mai haɗari, ciki har da uwaye masu shayarwa ko sojoji da ke jinya a asibiti, a tsakiyar karni na 19: likitan Hungary Ignaz Semmelweis da Ingilishi Florence Nightingale, wanda ya kafa aikin jinya na zamani.
A lokacin, mutane da yawa sun gaskata cewa ƙanshin miya yana sa mutane su kamu da cuta.
A shekarun 1980s, annobar abinci da cututtukan da ke da alaƙa da kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka su inganta tsabtar hannu a matsayin hanya mai mahimmanci don hana yaduwar cutar.
Cutar mura ta aladu ta 2009 da cutar COVID-19 ta 2020 sun haifar da wayar da kan jama'a a kasashe da dama game da bukatar wanke sabulu don kare kansu daga irin wadannan cututtuka.
Alal misali, a Jamus, an saka alluna da ke nuna yadda za a wanke hannu a wuraren wanka na jama'a da kuma a gine-gine da kuma filayen jiragen sama.
Wannan furcin "wanke hannuwansa" yana nufin cewa ba ya son ya ɗauki hakkinsa ko kuma ya yi tarayya da wani abu.
An samo asali ne daga nassin Littafi Mai Tsarki inda Bilatus na Pentateuch ya wanke hannunsa a lokacin da ya yanke shawarar giciye Yesu Kristi a cikin Linjilar Matta, amma ya zama sanannen magana a wasu al'ummomin Ingilishi.
A Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta da ƙarfi don wanke gashin kanta, wanda ke wakiltar lamirinta na laifi game da laifin da ta aikata da kuma ta sa mijinta ya aikata.
An kuma gano cewa mutane suna da muhimmanci sosai ga wanke hannu da kuma kayan wanke hannu bayan sun tuna ko kuma sun yi tunani a kan ayyukan lalata fiye da sauran mutane.
Bugu da ƙari, ba su da damar shiga wasu ayyukan 'yanci na 'yanci, kamar aikin sa kai, wanda aka ba su izinin wanke hannayensu bayan irin wannan tunani.
Addinai suna umurtar wanke hannu don tsabta da kuma dalilai na alama. Wanke hannu na alama, wanke hannu da sabulu ba tare da ruwa ba, shi ne tsarin wanke hannu ba tare da sabulu ba a addinai da yawa, har da Baha'i, Hindu, Tevilah da Netlai, Ya'dai a addinin Yahudanci, Lavabo a Kiristanci, da Wudu a Musulunci.
Addinin Hindu, addinin Yahudanci da Musulunci sun bukaci a wanke hannu bayan an gama wanka.
Kuma addinin Hindu, Buddha, Sikh, addinin Yahudanci da Musulunci sun bukaci wanke hannu kafin da kuma bayan kowane abinci.
Kula da hadarin aiki don COVID-19
Kula da haɗarin aiki don COVID-19 yana ba da damar kiyaye matakan tsaro na aiki don kula da cutar coronavirus 2019 (COVID-19).
Kula da haɗarin aiki na ainihi ya dogara ne akan wurin aiki da nau'in aiki, tare da bincika tushen haɗarin, yaduwar al'umma da kuma yanayin haɗarin mutum na haifar da COVID-19.
Hukumar Kula da Lafiya da Lafiya ta Aikin Aikin Amurka (OSHA) ta ce, ayyukan da ke da ƙananan haɗari sune ayyukan da ke da ƙananan hulɗa da jama'a da abokan aiki, wanda ke buƙatar kiyaye matakan rigakafin kamuwa da cuta kamar wanke hannu, kiyaye ma'aikata a gida idan suna rashin lafiya, aiwatar da numfashi, da ci gaba da aikin tsabtace jiki da kawar da kamuwa da cuta.
Ayyukan da ke da matsakaicin haɗari sune mutanen da ke hulɗa kai tsaye da mutanen da ba a san ko ake zargin suna da COVID-19 amma suna iya kamuwa da cutar saboda ci gaba da yaduwa ko tafiya ta duniya.
Wannan ya hada da mutanen da ke cikin al'umma, kamar su makarantu, wuraren da mutane ke da yawa, da kuma wuraren sayar da kayayyaki.
Don kula da haɗarin wannan rukunin, dangane da matakan rigakafin kamuwa da cuta na asali, ya kamata a sami na'urar numfashi da ke amfani da matattarar iska mai ƙarfi da kayan kariya na mutum idan mutum yana fuskantar COVID-19.
OSHA ta yi la'akari da haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin
Kula da hadari da ya dace da waɗannan ma'aikatan ya haɗa da kulawar injiniya, kamar su numfashin iska mai ƙarfi EFL da kayan kariya na mutum wanda ya dace da aikin.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata sun rasa aikinsu saboda rashin lafiya, kula da wasu, da kuma tsoron rashin lafiya.
Za a iya canja tsarin kasuwanci, har da irin kayayyakin da ake bukata da kuma yadda ake sayan su (a lokacin da ba a sa ran zuwa, ta wurin mai kawo kaya, ko kuma ta hanyar mota).
A ƙarshe, jigilar kayayyaki zuwa wuraren da ke da babban haɗarin COVID-19 na iya zama matsala. Za a iya amfani da shirye-shiryen annoba da kuma shirin amsawa don ɗaukar matakan kariya.
Akwai tsare-tsare da suka shafi wurare da nau'ikan ayyuka da yawa, wanda ke haifar da haɗari, haɗari daga gida da al'umma, da kuma haɗari ga kowane ma'aikaci da ke da shekaru da kuma rashin lafiya mai tsanani.
Sun kuma tattauna matakan da ake bukata don kaucewa waɗannan haɗarin da kuma tsare-tsaren da suka dace game da yiwuwar barkewar cutar.
Shirye-shiryen cututtuka masu yaduwa da shirye-shiryen amsawa na iya zama abin da aka ba da shawara na ƙasa ko yanki.
Manufofin maganin cutar na nufin rage yaduwar cutar tsakanin ma'aikata, hana mutanen da ke fuskantar matsalolin kiwon lafiya, kare ayyukan kasuwanci da rage tasirin da ke tattare da sauran bangarorin da ke cikin sarkar samar da kayayyaki.
"A cikin wannan yanayin, ana iya samun matsala a cikin ciwon daji, kuma ana iya samun matsala a cikin ciwon daji.
Ana amfani da tsarin tsarin kula da haɗari don ingantaccen sarrafa haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗari.
A wuraren da ba za a iya kawar da haɗarin COVID-19 ba, ingantattun hanyoyin sarrafawa sune sarrafa injiniya, wanda ke tallafawa ta hanyar gudanarwa da kuma kayan aikin kariya na mutum.
Kulawa ta injiniya na iya zama hanya mai tsada don keɓance ma'aikata daga haɗarin haɗarin aiki, ba bisa ga halayen ma'aikaci ba.
Kulawa ta gudanarwa canje-canje ne ga manufofin aiki ko hanyoyin aiki, wanda ke haifar da ma'aikaci ko mai aiki don ɗaukar matakai.
Kayan kare kai na mutum ba shi da inganci fiye da aikin injiniya da kulawar gwamnati, amma yana taimakawa rage wasu haɗari.
Ya kamata a zaɓi kowane irin kayan kariya na mutum, wanda za a iya mannewa yadda ya kamata (misali, masu tacewa) bisa ga ma'aikaci, a kai a kai kuma a kan hanya mai kyau, a bincika, a gyara, a maye gurbinsa, a kuma kawar da shi, a tsabtace shi, a adana shi, ko kuma a guje wa gurɓata.
Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA) ta ce, ayyukan da ke da ƙananan haɗari suna da alaƙa da ƙananan al'umma da sauran abokan aiki.
Matakan rigakafin kamuwa da cuta na yau da kullun da aka ba da shawarar ga duk wuraren aiki sune wanke hannu da yawa, ba da shawara ga mutane su zauna a gida idan suna rashin lafiya, matakan da suka shafi numfashi kamar su rufe tari da fitsari, shirya kayan wanki da shara, kasancewa a shirye don yin aiki ta waya da kuma nisantar canji, ƙarfafa ma'aikata su guji amfani da kayan aikin wasu, da kuma tsaftace wuraren aiki akai-akai.
Ganowa da kuma ware mutane da ke da cutar da sauri mataki ne mai muhimmanci na kare ma'aikata, abokan ciniki da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Amurka (CDC) sun ce mutanen da ke da mummunar matsalar numfashi da ke da zazzabi, alamun zazzabi, ko wasu alamun cutar suna bukatar su zauna a gida har tsawon sa'o'i 24, amma kada su sha wani magani da zai rage zazzabi ko kuma ya canza alamun cutar, kuma ya kamata a sauya manufofin hutun rashin lafiya, a ba ma'aikata damar zama a gida, kuma ma'aikata su san da hakan.
A cewar OSHA, ayyukan da ke da matsakaicin haɗari sune ayyukan da ke buƙatar kusanci na yau da kullun, har zuwa ƙafa shida (1.8 m), tare da mutanen da aka sani ko ba su da COVID-19, amma waɗanda ke da haɗarin haɗuwa saboda ci gaba da watsa SARS-CoV-2, ko kuma waɗanda suka yi tafiya kwanan nan zuwa ƙasashe tare da yaduwar COVID-19.
Wannan ya hada da tsaftace iska mai tasiri don wannan da kuma rukunin masu haɗari, ƙara yawan numfashi, saka shinge na jiki kamar su filastik mai hana iska, da kuma samar da sabis ga abokan ciniki ta taga lokacin da mota ke wucewa. Kulawa ta gwamnati da ƙarfafa ma'aikata da ke fama da wannan haɗarin, canza tarurruka zuwa taron kama-da-wane, ƙayyade jadawalin aiki na yau da kullun, dakatar da tafiye-tafiye da ba dole ba daga wuraren da ke da haɗari, da kuma inganta hanyoyin kiyayewa da kiyayewa na yau da kullun da kuma kiyaye lafiyar mutum, da kuma yadda za a magance COVID-19, da kuma yadda za a kula da masu haɗari da kuma kula da lafiyar mutum, da kuma yadda za a kula da lafiyar mutum da kuma kula da lafiyar mutum.
Ma'aikatan da ke cikin wannan rukunin masu haɗari ba sa yawan amfani da na'urar numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, kulawar da ta dace don kare ma'aikatan jirgin da sauran fasinjoji sun haɗa da gano mutumin da ke da rashin lafiya tare da nisan ƙafa 6, kula da mutumin da ke da rashin lafiya, da kuma sanya abin rufe fuska a gabansa. ko kuma neman su rufe bakinsu da hanci da kayan shafawa lokacin da suke rashin lafiya ko numfashi.
Ma'aikatan jirgin sama su yi amfani da safofin hannu na lokaci guda lokacin da suke kula da matafiyi mai rashin lafiya ko kuma idan suka taɓa ruwan jiki ko wani abu mai guba, kuma su yi amfani da ƙarin kayan kariya na sirri idan matafiyi yana da zazzabi, tari mai ci gaba ko kuma yana da matsala na numfashi.
Ya kamata a jefa safofin hannu da sauran abubuwan da za a iya cirewa a cikin jakar Biohazard, sannan a tsabtace da kuma lalata abubuwan da suka gurɓata. Kula da haɗarin jiragen ruwa na kasuwanci, gami da jiragen ruwa da sauran jiragen fasinja, sun haɗa da jinkirta tafiya yayin rashin lafiya, da keɓe kai da kuma sanar da su. Idan ka sami zazzabi ko wasu alamun cutar a cikin jirgin, nan da nan ka sanar da cibiyar kiwon lafiya a cikin jirgin.
Don makarantu da cibiyoyin kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci da tsabtace ko tsabtace kamuwa da cuta, duk lokacin da mutumin da ke da cutar ya shiga cikin ginin makaranta kuma ba tare da la'akari da yaduwar al'umma ba.
A cikin yanayin matsakaicin yaduwar cutar, ana iya aiwatar da dabarun nisantar jama'a kamar soke shirye-shiryen tafiye-tafiye, katse tarurruka da sauran abubuwa kamar su koyon makaranta, dakatar da manyan tarurruka a ɗakunan mawaƙa ko cafeteria, faɗaɗa tazarar wurin zama, raba lokutan isowa da fita, hana baƙi marasa mahimmanci da kuma gano ofisoshin keɓaɓɓu don yara masu nuna alamun.
Idan akwai yaduwar cutar a cikin al'umma, ban da dabarun nisantar jama'a, za a iya ganin ƙarin rufe makarantu a matsayin zaɓi. CDC ta kiyasta cewa haɗarin lafiya na nan take ga ma'aikatan tilasta bin doka waɗanda ke yin aikinsu na yau da kullun.
An shawarci jami'an tilasta bin doka da ke da alaƙa da waɗanda ke da cutar COVID-19 ko waɗanda ake zargi da su bi ka'idodin da aka ba da shawarar masu aikin likita na gaggawa, gami da kayan kariya na sirri.
Idan akwai kusanci a lokacin da ake damuwa, kafin a sake amfani da kayan aiki ko kayan aiki, ma'aikata su tsabtace belin aiki da kayan aiki daga kamuwa da cuta ta hanyar fesawa ko wankewa, kuma su adana da kuma kawar da PPE da kayan aiki da kayan wanki da aka yi amfani da su ta hanyar amfani da tsarin aikin da aka tsara.
OSHA ta bayyana wasu ma'aikatan kiwon lafiya da na gawa a matsayin masu matukar hadarin gaske ko kuma masu matukar hadari.
Ayyukan da ke da haɗari sosai sun haɗa da kulawar lafiya, tallafi, dakin gwaje-gwaje da kuma waɗanda aka sani ko ake zargi da cutar COVID-19.
Wannan babban haɗari ne idan ma'aikata suna aiki a kan hanyoyin samar da aerosol ko kuma suna aiki tare da marasa lafiya masu cutar COVID-19.
Ana yin amfani da shi wajen yin wasu abubuwa kamar su yin amfani da iska don yin ƙwayoyin cuta, yin amfani da bututu don yin numfashi, yin amfani da shi wajen yin ƙwayoyin cuta, yin amfani da shi wajen yin amfani da ƙwayoyin cuta, yin amfani da shi wajen yin amfani da ƙwayoyin cuta, yin amfani da shi wajen yin amfani da ƙwayoyin cuta, yin amfani da shi wajen yin amfani da ƙwayoyin cuta, yin amfani da shi wajen yin amfani da ƙwayoyin cuta, yin amfani da shi wajen yin amfani da ƙwayoyin cuta, yin amfani da shi wajen yin amfani da shi wajen yin amfani da shi wajen yin amfani da shi.
Ayyukan da ke da haɗari a cikin dakin ajiye gawa sun haɗa da aikin shirya gawawwakin mutanen da ake zargin suna da cutar COVID-19 a lokacin mutuwarsu, wanda ke nufin cewa waɗannan mutane za su kasance cikin haɗarin haɗari fiye da waɗanda ke yin autopsies. Ƙarin ƙwarewar injiniya don waɗannan ayyukan shine sanya waɗanda ake zargi ko sanannun COVID-19 a cikin keɓewa, idan ana yin ayyukan da ke fitar da ƙananan ƙwayoyin cuta.
Ana iya bukatar na'urar numfashi ta musamman don wasu asibitoci ko kuma don gawawwakin mutane.
Ana buƙatar ɗaukar samfurori a matakin tsaro na 3 na kiyayewa.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa marasa lafiya da ke shigowa su zauna a cikin wani yanki mai iyaka saboda zargin COVID-19. Baya ga PPE, OSHA ta ba da shawarar yin amfani da na'urorin numfashi a nesa da ƙafa 6 daga waɗanda ake zargi da cutar SARS-CoV-2 da waɗanda ke aiki a wuraren da ke haifar da ƙwayoyin iska.
A Amurka, NIOSH ta amince da yin amfani da abin rufe fuska na N95 a cikin tsarin tsarin kariya na numfashi wanda ya hada da kimantawa, horo da kuma duba lafiyar.
Wasu nau'ikan na'urorin numfashi suna ba da kariya sosai kuma suna haɓaka kwanciyar hankali. WHO ba ta ba da shawarar rufe fuska gaba ɗaya ba, kuma COVID-19 cuta ce ta numfashi kuma ana watsa ta ta ruwa na jiki.
WHO ta ba da shawarar cewa ma'aikatan da ke yin gwaji a ƙofofin shiga ne kawai za su sa abin rufe fuska.
WHO ta ba da shawarar cewa duk wanda ke kula da marasa lafiya na COVID-19 ko kuma ke ɗaukar marasa lafiya ba tare da fitar da ƙwayoyin cuta ba, ya yi amfani da abin rufe fuska, abin rufe fuska ko abin rufe fuska da safar hannu.
Idan an yi aikin tiyata, ana maye gurbin abin rufe fuska da N95 ko FFP2 mai sauya numfashi.
Dangane da rashin wadatar kayan aikin PPE a duniya, WHO ta ba da shawarar rage buƙatar PPE ta hanyar telemedicine, ƙuntatawa ta jiki, watau samun damar shiga ta hanyar windows masu tsabta, don amfani da kayan kariya na mutum don aiki ɗaya kawai, samar da kulawa ga mutane da yawa ba tare da cire na'urar numfashi ɗaya ba, kula da sarkar kayan kariya na mutum, da kuma daidaitawa ga mutanen da ba su da alamun.
Daga Katherine Maher, Shugabar Wikimedia Foundation
B: Duk ma'aikatan Wikimedia Foundation
[Covid-19] rage matsin lamba da kuma shirya don nan gaba
Ranar da aka aika: 14 ga Maris, 2020, 00:24 UTC
Mai bayarwa: CC0: Babu haƙƙin haƙƙin haƙƙin mallaka
A wannan watan, mun sami kanmu a wani yanayi na musamman.
Cutar COVID-19 ta bayyana alakarmu ta bil'adama da kuma nauyin da muke da shi ga junanmu.
Ko da yake ba mu da misali na ƙalubalen, amsarmu mafi kyau tana cikin daidaitawa, haɗin kai da kuma gina al'umma a tsakiyar wannan tsari.
Abokantaka da kulawa da muka gani a tsakanin ma'aikatanmu ta hanyar imel, waya da hira, tabbaci ne na yadda muke da himma wajen aiki tare da mutane masu ban mamaki.
Ina ganin kaina mai sa'a ne da na san ku duka a matsayin abokin aiki.
A makon da ya gabata, wani ya ce yana son aikinmu.
Wannan alama ce mai ban mamaki game da yadda duniya ta dawo cikin Wikipedia kuma wannan muhimmin abu ya kasance akan layi kuma yana samuwa ga kowa.
Aikinku zai sa hakan ya yiwu, idan kun ɗauki matsayin, idan abokan aikinmu suna samun albashi, ko kuma idan al'ummarmu tana da aminci.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa yanzu fiye da kowane lokaci.
Wannan lokaci ne da zai shafi duniya, ba kawai abin da muke yi ba amma yadda muke yi.
Wannan aikin da kuma rawar da kuke takawa yana da matukar muhimmanci, don haka za mu yi wasu manyan gyare-gyare ga yadda muke aiki tare, daga mako mai zuwa.
A shekara ta 2000, an soma yin wasu canje-canje a tsarinmu da kuma aikinmu.
Kamar yadda Robyn ya fada a baya, kungiyar C ta hadu a daren jiya don tattauna tsarinmu da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan jawabin, mun yi tunani game da abin da zai zama amsar da ta dace ga abin da ya faru da kuma abin da ya kamata mu yi don ci gaba da ƙungiyarmu a wannan lokacin.
Mun so mu guji damuwa sosai kuma mu ci gaba da hidimarmu na dogon lokaci.
Idan kana son ka sake kira, babu matsala.
Ga dukkan ma'aikata, masu hutu da ma'aikatan wucin gadi:
Za a yi aiki na awa 4 a rana ko kuma awa 20 a mako har sai an ba da ƙarin bayani.
Ba wai muna cewa hutu ne ba - idan za ku iya yin aiki na sa'o'i bayan aikin yau da kullum, aikin zai amfane ku.
Amma duniya ba ta da tabbas inda za ta tafi, ko kuna kula da iyalanku, ko kuna sayayya ko kuna zuwa likita, lafiyarku ita ce fifiko a gare mu.
Ba ma lura da lokacinku.
Idan sun yarda da kai, kada ka yi aiki.
Ba lallai ba ne a faɗi haka, amma za mu ce.
Babu buƙatar ranar rashin lafiya ko PTO - kawai kuna buƙatar gaya wa ma'aikacin gudanarwa kuma ku tabbatar da cewa ƙungiyarku tana da ɗaukar mahimman sassan aiki ta hanyar nazarin kalandarku da jadawalin.
(Idan ka sami sakamako mai kyau na gwajin COVID-19, don Allah ka sanar da Brienne don samun goyon baya da kuma tabbatar da cewa an kula da shari'arka yadda ya kamata daga gwamnati.)
Ana biyan mutane a kowane awa.
Mun riga mun samu, kuma za mu ci gaba da samar da abin da muke da shi ga 'yan kwangilarmu da ma'aikatan mu.
A lokacin da ake aiki, ana biyan kowa.
Wannan ya haɗa da waɗanda ba sa iya yin aiki domin rashin lafiya.
Idan kuna son yin aiki, za mu taimake ku.
Mutane da yawa suna amfani da aiki don su kawar da damuwarsu daga duniya.
A irin wannan lokacin, aikinmu zai iya kawo sakamako mai kyau.
Wannan kuma game da kula da kanka ne.
Tambayarmu ita ce ta hanyar tattaunawa da gwamnatin ku game da abin da za mu yi tsammani da kuma yadda za mu shirya.
An ɗauki wasu ayyuka da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
SRE, ayyukan HR, amintattu da tsaro, da ƙungiyoyin tara kuɗi (a tsakanin sauran) suna yin aiki mai mahimmanci wanda zai buƙaci ƙarin tallafi.
A cikin dukkan sassan, za mu fara aiwatar da abin da ke da mahimmanci don mayar da hankali ga abin da ake buƙata don manufarmu.
Muna da aiki da yawa, kuma muna mai da hankali ga abin da ya fi muhimmanci.
Ba zai yi kyau ka yi jinkiri ba.
Ba mu da shirin ninka lokacin aiki don kammala ayyukan da aka jinkirta bayan wannan annobar ta wuce.
A yanzu, ba za ka yi aiki na sa'o'i da yawa don ka cika wasu takunkumi ba.
Mun yarda cewa yanayi ya canza, kuma muna aiki don saita sababbin manufofi da jadawalin lokacin da ya cancanta.
Menene ke faruwa a APP (shirin shekara-shekara)?
Don daidaitawa da sabon gaskiyarmu da lokutan aikinmu na yau da kullun, muna buƙatar daidaita lokacin da za mu cimma nasarar shirinmu na shekara-shekara na 2020-2021.
Manufarmu ita ce ta ba da shawarar a tsawaita shirinmu na 2019-2020, wanda zai ba ma'aikata damar yin aiki na yau da kullun, su kula da kansu, su kula da danginsu, wanda zai iya biyan bukatun waɗanda ke son yin aiki na ɗan lokaci.
Wannan tsawaitawar lokaci zai rage matsin lamba da matsin lamba na shirin yanzu a kan ƙungiyar gaba ɗaya.
"Muna sanar da ma'aikatanmu ga hukumar a mako mai zuwa, kuma muna sanar da wakilanmu da kungiyoyinmu matakin na gaba da zarar mun sami bayanin".
Na gode da jagorancin da kuka nuna wa ƙungiyar APP a wannan lokacin.
Yanayin Ofishi, Haɗari, da Tsabta
A makon da ya gabata, mun gano cewa ɗayan abokan aikinmu na SF na iya kasancewa cikin haɗarin cutar COVID-19.
Amma, saboda mu yi taka tsantsan, mun dauki ma'aikatan rigakafin cutar a ofishinmu na San Francisco.
Sun sanya kowane bene ya zama mai hana kamuwa da cuta ta hanyar amfani da irin maganin kashe ƙwayoyin cuta da ake amfani da shi a asibitoci, ciki har da masu karɓar sararin samaniya da bankunan lif da ke isa bene.
Ginin yana da tsarin kulawa na kansa ta hanyar amfani da samfuransa don kare lafiyar masu haya.
Muna da tabbacin cewa lokacin da muka yanke shawarar komawa, ofishin zai kasance a shirye.
Ofishinmu na DC yana cikin WeWork kuma sun raba mana da ma'aikatanmu a DC game da aikin su na COVID-19.
A makon da ya gabata, ASEC ya sauya ofishin mu na D.C. zuwa matsayin da ya dace na San Francisco don yin aiki daga gida.
Kamar yadda wasu ma'aikatanmu a NYC suka sani, muna kuma tattaunawa kan yin hayar wani wuri a Brooklyn.
An ci gaba da tattaunawar, amma za a iya jinkirta.
Wasu abokan aikinmu sun fara yin aiki daga gida.
Abokan aikinmu na dogon lokaci sun san cewa zai iya zama gyara, kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon lokacin taron zuwa awa ɗaya ko biyu.
Idan ana bukatar dogon lokaci, yi la'akari da yadda za a iya raba shi zuwa gajerun lokatai na kwanaki da yawa.
Ka bayyana taron a fili, ka kafa tsarin ayyuka, kuma ka aika da kayan karatun a gaba.
Sanya bidiyo a matsayin tsoho, wanda ya haɗa da kayan aiki kamar Google Docs da Zoom, wanda ke ba da damar haɗin kai tsaye da sadarwa.
Ka sa wani ya ja-goranci kowane taro, ya kula da tattaunawar, ya kula da jerin masu jawabi, kuma ya taimake ka ka rubuta (ko kuma ka rubuta tare).
Idan kana son kayan kunne mai kyau, aika imel zuwa goyon bayan fasaha.
Ku yi amfani da kuɗin inshorarku don ku biya kuɗi.
Shiga shafin #remoties don tattauna ayyukan da aka raba tare da abokan aikinka
Kungiyar HR tana neman hanyoyin da za ta iya aiwatar da ayyukan da aka rarraba a cikin Gidauniyar ta hanyar samar da jagorar Ergonomics bisa ga yanar gizo.
A makon da ya gabata, mun nemi masu karɓar tallafi na al'umma su share abubuwan da suka faru a asusun Wikimedia, kamar yadda ake yi a Editatons, har sai WHO ta ce annobar ta ƙare.
Sun sanar da su cewa mun fahimci cewa neman sokewa na iya sanya musu wahala su cika yarjejeniyar tallafi da aka riga aka amince da ita, kuma ba za a hukunta kowa ba saboda jinkiri ko canji a cikin waɗannan manufofin.
A mako mai zuwa za mu kara ba da shawara a Wikimania da sauran taron yanki da kuma na iyakantaccen al'umma.
Halin da ke fitowa daga al'ummar duniya ba kawai baƙin ciki bane, amma kuma jin daɗin sauƙaƙewa saboda rashin tsaro da ya haifar da hangen nesa don mayar da hankali ga al'ummarsu, Wikimedia da sauransu.
Da yake magana game da nan gaba, CRT yana aiki don ƙirƙirar shafi a kan Meta-Wiki, don haka manufar ita ce ta iya sarrafa matsa lamba ga al'umma kuma ta ci gaba da hulɗa da su.
Kulawa sosai da al'amuran da suka shafi COVID-19
Za mu aika da gayyata don taron ma'aikata na musamman a ranar Alhamis mai zuwa 14:00 UTC/07:00 PT.
Muna amfani da wannan lokacin don raba ƙarin sabon bayani, amsa tambayoyinku, da kuma ciyar da lokaci akan alaƙarmu.
Muna cikin wannan tare kuma muna taimakawa duk yadda za mu iya.
A wannan lokacin, za ku iya samun bayanai daga wannan imel ɗin kuma ku sami wasu bayanan da suka shafi COVID-19 a cikin Office Wiki.
CRT tana sabunta waɗannan shafuka don samun duk bayanan a wuri ɗaya.
Bugu da ƙari, muna aiki don ci gaba da hulɗa tare da ma'aikata, musamman waɗanda ke aiki a ƙasashe masu wahala.
Idan kuna buƙatar taimako game da tafiya, yanayi, babban aiki ko ƙalubalen ɗaukar hoto, ko wani abu, don Allah kada ku yi jinkirin sanar da CRT kuma kuyi aiki tare da su.
Muna nan don bayar da tallafi da aiwatarwa kamar yadda ake buƙata.
Idan akwai wani abu da ya kamata a kula da shi, aika imel zuwa Bryan Judan - Daraktan Ayyuka na Human Power Global.
Babu wani daga cikin waɗannan canje-canjen da ya kamata a ɗauka cewa ya sa mu rasa aikinmu.
Amma a wannan lokacin, ya kamata mu fahimci cewa aikinmu da ayyukanmu suna bukatar gyara a hanyar da ba mu taɓa gani ba.
Muna bukatar mu tallafa wa juna, don haka muna bukatar mu ci gaba da aiki tare, don tallafa wa ayyukanmu, da kuma samar da ayyukan da duniya ke tallafawa.
Aikin da muka shirya zai sa mu jira a lokacin da ya dace.
A yanzu, lokaci ya yi da za mu tallafa wa juna da kuma samar da wuraren aiki don makonni da watanni masu zuwa.
Dukkanku kuna da mahimmanci don wannan ya zama gaskiya, kuma muna son ku duka ku kare kanku da danginku don mu fi dacewa a lokacin da ya zama dole.
Yanzu Don Allah - Ku Wanke Hannunku Kuma Kada Ku Taɓa Fuskarku!
Katherine ta yi aiki a matsayin mai kula da CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da kuma a matsayin mai kula da ƙungiyar (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin-converting enzyme 2 (ACE2) wani enzyme ne da ke jikin ƙwayoyin da ke cikin huhu, jijiyoyin jini, zuciya, koda, da kuma hanji.
ACE2 yana da tasiri sosai wajen maganin cututtukan jijiyoyin jini ta hanyar rage matakan angostin-II da kuma kara Ang (1-7), yana hana aikin enzyme mai canzawa na angotensin (ACE). ACE2 yana aiki a matsayin hanyar shiga wasu ƙwayoyin cuta zuwa ƙwayoyin cuta.
An kira wannan enzyme a cikin mutum hACE2.
Angrostin-2 enzyme, zinc ne mai dauke da ironloenzyme da ke cikin jikin mutum da kuma wasu ƙwayoyin halitta.
An sanya furotin ACE2 zuwa yankin N-terminal peptidase M2 da kuma yankin mai watsa amino acid na C-terminal collectrin na koda.
ACE2 wani nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
An cire wani enzyme na waje na ACE2 daga cikin kwayar halitta, wanda ake kira Shades, kuma an fitar da sakamakon a cikin jini a matsayin furotin mai narkewa kuma a ƙarshe a cikin fitsari.
ACE2 yana cikin yawancin sassan jiki: ACE2 yana haɗuwa da ƙwayoyin cuta na ƙwayoyin alveolar na nau'in huhu na II, ƙananan hanji, ƙwayoyin jini da ƙwayoyin jini da ƙwayoyin jini a yawancin sassan jiki.
Ana bayyana mRNA na ACE2 a cikin cortex na cervical, stratum, hypothalamus, da kuma cikin kwakwalwar kwakwalwa.
Babban aikin ACE2 shine daidaita daidaito ga ACE.
ACE yana sa angiotensin I ya zama hormone mai saurin rage jini.
ACE2 kuma yana cire amino acid phenylalanine, wanda shine tashar carboxyl, daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyzing shi zuwa angiotestin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH) mai sassauci.
ACE2 na iya lalata wasu peptides da yawa, ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana sarrafa membrane na SLC6A19, mai ɗaukar amino acid mai tsaka tsaki, wanda aka gano yana da alaƙa da cutar bugun zuciya.
A matsayin furotin mai wucewa, ACE2 yana aiki a matsayin babban wurin shigar da kwayoyin wasu ƙwayoyin cuta na corona, gami da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, sunadarai na SARS-CoV da SARS-CoV2 sunadarai na S1 sun haɗu da ƙwayoyin ƙwayoyin ƙwayoyin cuta na ACE2 wanda ke haifar da ƙwayar cuta da enzymes zuwa endosomes da ke cikin ƙwayoyin.
Wannan tsarin shigarwa yana buƙatar yin gwajin farko na furotin S akan mai sarrafawa na TMPRSS2, wanda zai iya zama magani na bincike a halin yanzu. Wannan ya sa wasu sun yi tunanin cewa zai iya taimakawa wajen yaƙar kamuwa da cuta ta hanyar rage matakan ACE2 a cikin kwayar halitta.
Koyaya, ƙwararrun ƙwararrun ƙwararru da hukumomin kulawa suna ba da shawarar ci gaba da maganin ACE mai hanawa da ARB na yau da kullun.
A cikin bita mai mahimmanci da meta-analysis, wanda aka buga a ranar 11 ga Yuli, 2012, FDA ta nuna cewa amfani da masu hana ACE yana da ƙimar rage ciwon huhu na 34% idan aka kwatanta da masu kula.
Bugu da ƙari, haɗarin kamuwa da ciwon huhu ya yi kama da waɗanda ke shan cutar cutar ACE, musamman a cikin ƙwaƙwalwa da bugun zuciya.
An kuma yi amfani da magungunan ACE a kan mutuwar da ke da nasaba da ciwon huhu, kuma sakamakon ya yi ƙasa da haɗarin ciwon huhu gaba ɗaya.
Kwayar ACE2 (rhACE2) na mutum ana tsammanin sabon magani ne don cututtukan huhu na gaggawa, cutar rashin numfashi da ke haifar da cutar liposaccharide, wanda ke inganta haemodynamics na huhu da kuma rashin iskar oxygen a cikin 'yan aladu.
Rabin rayuwar rhACE2 a cikin mutum kusan awa 10 ne kuma farkon aikinsa na tsawon sa'o'i 24 da minti 30 na aiki.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai kyau ga waɗanda ba su da rigakafin tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko kuma waɗanda ke da ƙarancin angiotensin II. An gwada rhACE2 a cikin gwaji na asibiti don magance matsanancin damuwa na numfashi.
Aikace-aikacen COVID-19 aikace-aikacen software ne na wayar hannu da aka tsara don biye da ko kuma taimakawa wajen gano hanyoyin gano mutanen da suka iya tuntuɓar mutumin da ke da cutar.
An shirya ko kuma an gabatar da aikace-aikace da yawa a wasu ofisoshin gwamnati da kuma jihohi tare da taimakon gwamnati.
An tsara tsarin da yawa don gina aikace-aikacen bin diddigin tuntuɓar.
An kuma yi ta ta'addanci game da tsarin da ke bin sawun inda masu amfani da manhajoji suke.
Zaɓuɓɓukan ƙananan tsangwama sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci da mai amfani da sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su yi aiki tare don daidaita aikin na'urorin da ke aiki da Bluetooth zuwa tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da hadin gwiwa da kamfanin Alipay, ta samar da manhajar waya da za ta sanar da 'yan kasa idan sun tuntubi mutanen da ke dauke da cutar COVID-19.
An fara amfani da shi a birane sama da 200 na kasar Sin, kuma ana amfani da aikace-aikacen TraceTogether a Singapore.
An gina manhajar ta hanyar al'ummar IT na yankin, wanda aka saki a matsayin mai budewa, kuma ana ba da ita ga gwamnati. A Arewacin Macedonia, Bekuulu ya ƙaddamar da wani app mai amfani da Bluetooth mai suna StopKorona! don bin diddigin haɗari da amsawa cikin sauri ga mutanen da ke fama da cutar.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka samar da manhajar.
Tun daga ranar 14 ga Afrilu, 2020, ana jiran izinin aikace-aikacen don kasancewa a cikin Google Play Store da Apple App Store.
"A ranar 12 ga Afrilu, gwamnatin Amurka ta bayyana cewa aikace-aikacen neman lambobin sadarwa yana kan matakin ci gaba sosai, kuma an shirya irin wannan aikace-aikacen a Ireland da Faransa ("StopCovid") wanda zai fara aiki a cikin makonni. "
Dukansu Ostiraliya da New Zealand suna la'akari da aikace-aikace bisa tsarin TraceTogether na Singapore da kuma yarjejeniyar BlueTrace. Rasha na shirin gabatar da aikace-aikacen geofencing ga marasa lafiya na COVID-19 da ke zaune a Moscow don hana su barin gidajensu.
Ross Anderson, Farfesa a fannin injiniyan tsaro a Jami'ar Cambridge, ya lissafa matsaloli da dama, ciki har da sakamakon da ba daidai ba wanda za a iya amfani da shi a tsarin da aka kafa ta hanyar aikace-aikace, da kuma idan an iyakance amfani da aikace-aikacen ga ƙananan jama'a.
"Don magance matsalar yaduwar aikace-aikacen cutar "coronavirus"" masu cutarwa, Apple ya sanya iyakoki kan irin kamfanonin da za su iya ƙara aikace-aikacen da suka shafi cutar coronavirus zuwa shagon aikace-aikacen, yana iyakance shi ga kamfanoni masu suna ko kuma masu suna".
Google da Amazon sun yi amfani da irin wannan takunkumi.
Masu kare hakkin dan adam sun nuna damuwa game da tasirin sa ido mai yawa ta amfani da aikace-aikacen cutar coronavirus, musamman ma cewa kayan aikin leken asiri da aka kirkira don magance cutar ta coronavirus na duniya za su lalace da zarar barazanar ta wuce.
Amnesty International da kungiyoyi sama da 100 sun yi kira da a kawo karshen irin wannan leken asiri.
Kungiyoyin sun bayyana sharudda takwas kan ayyukan gwamnati.
Dole ne a yi sa ido a kan abubuwa da suka dace, da kuma yadda ya kamata.
Tsawon kulawa da sa ido dole ne ya zama daidai da sakin layi na biyu;
Dole ne a iya iyakance amfani da bayanai don dalilai na COVID-19 kawai;
Tsaro da kuma ɓoye bayanan sirri dole ne a kiyaye su kuma a gano su bisa ga shaidar;
Dole ne a guji saka idanu na dijital don ƙara nuna bambanci da nuna bambanci;
Duk wani bayanin da aka raba wa wasu dole ne a bayyana shi ta hanyar doka;
Dole ne a sami kariya don hana cin zarafi da kuma hana cin zarafin 'yan ƙasa;
"Ana buƙatar ""matsayi mai ma'ana"" daga "duk masu ruwa da tsaki masu mahimmanci", gami da ƙwararrun masanan kiwon lafiyar jama'a da ƙungiyoyi masu tsari. Kungiyar Kwamfuta ta Keus ta Jamus (CCC) da masu ba da rahoto (Ohne Grensen) (RSF) sun ba da cikakkun bayanai na bincike ba tare da iyakancewa ba".
Idan shirin Google/Apple ba ya da mahimmanci don magance matsalar sa ido na yau da kullun, za a iya cire sa ido daga dandamali.
Wasu ƙasashe sun yi amfani da sa ido kan hanyar sadarwa maimakon aikace-aikace, suna kawar da damar saukar da aikace-aikace da kuma hana bin diddigin su.
An amince da saka idanu ta hanyar sadarwa a Isra'ila.
Maganin yanar gizo don samun damar bayanai a cikin bushewa yana da matsaloli masu yuwuwa.
Koyaya, ba duk tsarin da ke da babban uwar garke bane zai iya samun damar bayanan bayanan yanki na sirri, an ƙirƙiri tsarin tsare sirri da yawa waɗanda ke amfani da manyan sabobin don sadarwa kawai (duba sashe a ƙasa).
A Koriya ta Kudu, ana amfani da tsarin neman lambobin sadarwa ba tare da aikace-aikace ba.
Maimakon amfani da aikace-aikacen da aka tsara don manufa ɗaya, tsarin yana tattara bayanan sa ido daga tushe daban-daban, gami da bin diddigin na'urar hannu da bayanan ma'amala da katin, kuma yana haɗa isar da saƙonnin rubutu daga waɗannan mutanen da ke da cutar.
Baya ga amfani da wannan bayanin, gwamnati ta kuma samar da bayanan wurin ga kowa, saboda canje-canje masu yawa a cikin dokokin sirri na bayanai saboda barkewar cutar MERS a wannan ƙasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo da yawa. Kasashen da suka hada da Jamus suna amfani da tsarin tsaron tsakiya da na sirri.
Har zuwa ranar 6 ga Afrilu, 2020 ba a sake fitar da cikakkun bayanai ba.
Manufar mutunta sirri da bin hanyoyin sadarwa ya kasance tun da farko tare da tarihin bincike na ɗan adam, wanda ya fara aƙalla 2013. A ranar 7 ga Afrilu, 2020, sun yi amfani da mafita mai mutunta sirri, wanda ke amfani da Bluetooth Low Power (BLE) wanda ke sanar da yadda yake kusa da sauran wayoyin.
Duk da haka, PPP-PT haɗin haɗin gwiwa ne wanda ke ɗaukar hanyoyin da aka rarraba da kuma rarraba kuma ya ƙunshi yarjejeniya guda ɗaya, tare da haɗaɗɗun ladabi waɗanda ke da kariya ta kusa da keɓaɓɓun bayanai (DP-PPT / DP-3T), lambobin tuntuɓar wucin gadi, (TCN, lambobin taron lambobin sadarwa, CEN), ladabi na sirri da kuma bincike don sadarwa ta hannu (PACT), da sauransu.
Bayanan sirri da aka gano a cikin waɗannan ladabi ba za su taɓa barin na'urar ba, kuma duk abubuwan da suka dace suna aiki akan na'urar.
Kungiyar tsare sirri a MIT Media Lab tana haɓaka SafePaths, wani dandamali wanda ke amfani da dabarun tsare sirri yayin tattarawa da amfani da bayanan wuri ko hanyar wucewa don bin diddigin yaduwar COVID-19.
"Aikace-aikacen da aka samo asali ne daga wani bincike mai suna Gone Rogue: Kare Sirrin Mutum a cikin Cutar da aka fitar a ranar 6 ga Maris, 2020. Wani irin wannan yunƙuri kuma an kafa shi ne a MIT Media Lab, a cikin dandalin SafeTrace, kamfanin Ingma MPC wanda ke haɓaka fasahar tsare sirri".
SafeTrace fasaha ce ta kayan aiki mai aminci wacce ke ba masu amfani damar raba wuraren sirri da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi ba tare da yin watsi da sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN Alliance na duniya wanda ke da tsarin kama da juna kuma ya rarrabu tsakanin ƙungiyoyi, musamman ma hanyoyin haɗin kai, don rage gibin da kuma samar da haɗin kai na duniya don saka idanu da faɗakarwa na aikace-aikace.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da buɗe yarjejeniyar BlueTrace, wanda ke amfani da aikace-aikacen gwamnati na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, masu sarrafa dandamali na wayar hannu na Android da iOS, sun sanar da shirin sadarwa wanda suka bayyana cewa zasu kiyaye sirrin sirri bisa haɗin fasahar Bluetooth mai ƙarancin ƙarfi da bayanan sirri.
Ya kuma ba da cikakken bayani game da manyan fasahohin da ake amfani da su a cikin tsarin.
A cewar Apple da Google, an tsara tsarin don saki a matakai uku:
Jerin aikace-aikacen kayan aiki da ke ba gwamnatoci damar ƙirƙirar aikace-aikacen sa ido kan cutar coronavirus na tsare sirri na hukuma
Google da Apple suna shirin sauƙaƙe wannan aikin kai tsaye zuwa iOS da Android, kuma suna ƙoƙarin kawar da matsalolin sa ido na yau da kullun ta hanyar rarraba sabunta tsarin aiki na farko da kuma bayan barazanar ta wuce.
Gyaran magani (wanda kuma ake kira sake sarrafa magani, sake rarrabawa, sake sabuntawa ko sauyawar magani) magani ne da aka ba da izinin sake yin wani magani daban da wanda aka riga aka ba da izini.
Wannan shine ɗayan hanyoyin binciken kimiyya da ake yi a halin yanzu don haɓaka ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun hada da allurar rigakafin COVID-19 da kuma watsa jini. SARS-CoV-2 yana da furotin 66 da ke da damar maganin, kowannensu yana da manyan wuraren da ke da alaƙa da ligand.
Binciken waɗannan wuraren da ake buƙata ya haɗa da samar da ingantaccen maganin rigakafin cutar COVID-19 mai inganci.
Muhimman abubuwan da SARS-CoV-2 ke niyya sune sunadarai kamar su papine, RNA mai dogara da RNA polymel, helix, S protein, da ADP ribophosphatase.
Hussein A, et al sun yi nazarin wasu magungunan da aka ba da shawarar kuma daga baya binciken asibiti ya inganta kuma ya bincika su tare da ingantattun magungunan da aka amince da su don hanzarta haɓaka ingantaccen maganin SARS-CoV-2.
Chloroquine magani ne da ake amfani da shi wajen hana wasu cututtuka da ke sa jiki rashin ƙarfi.
A ranar 18 ga Maris, Hukumar Lafiya ta Duniya ta sanya chloroquine da hydrochlorquine mai alaƙa a cikin magunguna huɗu da za a gwada a gwajin asibiti na haɗin gwiwa.
Gwamnan New York Andrew Cuomo ya sanar da cewa jihar New York za ta fara gwajin chloroquine da hydrochloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da hydrochloroquine sulfate da chloroxine phosphate a karkashin lasisin amfani da gaggawa (USA).
Ba a amince da maganin ba a cikin gwajin asibiti na FDA, kuma an ba da izinin amfani da shi a matsayin magani na gwaji kawai a cikin EU don ba da agajin gaggawa ga marasa lafiya waɗanda ba za su iya samun magani a gwajin asibiti ba, duk da cewa suna asibiti.
A cewar CDC, ba a riga an ƙaddara amfani, sashi da lokacin da za a yi amfani da hydroxychloroquine don proplaxis ko maganin SARS-CoV-2 ba.
"Likitoci sun ce za su yi amfani da maganin ne idan ba su da wani zaɓi".
Wata ƙungiyar bincike ta Turkiyya a Istanbul tana gudanar da karamin bincike kan amfani da sinadarin chlorine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan bincike a Jami'ar Duke da Jami'ar Oxford.
Makarantar Lafiya ta NYU Langone tana gudanar da bincike kan amfani da inganci na maganin hydroxychloroquine.
Gwajin asibiti na kasar Sin a Wuhan da Shenzhen sun nuna favipiravir yana da tasiri sosai.
35 marasa lafiya a Shenzhen sun sami sakamako mara kyau a matsakaici a cikin kwanaki 4, kuma tsawon lokacin rashin lafiya ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba a kula da su ba.
A cikin wani bincike da aka yi a Wuhan, an yi wa marasa lafiya 240 da ciwon huhu, rabi sun sha favipiravir, kuma rabin sun sha umifenovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ake da ita a yanzu don tallafawa maganin ba ta da yawa kuma ba ta da asali.
A ranar 2 ga watan Afrilu, Jamus ta ce za ta sayi maganin daga Japan kuma ta adana shi, sannan ta yi amfani da sojojin don isar da maganin zuwa asibitocin jami'a inda za a yi amfani da shi wajen kula da marasa lafiya na COVID-19.
Shinzo Abe ya ce zai sayi maganin ne don tallafawa gwamnatin Trump, kamar yadda South China Morning Post ta ruwaito.
Ba shi da lafiya ga mata masu juna biyu ko waɗanda suke ƙoƙarin yin ciki.
"Bincike da aka yi a kan maganin rigakafi mai suna lopinavir da ritonavir / lopinavir / ritonavir (Kaletra) ya kammala da cewa ""ba a sami wani amfani ba"."
An tsara waɗannan magungunan ne don su hana cutar HIV ta haifa ta wajen haɗa kansa da ƙwayar farji.
Kungiyoyin bincike a Jami'ar Colorado na kokarin kirkirar wani abu da zai iya danganta maganin da ke dauke da kwayar cutar SARS-CoV-2. Akwai zargi da yawa a cikin al'ummar kimiyya saboda lalata kayan aikin da aka kirkira don maye gurbin magungunan cutar HIV/AIDS.
Hukumar Lafiya ta Duniya ta gwada lopinvir a cikin gwajin haɗin gwiwar duniya.
Kamfanin Gilead Sciences ya yi bincike kan yadda za a iya amfani da Remdesivir a matsayin maganin rigakafi, kamar yadda cutar Ebola ta yi. Kamfanin Gilead Sciences ya gano cewa Remdesivir yana da damar yin amfani da rigakafi a cikin in vitro, da kuma yawancin kwayoyin cutar philo-, pneumonia-, parmyxo- da corona.
Wani batun maganin rigakafin cutar shine ci gaban juriya ta hanyar juyin halitta wanda zai iya haifar da ƙarin cututtuka da yaduwa.
Wasu binciken farko na gwaji sun nuna cewa Remdesivir yana da iyakancewar kwayoyin halitta. Ana gudanar da gwaje -gwaje da yawa na asibiti, biyu a asibitocin Cleveland, ɗaya don marasa lafiya masu ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon.
Akwai jerin gwaje-gwaje na asibiti guda uku don mutanen da ke asibiti da ke fama da cutar COVID-19, biyu da ke kula da placebo (China, Kanada) da kuma guda ɗaya da ba a kula da su ba (Italiya).
An fara gwajin maganin rigakafin azithromycin a jihar New York a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya ta Japan (NCGM) tana gudanar da gwajin asibiti na Tejin Alvisco (Ciclosonide), wani maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Ana gudanar da gwajin maganin na matakin 2 na enzyme mai canzawa na Angtonistin 2, tare da lura da marasa lafiya 200 masu fama da cututtuka masu tsanani, a asibitocin Denmark, Jamus da Austria.
Masu bincike daga Cibiyar Kula da Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar colchicine wajen rage kumburi da ciwon huhu a cikin marasa lafiya da ke fama da cutar COVID-19.
Binciken COLCORONA ya yi amfani da manya 6000 masu shekaru 40 zuwa sama, waɗanda ke da alamun COVID-19 masu sauƙi waɗanda ba sa buƙatar asibiti.
Ba za a iya ba da izini ga mata masu juna biyu ko masu shayarwa ba idan ba su da maganin hana haihuwa mai kyau.
Ana gwada magungunan rigakafin ƙwayoyin cuta da yawa a Italiya.
Ana amfani da maganin heparin mai nauyin kwayoyin ƙasa don magance marasa lafiya, wanda ya sa Hukumar Kula da Magunguna ta Italiya ta ba da umarni game da amfani da shi.
An sanar da maganin a Italiya a ranar 14 ga Afrilu, a kan maganin rigakafi da maganin maganin rigakafi, a cikin binciken da aka yi a kan marasa lafiya 300 da ke shan enozaparin sodium.
A matsayin kwayar cutar SARS-CoV-2, an ba da hankali sosai ga ilimin kimiyya kan sake yin amfani da magungunan rigakafin cutar da aka amince da su don cututtukan cututtuka kamar MERS, SARS da cutar West Nile.
Ribavirin: An ba da shawarar samar da ribavirin a China a cikin bugu na 7 na jagororin don maganin COVID-19
Umifenovir: an bada shawarar umifenovir don maganin COVID-19 bisa ga littafin jagora na 7 na kasar Sin
Wasu kwayoyin cutar da aka gano cewa za a iya sake dawo da su kamar yadda ake yi da maganin COVID-19 sune:
An amince da Tocilizumab (mai hana IL-6).
Har ila yau, an gwada a Italiya da China. Duba Tocilizumab#COVID-19.
allurar b'A COVID-19 allurar rigakafin cutar coronavirus 2019 (COVID-19) ce ta gaba daya.
Ko da yake babu wani allurar rigakafin da za ta kammala gwajin asibiti, ana ci gaba da yin gwaji da yawa don samar da irin wannan rigakafin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya ta ce ba za a yi tsammanin samun allurar rigakafin cutar SARS-CoV-2 ba har sai bayan watanni 18.
An gudanar da binciken lafiyar masu neman allurar rigakafi guda biyar a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Babban annoba a duniya a shekarar 2020, wanda ke haifar da saka hannun jari da bincike mai yawa don samar da allurar rigakafi.
Kungiyoyi da dama suna amfani da kwayoyin halittar da aka buga don samar da alluran rigakafin cutar SARS-CoV-2.
Rahoton CEPI, wanda aka kammala a watan Afrilu na shekarar 2019, ya lura da ci gaban ci gaba, saurin, ƙarfin samarwa, daidaitawa, da kuma samun dama a duniya.
A farkon watan Afrilu na 2020, masana kimiyya na CEPI sun ba da rahoton cewa ana kan gudanar da bincike da ci gaban dandamali daban-daban na fasaha guda 10 don samar da ingantaccen rigakafin COVID-19.
Babban manufofin dandamali wanda aka inganta zuwa Nazarin Tsaro na Mataki na I sun haɗa da:
Nucleic acid (DNA da RNA) (mai haɓaka matakin I da kuma ɗan takarar rigakafin Moderna, mRNA-1273)
Mai ɗaukar hoto na kwayar cuta (matakan I da kuma allurar rigakafi: ilimin halitta na ciwon daji, adenovirus nau'in 5 mai ɗaukar hoto)
A watan Afrilu, masana kimiyya sun ba da rahoton cewa, a cikin dukkanin alluran rigakafi masu yiwuwa 115, 78 suna cikin matakan farko na ci gaba, tare da ayyukan aiki (79, bisa ga bayanan Cibiyar Milken), 37 kuma an sanar da su, amma ana tsammanin akwai ƙarancin bayanai a cikin jama'a (a cikin shirin ko ƙira).
Gwajin Mataki na I-II yana yin gwajin rigakafin farko da amintacce, wanda yawanci ana yin saurin sa ido, ana sanya ido a wurare da yawa kuma ana tantance shi a wurare da yawa, wanda ke ba da cikakken bayani game da mafi inganci da inganci.
Gwajin mataki na III ya hada da ƙarin mahalarta, wanda ya hada da ƙungiyoyin kulawa, don tantance tasirin maganin rigakafi, da kuma sakamakon rashin lafiya saboda yawan maganin.
Daga cikin alluran rigakafi 79 da ake ci gaba da su (kamar yadda aka tabbatar a watan Afrilu na 2020), 74 ba a gwada su a kan mutane ba (har yanzu suna cikin binciken farko).
A ranar 24 ga Janairu, 2020, Jami'ar Queensland ta Australia ta sanar da cewa tana nazarin samar da maganin alurar riga kafi wanda zai iya canza kwayar cutar ta kwayar cutar don motsa rigakafi.
A ranar 24 ga Janairu, 2020, Cibiyar Alurar riga kafi ta Duniya ta Jami'ar Saskatchewan (VIDO-InterVac) ta sanar da fara aikin yin allurar riga kafi, tare da niyyar fara gwajin ɗan adam a cikin 2021.
An bude ayyukan samar da allurar rigakafin ne a Cibiyar Kula da Cututtuka da Rigakafin Cutar ta kasar Sin da Jami'ar Hong Kong a ranar 26 ga Janairu, 2020.
Kamfanin Janssen Pharmaceutical ya sanar da cewa ya fara aikin samar da allurar rigakafin Hanneke Schuitemaker a ranar 29 ga Janairu, 2020.
Jansson tare da abokin aikinsa na fasahar kere kere Vaxart sun kirkiro allurar rigakafin baki.
A ranar 18 ga Maris, 2020, kamfanin na Emergent BioSolutions ya sanar da cewa ya kulla kawance da Vaxart don samar da allurar rigakafin.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya buga wani bincike don tsara allurar rigakafi mai fasahar kama da na maganin jijiyoyin cutar kansa.
A ranar 25 ga Maris, cibiyar bincike ta sanar da cewa sun kammala aikin samar da allurar rigakafin kuma a shirye suke su fara gwajin.
Za a iya hana su canza wurin zama a cikin jirgin. A ranar 27 ga Fabrairu, 2020, reshen Generex / NuGenerex Immuno-Oncology ya sanar da fara aikin samar da maganin maganin peptide na Ii-Key akan COVID-19.
Suna son samar da gwajin rigakafin da za a iya gwadawa a kan mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da shirye-shiryen samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Binciken Likitoci da Kayan Aikin Sojojin Amurka da ke Fort Detrick da Cibiyar Nazarin Sojoji ta Walter Reed da ke Silver Spring, dukansu suna cikin Yammacin Maryland, sun sanar da cewa suna kan aikin samar da allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da fara haɗin gwiwa tare da Novavax Inc.
A kan ci gaba da samar da allurar rigakafi.
Abokan hulɗarsu sun ba da ƙarin bayani game da cikakken bincike da gwajin asibiti na matakin I har zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa tana aiki tare da masu zaman kansu 11.
Maris 12, 2020, kamfanin kimiyyar kere kere na Medigo, Quebec, ya ba da rahoton ƙaddamar da wani tsari mai kama da kwayar cutar coronavirus wanda ke da wani ɓangare daga Cibiyoyin Kiwon Lafiya na Kanada.
Ana sa ran a yi gwajin rigakafin a dakin gwaje-gwaje tare da gwajin ɗan adam a watan Yuli ko Agusta 2020.
A farkon wannan makon, Jaridar Guardian ta ruwaito cewa Shugaba Donald Trump na Amurka ya ba da babbar kudin tallafin COVID-19 ga Kürtvög, yayin da gwamnatin Jamus ta yi adawa.
A ranar 17 ga Fabrairu, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da cewa ya kulla kawance da kamfanin BioNTech na Jamus don yin aikin tare kan allurar rigakafin mRNA.
BNT162, wanda ke da damar yin rigakafin mRNA, a halin yanzu yana cikin gwajin farko na asibiti tare da gwajin asibiti da ake tsammanin farawa a watan Afrilu na 2020.
Kamfanin fasahar kere-kere na Italiya, A.T. Italia ya sanar a ranar 17 ga Maris, 2020 cewa za a sami sakamakon gwajin farko na asibiti a watan Afrilu na 2020 kuma za a iya fara gwajin rigakafin su na ƙarshe a kan mutane.
A Faransa, a ranar 19 ga Maris, 2020, Cibiyar Tsaro da Shirye-shiryen Cutar (CEPI) ta saka dala miliyan 4.9 a cikin binciken allurar rigakafin COVID-19, wanda ya haɗa da Institut Pasteur, Themis Biosciences (Vienna, Austria) da Jami'ar Pittsburgh. Ya kai jimillar saka hannun jari na CEPI a cikin allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, masu bincike sun sanar da cewa sun ƙaddamar da alluran rigakafi guda shida don gwaji a kan dabbobi, jami'an kiwon lafiya na Rasha sun ce.
Masu bincike na Kwalejin Imperial London sun sanar a ranar 20 ga Maris, 2020 cewa za su samar da allurar rigakafin RNA mai sarrafa kanta don COVID-19.
An shirya wanda zai yi rigakafin cikin kwanaki 14 bayan an karɓi umarni daga China.
A karshen watan Maris, gwamnatin Kanada ta sanar da cewa za ta tallafa wa ayyukan bincike 96 na gwajin asibiti kan COVID-19, gami da masu neman allurar rigakafi da yawa a kamfanonin Kanada da jami'o'i, kamar gwajin Medicago da Jami'ar Saskatchewan, da dala miliyan 275 na Kanada.
A daidai wannan lokacin, Gwamnatin Kanada ta sanar da cewa ta ware dala miliyan 192 don tallafin COVID-19 kuma ta sanar da cewa Bankin allurar rigakafin kasa zai yi aiki don alluran rigakafi daban-daban don hana sake barkewar cutar coronavirus.
"A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoton cewa an gano yiwuwar gwajin allurar rigakafin PittCoVacc a cikin beraye, kuma sun sanar da cewa ""An gano alamun rigakafin cutar da ke nuna bayyanar cutar SARS-CoV-2 S1 makonni 2 bayan shan allurar rigakafin.
A ranar 16 ga Afrilu, 2020, Kwalejin Magunguna ta Jami'ar Waterloo ta Kanada ta sanar da shirin yin allurar rigakafin cutar ta HIV da za a iya fesawa a hanci.
Ta hanyar amfani da cututtukan kwayoyin cuta, an tsara DNA don yin kwafi a cikin kwayoyin halittar mutum don samar da ƙwayoyin cuta masu kama da ƙwayoyin cuta waɗanda ke motsa tsarin rigakafin jiki don samar da ƙwayoyin cuta ga cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun tattara kudaden shiga don siyan babban kwamfuta daga IBM, wanda ke kawo kayan aikin komputa daga Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako na ɗan lokaci, wanda ake kira sakamako na ɗan lokaci.
Wannan yana nufin cewa suna da amfani fiye da rigakafin cututtuka.
Ana neman ƙarin gwaji na bazuwar a cikin Australia don yin rajistar ma'aikatan kiwon lafiya 4,170.
Ba za a iya amincewa da rigakafin da ake samarwa ba kuma ba zai yi tasiri ba.
Bincike kan ingancin allurar rigakafin samfurin dabbobi da ke da alaƙa da COVID-19, kamar su ACE2 transgenic mice, sauran dabbobi masu gwaji, da sauran berayen da ba na mutum ba, sun nuna cewa akwai buƙatar lokaci don amfani da ƙwayoyin cuta masu rai na matakin 3 da haɗin gwiwar duniya don amfani da ƙa'idodin aminci.
An gwada alluran rigakafin SARS da MERS a cikin samfuran dabbobi waɗanda ba mutane ba.
Har zuwa 2020, babu magani ko rigakafin cutar SARS da aka tabbatar da cewa ba shi da haɗari kuma yana da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a shekarar 2005 da 2006, ganowa da kuma samar da sabbin alluran rigakafi da magunguna da aka tsara don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duniya.
A lokacin bayyanar cutar MERS, ana fatan cewa binciken SARS na yanzu zai iya samar da rigakafin da zai iya taimakawa wajen magance cutar MERS-CoV.
A watan Maris na shekarar 2020, an kammala gwajin gwaji na asibiti na MERS guda daya (wanda ya dogara da DNA), da kuma wasu uku da ake ci gaba da su, dukkansu sun kamu da kwayar cutar, biyu masu daidaitawa (ChAdOx1-MERS, BVRS-GamVac) da kuma daya mai dauke da MVA (MVA-MERS-S).
Bayanan da aka wallafa a shafukan sada zumunta sun haifar da ka'idar makirci da ke nuna cewa akwai kwayar cutar COVID-19 da kuma cewa an riga an gano maganin rigakafin.
Labarai a shafukan sada zumunta daban-daban sun nuna cewa akwai wasu nau'ikan kwayar cutar coronavirus kamar SARS coronavirus da kuma takardun shaida na allurar rigakafi.
Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da ke haifar da cutar cututtukan numfashi mai saurin kamuwa da cuta 2 (SARS-CoV-2).
Alamun da aka saba da su sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Sauran alamun sun hada da gajiya, ciwon tsoka, tashin zuciya, ciwon makogwaro, rashin wari da ciwon ciki.
Lokaci daga kwanaki biyu zuwa goma sha huɗu daga lokacin da aka fara nuna alamun cutar zuwa kwanaki biyar.
Kodayake yawancin lokuta suna haifar da alamun rashin lafiya, an sami ci gaba a cikin cutar huhu da kuma yawancin gabobin jiki.
Ya zuwa ranar 17 ga Afrilu, 2020, an ba da rahoton fiye da miliyan 2.24 daga ƙasashe da yankuna sama da 210, tare da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke daga cutar. Ana yaduwar cutar ta hanyar hulɗa da mutane, yawanci ta hanyar tsotsa, ta hanyar yin taushi, ko kuma ta hanyar magana.
Ana yin wannan saurin sa'ad da mutum ya numfasa kuma sau da yawa yakan sauka a ƙasa ko kuma a jikin mutum maimakon ya yi nisa.
Hakanan mutane na iya auna ta hanyar taɓa ƙasa mai ƙazanta sannan kuma ta taɓa idanunsu, hanci, ko bakinsu.
Kwayar cutar na iya rayuwa har zuwa awanni 72 a cikin busassun wurare.
Yana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya watsa shi kafin bayyanar cututtuka da kuma matakan cutar daga baya (rRT-PCR) daga nasopharyngeal kumburi.
Ana ba da shawarar cewa duk wanda ke da cutar da masu kula da su su sanya abin rufe fuska.
Shawarwarin amfani da abin rufe fuska ga jama'a na iya bambanta, wasu hukumomi suna ba da shawarar yin amfani da shi, wasu kuma suna ba da shawarar yin amfani da shi.
A halin yanzu babu allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An samu yaduwar cutar a duk yankuna shida na Hukumar Lafiya ta Duniya, a mafi yawan yankuna.
Wadanda suka kamu da cutar na iya nuna alamun mura kamar zazzabi, tari, gajiya da kuma rashin numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsin lamba, rikicewa, matsalar motsin rai, da launin shuɗi na fuska ko lebe. Idan waɗannan alamun sun bayyana, ana ba da shawarar a nemi kulawa ta likita nan da nan.
Sau da yawa, ana ganin alamun cututtukan numfashi na sama kamar cizon yatsa, hanci, ko ciwon makogwaro.
Alamun ciwon ciki kamar su tashin zuciya, tari da kuma tari sun bayyana a cikin kashi daban-daban.
A China, an fara gabatar da wasu maganganu ne kawai game da ciwon kirji da nakasa.
A wasu, cutar za ta iya kai wa ga ciwon huhu, ciwon da ke sa mutum ya yi ciwon da ke sa mutum ya yi ciwon da ke sa mutum ya yi ciwon da ke sa mutum ya yi ciwon da ke sa mutum ya yi ciwon.
Wannan shi ne lokacin da za a fara nuna alamun cutar.
Lokacin haifuwa don COVID-19 yawanci kwanaki biyar zuwa shida ne amma yana iya zuwa kwanaki biyu zuwa 14.
Kashi 97.5% na mutanen da ke nuna alamun cutar suna nuna alamun cutar cikin kwanaki 11.5 daga ranar kamuwa da cutar.
Ba a san cikakken matsayin wadannan masu dauke da cutar ba a yaduwar cutar, amma, kamar yadda shaidar farko ta nuna, suna iya taimakawa wajen yaduwar cutar.
Ba a san adadin mutanen da ke dauke da cutar ba tare da nuna alamun cutar ba kuma ana ci gaba da bincike, yayin da Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Koriya (KCDC) suka ba da rahoton cewa kashi 20 cikin ɗari na waɗanda aka tabbatar da su ba a gano su ba yayin da suke asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta sanya wasu shari'o'i na farko a matsayin masu zaman kansu, ciki har da wadanda suka kamu da cutar a ranar 1 ga Afrilu. 130 (78%) na kamuwa da cutar 166 a wannan ranar sun kasance iri ɗaya a lokacin gwaji.
Dukansu acta da amphora na iya ɗaukar nauyin kwayar cutar.
Yin magana da babbar murya yana sa mutum ya yi ɗumi fiye da yadda yake yi.
Wani bincike da aka yi a Singapore ya nuna cewa idan ba a rufe hancin mutum ba, zai iya sa ɗigon ruwa ya kai tsawon mita 4.5 (mita 15).
Ko da yake cutar ba ta da iska, National Academy of Sciences ta ce ana iya watsa bioraerosol kuma masu tattara iska suna ba da sakamako mai kyau ga RNA na kwayar cutar a cikin hanyar da ke bayan jikin mutum.
Wasu hanyoyin kiwon lafiya, kamar su yin kwankwasawa da kuma yin amfani da maganin zuciya (CPR), suna iya sa numfashi ya shiga cikin iska kuma ya yi yawo a cikin iska.
A lokacin da mutane suke nuna alamun cutar, kwayar tana da saurin yaɗuwa. Duk da haka, cutar tana iya yaɗuwa kafin a nuna alamun cutar, amma ba ta da haɗari sosai.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce, ba a bayyana yadda sauƙin cutar ke yaduwa ba, amma mutum ɗaya yana iya cutar da mutane biyu zuwa uku.
Musamman, an gano kwayar cutar a cikin kwali har zuwa kwana ɗaya, a cikin filastik (polyvinyl acetate) da bakin karfe (AISI 304) da kuma jan ƙarfe har zuwa kashi 99% na tsawon awanni huɗu.
Koyaya, wannan ya bambanta dangane da zafi da zafin jiki.
Sabulu da kayan wankewa ma suna da tasiri idan aka yi amfani da su daidai. Samfuran sabulu suna lalata, lalata, da kuma kawar da fatar rigakafin kwayar cutar daga fata da sauran abubuwa.
Sauran magunguna kamar su benzalkonium chloride da clohehydidine gluconate (mai hana tiyata) ba su da tasiri. A cikin binciken Hong Kong, an ɗauki samfurori na matsakaici na kwanaki biyu bayan fara asibiti.
Daga cikin marasa lafiya shida, samfurin farko cikin biyar ya nuna mafi girman kwayar cutar, kuma na shida ya nuna mafi girman kwayar cutar a ranar da aka gwada mai haƙuri a rana ta biyu.
Cutar numfashi mai saurin gaske Coronavirus 2 (SARS-CoV-2) wani sabon kwayar cutar numfashi mai saurin gaske, wanda aka fara ganowa a cikin mutane uku da ke fama da cutar numfashi mai saurin gaske a cikin ruwa, wanda ke da alaƙa da ciwon huhu.
Dukkanin halayen kwayar cutar SARS-CoV-2 na faruwa ne a cikin coronaviruses masu alaƙa da yanayi.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke karya murfin rigakafin. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Fuka-fukan mutane ne masu saukin kamuwa da cutar COVID-19, saboda kwayar cutar tana kaiwa ga kwayoyin da ke dauke da cutar ta hanyar enzyme na 2 (ACE2), wanda shine mafi yawan kwayoyin alveolar II a cikin huhu.
Kwayar cutar tana amfani da wani takamaiman takarda / kwayar halitta mai suna "peplomer" don haɗuwa da ACE2 da shiga cikin ƙwayoyin mai masaukin baki.
Cutar zuciya ta gaggawa a asibiti a Wuhan, China, kashi 12 cikin dari na waɗanda suka kamu da cutar sun kamu da cutar sau da yawa.
Alamar zuciya tana da ƙarfi saboda amsawar kumburi na tsarin da matsalolin tsarin rigakafi yayin ci gaban cutar, amma lalacewar myocardial mai tsanani tana da alaƙa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna bayyana sosai a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An gano yawan jini mai jini (31%) da kuma jini mai jini (25%) a cikin marasa lafiya na ECI tare da kamuwa da COVID-19, kuma ana iya danganta su da post-prostate.
Kodayake SARS-COV-2 yana da tasiri ga ƙwayoyin numfashi waɗanda ke bayyana ACE2 don bayyana yanayin numfashi, marasa lafiya da ke da mummunan COVID-19 suna da alamun cutar hawan jini.
Musamman, an nuna cewa kwayoyin T-cell na GM-CSF-masu ɓoyewa suna da alaƙa da fashewar ɓoye na In-6 a cikin marasa lafiya na COVID-19 da kuma haɗuwa da cututtukan huhu masu tsanani.
An kuma bayar da rahoton kamuwa da cutar lymphocytic a binciken gawa.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji na cutar.
Hanyar gwajin ita ce amsa sarkar polymerase mai rikitarwa (rRT-PCR).
Ana yin gwajin ne a kan samfurin numfashi da aka ɗauka da nasopharyngeal swab. Amma ana iya yin amfani da kumburi ko kuma samfurin acta.
Sakamakon zai kasance a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya amfani da gwaje-gwajen jini, amma ana buƙatar samfuran jini biyu a cikin makonni biyu kuma sakamakon ba shi da mahimmanci.
Masana kimiyya na kasar Sin sun gano cutar coronavirus kuma sun buga jerin kwayoyin domin dakunan gwaje-gwaje a duniya su samar da gwajin polymerase chain reaction (PCR) don gano wadanda suka kamu da cutar.
Tun daga ranar 4 ga Afrilu, 2020, ana ci gaba da yin gwajin rigakafin cutar (wanda zai iya gano cututtukan da ke aiki kuma idan mutum yana da cutar a baya), amma har yanzu ba a yi amfani da su sosai ba.
Kwarewar Sinawa a aikin bincike ya nuna cewa kashi 60 zuwa 70% ne kawai suka dace.
FDA a Amurka ta amince da gwajin farko-ci gaba-bincike a ranar 21 ga Maris, 2020, a ƙarshen watan. Jagororin gwajin da aka fitar a asibitin Zongnan na Jami'ar Hafen sun ba da shawarar hanyoyin gano cututtuka bisa ga halayen asibiti da haɗarin mura.
Rashin ruwa na biyu da ke da gilashi da gilashi da ke da tushe, asali da kuma watsawa na baya sun fi yawa a cikin kamuwa da cuta na baya.
Ana iya ganin ƙananan ƙwayoyin cuta, kumburi mai tsanani (da kuma ƙarancin ƙwayar ƙwayar ƙwayar cuta tare da cikawar alveolar), da kuma ƙaruwa yayin da cutar ke ci gaba.
Akwai karancin bayanai game da ƙananan raunuka da kuma yanayin canjin da ke haifar da cutar COVID-19.
Babban binciken cututtuka na jikin gawa:
Macrocopy-pleurisy, pericarditis, ƙuƙwalwar huhu, da kuma kumburi na huhu
Za a iya gano nau'o'in cutar huhu guda hudu:
Ƙananan ciwon huhu: ciwon huhu, ciwon huhu mai yawa, cututtukan da ke saurin kamuwa da cuta, ciwon daji na lymphocytic, da kuma babban ƙwayoyin cuta da ke tsakiya
Cutar huhu mai tsanani: lalacewar alveolar (DAD) tare da yaduwar alveolar axis.
DAD na iya haifar da ciwon numfashi mai tsanani (ARDS) da kuma rashin lafiya mai tsanani.
Warkar da ciwon huhu: Yana fallasa cikin tsakiyar fibrosis tsakanin alveolar pores da huhu
Jini: rarrabawar jini cikin jijiyoyin jini (DIC); halayen leukoerythroblastic
Matakan kariya na rage yiwuwar kamuwa da cutar sun hada da zama a gida, guje wa wuraren taruwa, wanke hannu da sabulu da ruwa na akalla sakan 20, da kuma kiyaye tsaftacewar numfashi mai kyau da kuma gujewa taɓa idanu, hanci ko hanci da hannaye marasa wanke.
CDC ta ba da shawarar rufe baki da hanci da sutura yayin numfashi ko yin amai da kuma amfani da sutura a ciki idan ba a yi sutura ba.
Ana ba da shawarar tsabtace hannu sosai bayan duk wani tari ko tari.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a don rage yaduwar cutar idan mutum yana da cutar. Dabarun nisantar jama'a sune dabarun rage hulɗa tsakanin manyan ƙungiyoyin mutane masu cutar ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiye-tafiye, da soke manyan tarurrukan jama'a.
Dokokin nesa sun haɗa da nisantar mutane da nisan akalla ƙafa shida (1.8).
"Babu wani magani da aka sani da zai iya hana COVID-19, kuma ba a sa ran samun allurar rigakafin har zuwa 2021, wani muhimmin bangare na gudanar da COVID-19 shine ƙoƙarin rage barkewar cutar, wanda aka sani da ""rage yaduwar kwayar cutar"".
CDC ta kuma ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na akalla sakan 20, musamman bayan sun je bayan gida ko kuma idan hannayensu sun kasance da datti, kafin su taɓa hanci da hancin su, ko kafin su ci abinci da kuma bayan sun ci abinci.
WHO ta ba da shawarar yin amfani da wanke hannu mai dauke da barasa wanda ya ƙunshi aƙalla kashi 60% na barasa, kawai idan sabulu da ruwa ba su da sauƙi.
A cikin waɗannan ƙwayoyin, ana samun maganin rigakafi daga ethanol ko isosopropanol.
Hydrogen peroxide shine abin da ake amfani dashi don kawar da ƙwayoyin cuta a cikin giya; ba shine mai aiki na maganin antiseptic na hannu ba.
An ƙara glycerol a matsayin mai ɗumi.
Mutane suna yin hakan ta hanyar tallafi na kuɗi wanda zai iya haɗa da maganin ruwa, tallafin oxygen, da sauran sassan jiki masu mahimmanci da tallafi.
CDC ta ba da shawarar cewa duk wanda ke da tabbacin cewa yana da kwayar cutar ya sa abin rufe fuska mai sauƙi.
An yi amfani da maganin maganin oxygen na EFROACLOR (ECMO) don magance matsalar numfashi amma har yanzu ana ganin fa'idodi.
Ana ba da shawarar tsabtace mutum da salon rayuwa mai kyau da abinci don inganta rigakafin cutar.
Magungunan tallafi na iya zama da amfani ga mutanen da ke da alamun rashin lafiya a farkon matakin cutar. Hukumar Lafiya ta Duniya da Hukumar Lafiya ta China sun ba da shawarwari don kula da mutanen da ke asibiti a cikin COVID-19.
Likitocin marasa lafiya da likitocin numfashi a Amurka sun yi biyayya da shawarwarin likitoci daga hukumomi daban-daban don amfani da IBCC, tushen bayanan kyauta.
Har zuwa watan Afrilu na 2020, babu wani magani na musamman don COVID-19.
Don gwaji, wasu likitocin sun ba da shawarar yin amfani da papetamol (acumammonoin) a matsayin abuprofen don amfani da layi na farko.
Ya kamata a yi taka tsantsan don rage haɗarin yaduwar kwayar cutar yayin aiwatar da hanyoyin samar da iska, kamar su inhalation ko numfashi na hannu.
Kwararrun masu kula da lafiyar da ke kula da mutane da COVID-19 CDC ta ba da shawarar cewa mutum ya yi amfani da matakan tsaro na yau da kullun, matakan kariya, da matakan tsaro na iska, kuma ya sanya mutum a cikin Rukunin Tserewa Cutar Cutar Cutar Cutar (IIR).
Abin da ake so: tufafin PPE, kayan numfashi ko abin rufe fuska, abin rufe ido da safofin hannu. Idan akwai, ana so a yi amfani da kayan numfashi (maimakon abin rufe fuska).
An amince da masu numfashi na N95 don saitunan masana'antu amma FDA ta amince da su a matsayin abin rufe fuska don amfani a ƙarƙashin lasisin amfani da gaggawa (EUA).
An tsara su don karewa daga ƙwayoyin iska, kamar ƙura, amma ba a ba da tabbacin inganci a kan takamaiman wakili na halitta don amfani da shi ba tare da bayanin samfurin ba.
CDC ta ba da shawarar yin amfani da abin rufe fuska ko yin amfani da abin rufe fuska na gida a matsayin zaɓi na ƙarshe idan ba a sami abin rufe fuska ba.
Yawancin raunin COVID-19 ba su da tsanani kamar yadda ake buƙatar iska mai iska ko madadin, amma ƙananan raunin suna da tsanani.
Ana nazarin nau'ikan numfashi na mutane masu fama da cutar COVID-19 a cikin asibiti, wanda za a iya kawar da cutar ta hanyar yawan hanci ko matsin lamba mai kyau na iska.
Ba a san ko waɗannan sunadarai biyu suna da amfani iri ɗaya ga marasa lafiya masu ciwo mai tsanani ba.
Wasu likitoci suna amfani da na'urar numfashi mai aiki da gas a lokacin da suke wurin domin na'urar numfashi tana hana iska ta shiga cikin jiki fiye da na'urar numfashi mai ƙarfi.
Yawancin ƙasashe masu tasowa ba su da isasshen gadajen asibiti a kowane mutum, wanda ya haifar da ƙaruwar adadin marasa lafiya masu cutar COVID-19 da ke buƙatar asibiti, wanda ya hana tsarin kiwon lafiya kula da su.
Wani bincike a kasar Sin ya nuna cewa kashi 5% na marasa lafiya sun shiga sashen kula da marasa lafiya, kashi 2.3% na bukatar taimakon numfashi, kuma kashi 1.4% sun mutu.
Kashi 30% na mutanen da ke asibiti da COVID-19 a China suna shiga ICU.
Lokacin da cutar ta COVID-19 ta haifar da ciwon ciwon numfashi mai saurin motsa jiki (ARDS) kuma yana da wuya a sami iskar oxygen, iska ta zahiri ta zama mai rikitarwa.
Ana buƙatar masu numfashi waɗanda ke ƙara yanayin sarrafa iska da PEEP mai ƙarfi don haɓaka isar da iskar oxygen yayin rage haɗarin lalacewar huhu da cututtukan huhu.
Ba a gano PEEP mai yawa a kan na'urorin iska masu iska.
An fara binciken hanyoyin da za a iya bi da cutar a watan Janairun 2020, kuma ana gudanar da gwajin magungunan rigakafin cutar a asibiti.
Remdesivir yana da kyakkyawan fata.
Kodayake ana iya ɗaukar har zuwa 2021 don haɓaka sabbin magunguna, yawancin magungunan da za a gwada sun riga an amince da su don sauran amfani ko kuma suna cikin babban gwaji.
Ana iya gwada maganin rigakafin cutar a kan mutanen da ke da ciwo mai tsanani.
Hukumar Lafiya ta Duniya ta ba da shawarar shiga cikin gwajin inganci da aminci na hanyoyin magani tare da masu sa kai da kuma yiwuwar tasiri. FDA ta ba da izinin FDA na ɗan lokaci don yin bincike a lokacin da rayuwar mutum ke cikin haɗari mai tsanani ko haɗari kai tsaye.
Ba a bincika nazarin asibiti da ake buƙata don tabbatar da amincinsa da ingancinsa ga cutar ba.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da manhajar wayar salula domin magance annobar.
Ana buƙatar masu amfani su shigar da sunayensu da lambar ID.
Aikace-aikacen na iya gano 'saduwa ta kusa' ta amfani da bayanan leken asiri, don haka gano yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya bincika wasu masu amfani uku.
Idan aka gano wani hatsari, app ɗin zai faɗakar da masu kula da lafiyar yankin ba kawai game da keɓe kai ba, ana amfani da nazarin fuska a kan bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu da kuma ilimin kere kere don bin diddigin mutanen da ke da cutar. An gano a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da damar jami'an tsaro su lura da bayanan wayar salula na mutanen da ake zargin suna da cutar coronavirus.
An dauki matakai don ganowa da kare wadanda zasu iya hulɗa da 'yan ƙasa masu kamuwa da cutar.
Bugu da kari, a watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanai kan inda wayar take da kuma hukumar gwamnatin tarayya ta Jamus, Robert Koch Institute, don ganowa da kuma hana yaduwar cutar.
Rasha ta tura fasahar gano fuska don gano wadanda ke tserewa daga keɓewa.
Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce, 40% na mutane sun ci gaba da tafiya ta kowace hanya, kamar yadda masu samar da wayar hannu suka sanar.
Gwamnatin Jamus ta gudanar da bincike na tsawon sa'o'i 48 a karshen mako tare da mahalarta sama da 42,000.
Shugaban Estonia Kersti Kaljulaid ya kuma yi kira ga kasashen duniya da su samar da sabbin hanyoyin magance yaduwar cutar korona.
Mutane suna iya fuskantar haɗarin ware kansu, hana su tafiya, da kuma sakamakon jinya ko kuma kamuwa da cutar.
BBC ta ruwaito Rory O'Connor cewa "rashin zaman lafiya, kadaici, rashin lafiya, damuwa da kuma koma bayan tattalin arziki sune cikakkun raƙuman ruwa da ke cutar da lafiyar kwakwalwa da lafiyar mutane".
Alamar da ke kama da wasu cututtukan numfashi na yau da kullun, kamar su mura, na iya zama mai sauƙi ba tare da bayyanar cututtuka ba.
Masu rashin lafiya sukan warke cikin makonni biyu, amma masu ciwo mai tsanani suna iya ɗaukar makonni uku zuwa shida.
Mata masu juna biyu na iya samun cutar COVID-19 mai tsanani dangane da wasu ƙwayoyin cuta kamar SARS da MERS, amma akwai ƙarancin bayanai game da COVID-19. A cikin wasu mutane, COVID-19 na iya kai hari kan huhu kuma ya haifar da ciwon huhu.
A cikin mutanen da cutar ta fi shafa, COVID-19 na iya haifar da saurin numfashi, rashin ƙarfi ko kuma rashin ƙarfi na jiki zuwa ciwon numfashi mai saurin kamuwa da cuta (ARDS).
Matsalar COVID-19 ta hada da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Magungunan rashin lafiya, musamman ma karuwar ƙwayar prostate, sun kasance kashi 6% na waɗanda aka kwantar da su a asibiti dangane da COVID-19, kuma aikin koda mara kyau ya bayyana a kashi 4% na wannan rukunin.
Kimanin kashi 20 zuwa 30% na mutanen da ke fuskantar COVID-19 suna nuna ƙwayoyin hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki goma, daga cikinsu biyar ana kwantar da su a asibiti.
Duk da haka, marasa lafiya da aka tura zuwa ICU suna da matsakaicin lokaci tsakanin asibiti da mutuwa na kwanaki bakwai.
A cikin binciken da aka yi a baya, yanayin ya kasance kusan kwanaki 14 daga tsakiyar bayyanar cututtuka na farko zuwa mutuwa, tsakanin kwanaki shida zuwa 41.
Wani bincike da Hukumar Lafiya ta kasar Sin (NHC) ta gudanar ya nuna cewa mace-macen maza sun karu da kashi 2.8 cikin dari, yayin da mace ta karu da kashi 1.7 cikin dari.
Binciken binciken tarihi na samfurori na huhu bayan mutuwa ya nuna fibroxide na hannu a cikin huhu biyu, tare da lalacewar Alveolar.
An gano canje-canje na kwayar cutar cytopathic a cikin ƙwayoyin cuta.
Hoton huhu yana kama da cutar rashin numfashi mai saurin tashi (ARDS).
Hukumar Lafiya ta kasar Sin ta ce, kashi 11.8% na mutuwar da aka ruwaito, cututtukan zuciya ne suka haifar da cutar ropponin ko kuma ciwon zuciya.
A cewar bayanai daga Amurka a watan Maris, kashi 89 cikin dari na mutanen da aka kwantar a asibiti suna da cututtuka na farko. Samun kayan aikin likita na iya shafar zamantakewar tattalin arziki da mutuwa na yankin.
Mutuwa ta bambanta bisa ga yanayin saboda waɗannan bambance-bambance na yanki, amma kuma saboda matsalolin siyasa.
Idan aka yi la'akari da ƙananan abubuwa, za a iya samun adadi mai yawa na mutuwar.
Amma, an rage yawan mutuwar yanzu saboda an yi la'akari da cewa mutuwar ta faru ne saboda abubuwan da suka faru a baya.
Masu shan sigari sun fi sau 1.4 na masu cutar COVID-19 kuma suna iya buƙatar kulawa mai tsanani, ko kuma kusan sau 2.4, idan aka kwatanta da masu shan sigari. An yi damuwa game da tsawon lokacin cutar.
Jami'an asibiti a Hong Kong sun tabbatar da cewa wasu daga cikin mutanen da suka warke sun sami raguwar karfin huhu daga kashi 20 zuwa 30 cikin dari, kuma an gano lalacewar sassan jikin su ta hanyar binciken hoto.
Wannan na iya haifar da alamun rashin lafiya bayan kulawa mai tsanani bayan warkewa.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar da ta gabata tana ba da damar samun nasarar ci gaba da tsawon lokaci a cikin mutanen da suka warke daga cutar ba.
An lura da yanayin kamuwa da cutar dangane da halayen wasu coronavirus, amma daga baya an ba da rahoton cewa an gwada tabbatacce ga coronavirus bayan warkewa daga COVID-19.
An yi imanin cewa maimakon a sake magance waɗannan batutuwan, cutar za ta ci gaba da ƙaruwa.
Ana ganin cewa kwayar cutar ta samo asali ne daga dabbobi ta hanyar kamuwa da cuta da aka samar da kuma yaduwa.
Ba a san ainihin asalin cutar ba, amma a watan Disamba na 2019, za a iya samun yaduwar cutar daga mutum zuwa mutum.
Nazarin farko na 41 da aka tabbatar da cutar COVID-19 wanda aka buga a cikin Janairu 2020, ya nuna ranar farko ta bayyanar cututtuka shine 1 ga Disamba, 2019.
Hukumar Lafiya ta Duniya ta ba da rahoton alamun farko na cutar tun daga ranar 8 ga Disamba, 2019.
An dauki matakai daban-daban tare don auna yawan mutuwar.
Wadannan lambobin sun bambanta ta yanki da lokaci kuma suna tasiri kan girman gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, farkon barkewar cutar, da halayen jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
A ƙarshen 2019, an ba da lambar ICD-10 ta gaggawa ta mutuwar da ke tattare da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje, U07.1, da kuma lambar U07.2 a cikin gwajin COVID-19 wanda ke nazarin asibiti ko cututtuka masu alaƙa da cutar SARS-CoV-2 da aka tabbatar ba tare da dakin gwaje-gwaje ba.
A cewar kididdigar Jami'ar Johns Hopkins, mutuwar duniya tun daga ranar 17 ga Afrilu, 2020 ya kai kashi 6.9% (153,822/ 2,240,191).
Sauran matakan sun hada da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da suka mutu daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), yawan mutanen da suka kamu da cutar (waɗanda aka warkar da waɗanda ba a warkar da su ba).
Kuma ba a kiyaye waɗannan ƙididdigar har zuwa lokacin da za a yanke shawarar ƙayyade mutane daga allurar rigakafi.
Ko da yake ba duka mutane da suka kamu da cutar ba ne ke da tsarin rigakafi, amma kasancewar tsarin rigakafi na iya ba da bayanin yawan mutanen da suka kamu da cutar.
A Castiglione d'Adda, wani karamin ƙauye mai mutane 4,600, wanda shine cibiyar annobar a Italiya, mutane 80 (1.7%) sun mutu.
A Gangelt, cutar ta yadu a wurin bikin bikin Carnival, kuma ta haifar da ƙananan mutuwar, kuma ta bazu ga matasa, wanda ke haifar da yiwuwar duk mutuwar COVID-19 ba a rarraba su ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai wuce gona da iri ba.
An kiyasta cewa kashi 3% na masu ba da gudummawar jini a Netherlands suna da rigakafi.
An tabbatar da mutuwar mutane 69 (0.004% na yawan jama'a) daga COVID-19.
Tasirin cutar da yawan mace-macen sun bambanta ga maza da mata.
A cikin binciken da aka yi a China da Italiya, adadin mutuwar ya fi girma.
Mafi yawan hadarin maza suna cikin shekaru 50, kuma bambancin tsakanin maza da mata kusan kusan 90 ne.
A ƙasar Sin, maza sun mutu kashi 2.8 cikin ɗari, mata kuma kashi 1.7 cikin ɗari.
Ba a san ainihin dalilan da ke haifar da wannan bambancin jinsi ba, amma za a iya cewa launin fata da halayyar mutum suna da hannu.
"A cikin bambancin da ke tsakanin jima'i, shan sigari, kamar ƙananan hawan jini, na iya haifar da ƙarin mutuwar maza fiye da mata".
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne, kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu na 2020, gwamnatin Amurka tana bin diddigin bayanan batsa da suka shafi kamuwa da cutar COVID-19.
Bincike ya nuna cewa cututtuka kamar Ebola, HIV, mura da SARS sun bambanta tsakanin maza da mata.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya mata ne kuma suna cikin babban hadarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta bayyana sunan cutar a ranar 11 ga Fabrairu, 2020.
A cewar babban daraktan Hukumar Lafiya ta Duniya Theodore Adhanom Ghebreyesus, cutar carbon corona, cutar da aka gano a karon farko, ta kamu da cutar, kuma ta kamu da mutane 19 a ranar 31 ga Disamba, 2019.
Don hana nuna bambanci, an zaɓi sunan daidai da shawarwarin duniya don kauce wa magana da wani yanki na musamman (misali China), nau'in dabbobi, ko rukunin mutane. Kwayar cutar da ke haifar da COVID-19 ana kiranta cutar rashin numfashi mai tsanani 2 (SARS-CoV-2).
Hukumar Lafiya ta Duniya ta kuma yi amfani da kalmomin COVID-19 da kuma cutar da ke haifar da COVID-19 a cikin hanyoyin sadarwa na hukuma.
"An fi kiran cutar da kwayar cutar ""coronavirus"".
An fi kiran kwayar cutar da cutar coronavirus da Wuhan coronavirus, inda aka fara gano ta a Wuhan, China.
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da sunayen wucin gadi don ƙwayoyin cuta da cuta bisa ga jagorar ta 2015 game da amfani da wuraren a cikin sunayen ƙwayoyin cuta da ƙwayoyin cuta na cutar 2020-nCov da 2019-nCoV.
An sake sanya sunan COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iyawa a cikin sarkar samar da kayayyaki na yau da kullun, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su hanci da kuma kayan aikin iska.
A wani misali, asibitin Italiya yana buƙatar bawul ɗin iska na gaggawa kuma mai ba da sabis ɗin ya iya samar da shi a cikin adadin lokacin da ake buƙata, sai mai aikin jinya na gida ya buga bawul ɗin 100 a rana ɗaya, wanda ya buƙaci dare ɗaya.
Tun bayan barkewar COVID-19, asalin cutar, sikelin, rigakafi, magani da sauran fannoni da bayanai sun bazu cikin sauri ta yanar gizo.
Mutane na iya yada kwayar cutar zuwa wasu dabbobi.
Binciken bai sami wata hujja ta kwayar cutar a aladu, ducks da kaji ba.
Akwai magani ko kuma rigakafi da za a iya yi wa wannan cuta.
Ana gudanar da bincike na duniya kan alluran rigakafi da magunguna kan COVID-19 ta hukumomin gwamnati, kungiyoyin ilimi da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta kafa gwajin Solidarity don kimanta sakamakon maganin sunadarai huɗu na riga -kafi da ke da alƙawarin tasiri sosai.
Babu allurar rigakafi amma hukumomi daban-daban suna haɓaka masu neman allurar rigakafi.
SARS-CoV da SARS-CoV-2 sun riga sun yi amfani da su a SARS-CoV saboda dukansu suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin cuta.
Akwai hanyoyin rigakafi guda uku da ake bincike a kai.
Da farko, masu bincike suna da burin samar da maganin rigakafin cutar gaba ɗaya.
Amfani da wannan nau'in kwayar cutar, mai aiki ko mutu, don rage rigakafin jikin mutum a cikin martani ga sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafi, shine ƙirƙirar allurar rigakafi wacce ke sa ido kan tsarin rigakafin wasu ƙananan ɓangarorin kwayar cutar.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya mai da hankali ne kan furotin S-spike wanda ke taimakawa kwayar cutar ta shawo kan mai karɓar enzyme ACE2.
Hanya ta uku ita ce yin allurar rigakafin nucleic acid (wani sabon tsari na yin allurar rigakafin DNA ko RNA).
A cikin waɗannan hanyoyin, dole ne a gwada alluran rigakafin gwaji don aminci da tasiri. A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko a kan masu sa kai huɗu a Seattle.
Allurar rigakafin ta ƙunshi lambar kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An gabatar da shi azaman ingantaccen maganin rigakafin cutar da ke da haɗari don shirya allurar rigakafin SARS-COV-2, amma wannan ya kasance mai rikitarwa.
Fiye da gwaji na asibiti 300 suna gudana tun daga watan Afrilu na 2020.
Ana nazarin magungunan da aka amince da su na cutar zazzabin cizon sauro, ciki har da gwaje-gwaje huɗu da aka amince da su, ciki har da bakwai na hydrochlorquine ko chloroquine.
Yawancin magungunan rigakafin cutar da aka sake amfani da su sun kasance bincike na kasar Sin, wanda aka ruwaito a ƙarshen Afrilu a cikin tara na gwaji na babi na III a ƙasashe da yawa.
Ya zuwa watan Afrilu na 2020, an gudanar da wani bita mai tsauri kan ci gaban asibiti na allurar rigakafin COVID-19 da kuma magungunan da ake son a yi. An sake nazarin magungunan rigakafin cutar da yawa da ake da su na maganin COVID-19 tare da maganin Reflovir, chloroquine da hydrochloroquine, lopevia/rutanavir da lopenavir/rudonavir tare da interferon beta.
Akwai tabbaci mai mahimmanci game da tasirin rage farashin har zuwa Maris 2020.
An ga ci gaba a asibiti a cikin marasa lafiya da aka yi amfani da maganin tausayi.
Ana gudanar da gwajin asibiti na mataki na III a Amurka, China da Italiya. Chloroquine, wanda a baya aka yi amfani da shi wajen magance zazzabin cizon sauro, an fara nazarin shi a China a watan Fabrairun 2020.
Koyaya, an yi kira don kimantawa don kimantawar takwarorin bincike.
Hukumomin lafiya na Koriya da China sun ba da shawarar yin amfani da Chloroquine.
Koyaya, Cibiyar Kiwon Lafiyar Kwayoyin cuta ta Wuhan ta ba da shawarar shan gram ɗaya a rana, amma sau biyu na iya zama mai haɗari da kisa.
A ranar 28 ga Maris, 2020, zabin likitocin da ke kula da mutane da COVID-19 sun ba da izinin amfani da gaggawa na hydrochloroquine da chloroxine. Shafin na 7 na jagororin na kasar Sin ya hada da amfani da intervirone, ribavirin ko umfenovirene akan COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban adadin ribavirin don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar yin amfani da Nitazoxanide a matsayin ƙarin a cikin binciken VIVO bayan ya nuna ƙananan ƙarfin ƙarfin SARS-CoV-2. Nazarin ya nuna cewa, babban adadin furotin mai amfani da sinadarin protease serine 2 (TMPRSS2) ta hanyar hulɗa tare da mai karɓar ACE2 yana da mahimmanci don shigar da SARS-CoV-2.
Chloroquine da hydrochloricure tare da ko ba tare da arthromycin ba suna da manyan iyakoki waɗanda ke hana ƙungiyar likitanci kula da waɗannan jiyya ba tare da ƙarin bincike ba. Oseltamivir ba ya ɗaukar SARS-CoV-2 a cikin vitro kuma ba shi da wani sanannen matsayi a cikin maganin COVID-19.
Guguwar Sitokin na iya zama mai rikitarwa a cikin matakan COVID-19 na ƙarshe.
Akwai shaidar cewa hydroxychloroquine na iya samun tasirin anti-cytokine. An haɗa Tocilizumab a cikin jagororin magani na Hukumar Lafiya ta China bayan an kammala karamin bincike.
Ana gudanar da gwajin gwaji na matakin 2 a Italiya bayan da ya nuna sakamako mai kyau a cikin mutane masu fama da cututtuka masu tsanani.
An yi amfani da gwajin jini tare da Sam Fritzstein don gano guguwar toxins, wanda aka yi niyya don magance irin waɗannan ci gaban da ake tsammanin suna haifar da mutuwa a cikin waɗanda suka kamu da cutar.
An amince da FDA bisa ga binciken da ya danganci dawo da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Har zuwa yau, babu wani bincike da aka yi a hankali, wanda aka yi amfani da shi don tabbatar da cewa maganin toshewar yana da tasiri ga CRS.
Ana nazarin kwayoyin rigakafin da mutanen da suka warke daga COVID-19 suka samar a matsayin hanyar da za a ba da shawarar yin allurar rigakafi ga mutanen da ke buƙatar tsararru da kuma adana kwayoyin rigakafi.
Wannan dabarar ta haifar da sakamako mara kyau ga kwarewar SARS.
An yi niyyar yin amfani da maganin rigakafi mai zaman kansa wanda zai iya zama matsakaici ga rigakafin cutar SARS-CoV-2.
Koyaya, akwai wasu hanyoyin da zasu yiwu, kamar su anti-dependent cellular cytotoxic da / ko fungio-toto.
Wasu hanyoyin maganin rigakafin cutar na kai tsaye, misali, amfani da kwayoyin halitta masu amfani da sinadarin monoclonal, suna cikin ƙarancin.
Samfurin kwayar cutar, wanda shine wani ɓangare na jini na marasa lafiya da suka dawo daga cutar, wanda ke dauke da kwayoyin cutar da aka gano don cutar, na iya haɓaka don saurin turawa.
Cutar Coronavirus, Ciwon Da Ya Dace Da Ita
Li Wenliang, likita, ya mutu sakamakon kamuwa da cutar COVID-19 bayan ya wayar da kan jama'a game da yaduwar cutar a asibitin Wuhan.
